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The acquisition of renogenic competence (the ability to give rise to kidney) during 
embryonic development is not yet fully understood. Clarifying the temporal and 
molecular aspects of this process is equally essential for understanding excretory system 
development and for devising methods for successful differentiation of embryonic stem 
cells (ESCs) to renal cells for disease modeling, toxicology screening and potential cell 
replacement therapies. 
 
In embryo development, the metanephric (permanent) kidney arises as a result of 
inductive interactions between two embryonic structures that arise in the intermediate 
mesoderm - the ureteric bud (UB, a diverticulum of the Wolffian duct) and the 
metanephric mesenchyme (MM). The UB develops into the collecting duct system and 
the MM undergoes an epithelial-to-mesenchymal transition to form the secretory units of 
the kidney - the nephrons. 
 
In this thesis, I used a tissue disaggregation-reaggregation method that allows the 
reconstruction of mouse organotypic kidney rudiments to place different embryonic cells 
in the environment of a developing kidney and assess their potential to integrate into 
kidney epithelia and differentiate to renal cells. First, the suitability of this method was 
evaluated and a quantitative assay for evaluating the numbers of test cells integrating 
in various renal compartments was developed. Second, the reaggregation method 
was used to characterise the renogenic potential of undifferentiated mouse ESCs, 
ESC-derived cells after Notch inhibition, and cells derived from the presumptive 
nephrogenic regions of embryos at various stages of development. 
 
ESCs are isolated from the inner cell mass of an embryo and have the potential to 
differentiate to any tissue of the body when injected into mouse blastocysts. Strategies 
have successfully been devised for ESC differentiation to many lineages, but very few 
studies reported any success with the differentiation of ESCs to a renal lineage. 
 
Undifferentiated ESCs showed a very good ability to form chimeric structures with 
developing kidney tubules (both nephrons and extending UBs). Nevertheless, the 
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resulting structures were morphologically different from renal epithelia in most cases 
and integrated ESC-derived cells were not positive for several combinations of kidney 
markers. These results suggested that the influence of the niche was not sufficient for a 
successful ESC differentiation to renal cells. Treatment of ESC with an inhibitor of the 
Notch pathway to increase the proportion of mesodermal cells did not improve this 
outcome. On the basis of these results, it was speculated that the earliest lineage to which 
embryonic stem cells must be differentiated in order to become competent to make renal 
cells should first be identified. I addressed this by determining the developmental stage 
at which cells able to contribute to the formation of metanephric epithelia first appear in 
mouse embryo development. When mixed in embryonic kidney reaggregates labelled 
cells isolated from the nephrogenic regions of E9.5 embryos integrated into various renal 
compartments. These cells were seen in UBs, nephrons, glomeruli and the condensing 
mesenchyme. Marker expression studies showed that the exogenous E9.5 cells expressed 
an array of kidney markers - Pax2 in renal epithelia and the condensing mesenchyme, 
Wt1 in glomeruli and Six2 in the condensing mesenchyme. Furthermore, exogenous 
E9.5 cells also co-expressed Pax2/Wt1 in the condensing mesenchyme, Megalin/E-
cadherin in the proximal tubule and Pax2/E-cadherin in renal epithelia. This provides 
evidence that challenges the existing model and suggests that some cells from the 
intermediate mesoderm at a stage where the metanephric blastema is yet formed are 
competent to contribute to kidney structures. Furthermore, experiments with E8.5 
embryos showed that such a renocompetence could be acquired even before the 
specification of intermediate mesoderm.  
 
These findings contribute to our knowledge about kidney cell specification and provide 
valuable information to guide future attempts to develop an efficient method for deriving 
renal cells from ESCs. Furthermore, the reported ability of ESC-derived non-kidney 
cells to form chimeric structures with renal tubules provides a proof-of-principle that it 
might be possible to use exogenous types of cells for physiological support to injured 
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 2
1.1 Aims 
The focus of this thesis is on understanding more about the process of how cells 
acquire a renal fate in vivo and in vitro. This problem has been approached from two 
very different angles - trying to understand how embryonic stem cells (ESC) can be 
differentiated into renal cells and looking at early embryo development to dissect 
how and when this process happens in vitro. 
 
The aim of the former approach, which targets ESC differentiation, is to investigate 
whether these cells can differentiate into renal cells when subjected to the 
environment of a developing embryonic kidney rudiment, at the stage where 
nephrogenic processes are just starting to define the morphology of the kidney. 
Furthermore, it is important to see how pre-differentiation of ESCs compares to 
using undifferentiated cells, still in combination with exposing the test cells to the 
inductive signals present in the embryonic kidney. As discussed more extensively in 
section 1.6.2, the differentiation of pluripotent cells to kidney cells has not been well 
described and the processes and steps taking place have not been characterised.  On 
the basis of previous publications, it becomes clear that much more work is 
necessary to understand these processes. 
 
The aim of the second approach in this work was to find out more about the 
processes naturally occurring in a developing mouse embryo, which are related to the 
production of kidney cells. For example, it would be extremely useful to pinpoint the 
stage in embryonic development where cells acquire competence to produce renal 
cells. This will contribute to understanding the process of lineage specification in the 
embryo. It will also make possible the isolation and possibly propagation of these 
progenitor cells, which would be an extremely valuable tool for studying kidney cell 
specification and stem cell differentiation in vitro. Identification of the first 
developmentally occurring cells, capable of giving rise to kidney cells independently 
of the signals provided by the embryo, would also answer the question of which 
lineage do embryonic stem cells have to be differentiated to, in order to be able to 
produce renal cells efficiently. 
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1.2 Chapter introduction 
As mentioned in the previous section, the main focus of this thesis (in short) is to 
explore the potential of embryonic stem cells to differentiate to kidney cells in 
certain conditions and to investigate when cells in the early embryo acquire 
renogenic capacity. These two aims are a part of a bigger scientific endeavour to 
understand how nature works and devise ways of correcting it when it stops working. 
Since the interlinks between stem cell biology, kidney development and therapeutic 
potential are quite complex, a separate section (section 1.7 of this chapter) was 
dedicated to demonstrating how the work of this thesis is positioned in a more global 
initiative. Before these concepts can be discussed and the results of this work 
examined several different scientific areas need to be introduced – how the kidney 
functions, what developmental processes lead to the formation of a functional kidney 
in embryogenesis, what are embryonic stem cells and their potential applications. 
 
I will start this introduction by providing information about the function and anatomy 
of the kidney as a general overview of the complexity of this organ. Understanding 
these concepts first is a prerequisite to exploring how they come into being. Then, 
important processes of early embryo development will be examined, to clarify the 
origins of the kidney and to demonstrate the complex processes that cells undergo to 
acquire renocompetence.  In this work renocompetence is defined as the ability of 
test cells to give rise to kidney cells in vitro, independently of the signals provided by 
the embryo. Examining some aspects of early embryo development in depth will be 
particularly relevant to Chapter 6 of this thesis, where cell mixing experiments 
containing early embryo cells will be described to assess the renogenic potential of 
these tissues. The focus of embryo development will be narrowed down to the 
formation of mesoderm and intermediate mesoderm, from which the kidneys are 
derived. Furthermore, the specification of the transient embryonic kidneys, the 
pronephros and mesonephros will be described prior to that of the permanent 
metanephros. Since the first two are formed earlier, this information will be 
especially important when discussing the cell mixing experiments mentioned above 
to study the acquisition of renogenic potential of early embryo tissues. This will be 
followed by an introduction of the metanephros and the morphogenetic and 
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regulatory processes that allow its development to a fully functional kidney after the 
completion of embryo development. Then, a transition will be made to stem cell 
biology. All information mentioned up to here will also be relevant to the ESC 
differentiation experiments described in Chapter 4 and 5. First, understanding how 
the metanephros develops and where it originates from might be key to the 
successful differentiation of ESCs to renal cells. When studying directed 
differentiation of ESCs, it might be necessary to try to reproduce embryonic 
development in vitro and try to transition these cells (in a directed manner) first to 
mesoderm and then intermediate mesoderm to push them to acquire renogenic 
ability. In addition, information will be provided about ESCs, their discovery and 
properties, together with concepts of differentiation and directed differentiation. A 
literature summary about differentiation of ESCs to renal cells will critically review 
the current advancements in this field. Finally, the impact and perspectives of a work 
integrating stem cell biology with kidney development and embryo development will 
be provided, accompanied by some perspectives to translational studies. 
 
1.3 The kidney - function and anatomy 
Many aspects of kidney anatomy, function, development and disease have already 
been described. A recent summary of these is provided in the book “The kidney: 
from normal development to congenital disease” (eds. Vize, Woolf and Bard, 2003). 
This source has been used for most of this section as it provides a modern summary 
of kidney anatomy. Additional sources are cited as appropriate. 
 
The kidneys are bean-shaped organs located at the posterior abdominal wall. They 
have an excretory function and are a part of the urinary system, together with the 
ureters (connecting the kidney and the bladder), the bladder and the urethra, the latter 
two located at the midline caudally from the kidneys. Each kidney has a collecting 
duct system, leading to a ureter, which clears urine to the bladder and out of the 
body. The kidney is often described as having two layers referred to as the cortex 
(outer) and the medulla (inner). The renal medulla is composed of structures called 
pyramids, which are not clearly separated, but divided by septa of cortical tissue, 
known as the columns of Bertin. Although the medulla and cortex do not have a 
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physical boundary, the corticomedullary junction can be distinguished visually due to 
the differences in appearance of those two compartments (reviewed by Hallgrimsson 
et al.., 2003). Urine flows from the medulla, out of the pyramids, into the minor 
calyces via a porous region called the cribriform plate.  The human kidney contains a 
highly branched and complex drainage system, in which the minor calyces converge 
to form major calyces, which also converge to become the renal pelvis. The calyces 
and the renal pelvis are contained into a recess - the renal sinus. The renal sinus also 
contains the blood vessels, lymphatic vessels and nerves entering the kidney through 
the hilum, or the exit point of the ureter. After passing through the minor and major 
calyces, the urine produced in nephrons flows through the renal pelvis and the ureter 
to reach the bladder - an elastic musculomembranous organ, which serves for the 
storage of urine. The bladder is composed of four coats called serous, muscular, 
submucous and muscous (Gray, 1918). The contraction of the muscle layers, in 
combination with other processes, leads to voiding of the bladder and expelling urine 
out of the body. 
 
The nephron is a structure responsible for the filtration of blood and production of 
urine. A human kidney contains about 500,000 to 1,500,000 nephrons (Sariola and 
Philipson, 1999). Although nephrons are essentially hollow tubes able to transport 
fluid to the collecting duct system, their structure and mechanism of work are much 
more complex than originally thought. The mature functional nephron is made up of 
more than 14 different types of cells (Herzlinger et al, 1992).  
 
The two main components of the nephron are the renal corpuscle and the renal tubule 
(Little et al., 2007). The renal corpuscle consists of Bowman’s capsule and the 
glomerulus. The renal tubule is segmented into proximal tubule (with convoluted and 
straight parts), the thin limbs of the loops of Henle, the thick ascending limb, the 
distal tubule (which also consists of a convoluted and distal part) and the connecting 
segment, which takes fluid into the collecting duct system (reviewed by Madsen et 
al., 2007). The positioning of nephrons in the kidney is not random, but rather 
organised. Nephrons can be classified according to the length of their loops of Henle, 
which can be either long or short (reviewed by Hallgrimsson et al., 2003). 
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The part of the nephron responsible for the filtration of blood is the renal corpuscle. 
As mentioned before, it consists of the Bowman’s capsule and a glomerulus, along 
with connective tissue that supports them. The glomerulus is a vascular tuft that 
invades the renal corpuscle from the vascular pole (reviewed by Hallgrimsson et al., 
2003). The primary mechanism for filtration of blood in the renal corpuscle involves 
three barriers - a fenestrated endothelium, a 1200-1500Å - thick glomerular basement 
membrane (GBM) and the slit diaphragm of the glomerular visceral epithelial 
podocytes (Farquhar et al., 1961; Kestila et al., 1998). The endothelia of the invading 
capillaries have numerous fenestrations that are 500-1000Å in diameter and do not 
have diaphragms. The fenestrations contain a glycocalyx secreted by the endothelial 
ells and are responsible for retaining cellular components and large macromolecules 
(reviewed by Satchell and Braet, 2009; Miner, 2011; Hallgrimsson et al., 2003). 
Unlike the other two layers, the second component of the filtration barrier, the GBM, 
is acellular.  It is a specialised matrix, which consists of primarily laminin-521 
(α5β2γ1), collagen IV (α3α4α5), nidogen1, nidogen2 and agrin (reviewed by Miner, 
2011). Even though the GBM shares a lot of similarities with other more typical 
basement membranes, it is unusually thick and has a more unusual composition. 
Evidence has been shown that both the endothelial cells and podocytes synthesise 
and secrete components of the GBM (Abrahamson, 1985; St. John and Abrahamson, 
2001; Abrahamson et al., 2009) 
 
The outermost layer of the filtration barrier consists of highly specialised epithelial 
cells called podocytes. These cells possess primary (trabeculae) and secondary foot 
processes (pedicels), which interdigitate to form a tight meshwork, which sits on top 
of the GBM (reviewed by Madsen et al., 2007). The podocytes are anchored to the 
GBM by α3β1 integrin.  The spaces between foot processes are referred to as 
filtration slits and are joined by a slit diaphragm (reviewed by Mundel and 
Shankland, 2002; Ruotsalainen et al., 1999. Farquhar et al., 1961). The mesh-like 
mechanical filter excludes all molecules larger than albumin (69kDa, radius 3.6nm). 
In addition to the purely physical filtration of fluid, the negatively charged 
components of the filtration barrier, such as glycoproteins and heparan sulfate 
(components of the glycocalix of the secondary processes of podocytes, the GBM 
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and the internal membrane of the capillary endothelial cells), repel negatively 
charged proteins, which causes them to be retained in the blood (reviewed by 
Hallgrimsson et al., 2003). The produced filtrate, called ultrafiltrate, is expelled into 
Bowman’s space and then enters the proximal tubule. Furthermore it is important to 
emphasise on the importance of the three barriers in the glomerulus for the proper 
functioning of the kidney. An example is the protein nephrin, which is found on the 
slit diaphragm of podocytes (Ruotsalainen et al., 1999). A mutation in the gene 
encoding for this protein has been implicated in the cause of congenital nephrotic 
syndrome of the Finnish type and leads to a massive leakage of albumin and larger 
plasma proteins in the urine (Kestila et al., 1998). This is a result of podocytes failing 
to form normal foot processes. 
  
A very different type of cells sit in the spaces between the glomerular capillaries and 
these are the mesangial cells, which help maintain the structural integrity of 
glomerular capillary loops. They generate extracellular matrix, regulate capillary 
flow and ultrafiltration surface and produce prostaglandins and cytokines (reviewed 
by Schlondorff, 2009). 
 
Up to this point in the introduction it was demonstrated that a lot of structural and 
functional complexity is implicated in only one of the many steps on the way of 
producing urine. The ultrafiltrate resulting from the direct passage of water and small 
molecules from blood to the tubular units undergoes a lot of further processing when 
it passes through the whole length of the nephron, as it still contains many valuable 
components. Proteins, amino acids, glucose, water and salts are resorbed in the 
proximal tubule (PT; Sekine et al., 2011). The beginning of the PT is 
morphologically defined by the zone of transition from the simple squamous 
epithelium of the Bowman’s capsule, to the cuboidal epithelium of the tubule. 
(Bulger, 1979).  In some species (for example the rat), the PT consists of three 
subsegments (S1, S2 and S3), which show different protein expression patterns and 
function (Walmsley, 2010). These cells are equipped with a dense brush border of 
microvilli to maximise the area available for resorption (Heidrich et al., 1972). The 
PT leads to the thin limbs of the loop of Henle (Bulger, 1979). The short cortical 
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nephrons tend to lack the thin ascending portion, while the juxtamedullary ones have 
long ascending and descending limbs. The three segments of the loop of Henle are 
also responsible for the transport of salts and water and have great differences in 
their permeability (reviewed by Hallgrimsson et al., 2003). This part of the nephron 
is extremely important in establishing and maintaining the osmotic gradient in the 
renal medulla. The following segment of the nephron, the distal tubule (DT), also 
contributes to this process by removing salts from the tubule lumen by remaining 
impermeable to water. The DT consists of a straight and convoluted part and begins 
with the thick ascending limb (Bulger et al., 1979). Two different configurations of 
the epithelium lining the thick ascending limb have been reported. Some cells have a 
rough surface with numerous microprojections, while others have a smooth surface. 
Most cells possess one or two cilia (Madsen et al., 2007). The thick ascending limb 
possesses a specialised structure called the macula densa. It is a specialised region 
where the DT can be seen immediately adjacent to the hilus of the glomerulus 
(Bulger et al., 1979). The cells of the macula densa interdigitate with the mesangial 
glomerular cells (Barajas, 1979).  This connection with the juxtaglemerular 
apparatus, serves as an important checkpoint for the content of urine in the distal 
tubule and is able to regulate the secretion of renin - an essential component of the 
renin - angiotensin - aldosterone system, which is crucial for control of blood 
pressure and volume (Skeggs et al., 1954; Goormaghtigh, 1940).  
 
1.4 Development 
The previous section illustrated the complexity of the kidney, both in terms of 
structure and function. In order to be able to address the problems of acquisition of 
renocompetence in ES cells or in embryonic development, it is first necessary to look 
at the known developmental processes, with three aims. An introduction of mouse 
embryonic development is necessary to follow the processes of cell specification that 
lead to the formation of the kidney primordia. Since the kidneys have been shown to 
derive from the intermediate mesoderm, its formation from mesoderm should also be 
discussed. The existence of three types of kidneys present in embryonic development 
will be covered with relevance to analysing cell mixing experiments in Chapter 6, 
containing tissues from early embryos. Finally, the mechanisms, which lead to the 
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formation of the adult kidney will be described to understand the mechanism of 
kidney formation and the properties of renocompetent cells. All these are also 
necessary for trying to understand what pathways ESCs should take to acquire the 
ability to make kidney cells in vitro. 
 
1.4.1 Mouse embryonic development 
1.4.1.1 Early embryo development 
The beginning of a new organism starts by the fusion of the male and female gametes 
to produce a conceptus. The fertilised egg, or zygote, starts undergoing consecutive 
cleavages. The cells that result from these divisions are called blastomeres. One 
feature that distinguishes mammalian early development from that of other 
organisms is a process called rotational cleavage (Gulyas, 1975). Usually blastomere 
cleavages are symmetrical. In mammals, the first cleavage produces 2 blastomeres 
and happens meridionally, while in the second division one of these divides 
meridionally and the other – equatorially (Piotrowska-Nitsche and Zernicka-Goetz, 
2005). Another major specificity of early mammalian development is the asynchrony 
of cell division, which rather than producing 4-cell, 16-cell and etc stages, often 
produces an odd number of cells (Mulnard, 1978).  
 
One of the most crucial distinct features in mammalian development is the 
phenomenon of compaction. The blastomeres of an 8-celled mouse embryo are 
spherical and clearly distinct from each other (Pratt et al., 1982). At this stage, the 
cells begin the process of compaction, which results in the cells getting very tightly 
packed next to one another, forming a compact ball of cells (Pratt et al., 1982). This 
process is stabilised by the formation of tight junctions by the cells located on the 
outside of the ball, which essentially isolate the inner side of the sphere. In contrast, 
the inner cells start expressing gap junctions, which allow for easy exchange of 
signals and transport of small molecules (Ducibella and Anderson, 1975). During 
compaction, E-cadherin becomes localised to the cell-cell adhesion surfaces of 
blastomeres and remains evenly distributed in the inner cell mass after progression to 




The cells of a compacted 8-cell embryo divide a fourth time to produce 16-cells or a  
morula. At that stage, the fate of the cells on the outside of the ball starts to be 
specified - they are going to produce the trophectoderm or the extraembryonic 
component (for example, the chorion and the placenta; Papaioannou, 1982). The 
cells on the inner side of the ball will give rise to the embryo proper, yolk sac, 
Figure 1.1 - Early development in the mouse 
 11
allantois and amnion. From about the 32-cell stages these cells start to be called the 
inner cell mass and at the 64-cell stage are approximately 13 cells. This stage is 
considered as a landmark for the first differentiation process in embryogenesis - the 
differentiation of trophectoderm and inner cell mass (ICM; Rossant, 1975). 
Although, these become two separate cell populations, the trophectoderm is being 
supported by the ICM by the secretion of FGF4 (Leunda-Casi et al., 2001).  Its cells 
start secreting fluid, which supports the formation of a blastocoel and initiate the 
process of cavitation of the morula (Watson et al., 1990). This leads to the formation 
of another developmental stage, specific of mammalian development - the blastocyst. 
The next important process that happens during embryonic development is the 
hatching of the blastocyst - it squeezes through a small hole lysed in the wall of the 
zona pellucida enwrapping it. At that stage, the trophectodermal cells become 
exposed and the embryo is ready to implant in the endometrium (uterine wall). In the 
mouse this process happens at around E4.5 (Theiler, 1989). 
 
Post implantation, the three germ layers of the embryo start to be formed by 
extremely complex morphogenetic movements in the process of gastrulation. The 
primary function of gastrulation is to ensure the correct placement of precursor 
tissues for subsequent morphogenesis (reviewed by Tam and Behringer, 1997). After 
implantation into the uterus, the mouse embryo develops as a cylindrical structure 
and subsequently changes dramatically in size and shape during a very short period 
of time. Epithelisation of the ICM occurs concomitantly with the formation of the 
proamniotic cavity, which results in the specification of two layers - the inner 
epiblast and the outer visceral endoderm. At this stage, the mouse embryo is called 
the egg cylinder. It has a well defined embryonic and extraembryonic component and 
starts to specify the dorsal-ventral and proximal-distal axes. The epiblast cells, or 
embryonic ectoderm, are recruited to a transient embryonic structure called the 
primitive streak. The primitive streak also defines the antero-posterior axis as it is 
situated at the posterior of the developing embryo. At the primitive streak, the cells 
of the epiblast undergo an extremely interesting process, in which they change their 
identity from epithelial to mesenchymal (reviewed by Hay, 1995). This is called 




development, initiates the formation of either the definitive endoderm or mesoderm. 
The newly formed mesoderm appears as a new layer of cells emanating from the 




Many aspects of mammalian embryonic development are tightly interlinked and 
work in cooperatively to allow further embryogenesis, for example, induction of 
neighbouring tissues, formation of signalling gradients, cell migration, spatial 
arrangements, cell contact and etc. Although, the importance of these could not be 
overestimated, I would like to focus on providing more background information 
Figure 1.2 - Gastrulation in the mouse embryo 
The embryo shown on the left is approximate age E6.5, while the embryo on the right - 
E7.5. During gastrulation, epiblast cells (shown in blue) move through the primitive 
streak (red) to give rise to mesoderm and definitive endoderm (not shown). 
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about the mesodermal lineage in particular, as mesoderm is considered to the 
precursor of the more specified renal lineages of cells.  
 
Several experimental techniques have proven absolutely essential for studying cell 
origin, for instance, cell mapping analysis. Single epiblast cells are marked and 
followed in development or cells are orthotopically transplanted (Lawson et al., 
1991). Such experiments have proved that there are domains in the three germ layers, 
which form distinct populations of cells that will form most of the major tissue types 
present in an adult organism (Beddington, 1982). The mechanisms of how this 
happens are also starting to be uncovered. Recent experiments, for example, have 
shown that well before primitive streak formation, epiblast cells form two counter-
rotating vortices, which merge at the posterior part of the embryo (Chuai et al., 
2006). The authors have also shown that FGF signalling is implicated in this process 
leading to primitive streak and therefore also mesoderm formation.  
 
The mesoderm, in particular, is found between the progenitors of the ectoderm and 
the vegetal or extraembryonic tissues. It is formed in the process of gastrulation by 
ingression of the embryonic ectoderm, which migrates through the primitive streak 
(reviewed by Tam and Behringer, 1997). It appears that in the migratory movements, 
mesodermal cells use extra cellular matrix (ECM) components (like fibronectin, type 
IV collagen and heparan sulfate proteoglycan) as a migratory substratum during 
gastrulation (Smith et al., 2009). When epiblast cells undergo EMT at the primitive 
streak to give rise to mesodermal cells, they downregulate E-cadherin, the calcium-
dependent cell-cell adhesion molecule present in epithelial cells, and start expressing 
the cytoskeletal protein vimentin, characteristic of primitive streak mesoderm 
(Burdsal et al., 1993). During the 12-24h following primitive streak formation, the 
streak elongates and forms a specialised structure at its anterior end, known as the 
node. The node is considered analogous to the organising centre of other vertebrate 
embryos (Zhou et al., 1993). It generates axial mesendoderm, which consists of: 1 - 
the mesoderm that will populate the midline of the embryo (prechordal plate and 
notochord); and 2 - the definitive gut endoderm. The lateral plate mesoderm and 
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paraxial mesoderm emerge from the intervening levels of the streak (Beddington and 
Robertson, 1999). 
 
At neurula stage, the mesoderm can be divided into five regions. For example, the 
chordamesoderm forms the notochord, a structure present only in embryonic 
development, which is a source of midline signals responsible for patterning the 
surrounding tissues, for example, neural tube patterning and establishing left-right 
asymmetry (reviewed by Stemple, 2005; Kingsbury, 1920). The paraxial mesoderm, 
which is also known as somitic dorsal mesoderm, will form the somites, as the name 
suggests. The somites are distinct regions of mesodermal cells, situated 
symmetrically on both sides of the neural tube. They produce many of the connective 
tissues of the embryo, such as bone, muscle, cartilage, and dermis (Ordahl and 
Douarin, 1992). The lateral plate mesoderm, which as the name suggests, is the most 
distant from the notochord mesodermal layer, gives rise to the heart, blood vessels of 
the circulatory system, the lining of the body cavities and to all mesodermal 
components of the limbs except the muscles (Garcia-Martinez and Schoenwolf, 
1993; reviewed by Noden and Francis-West, 2006). The head mesenchyme forms the 
connective tissues and the musculature of the face. The intermediate mesoderm, or 
the mesodermal layer situated between the paraxial and lateral plate mesoderm, will 
be discussed more extensively in the following section, as it gives rise to the 
urogenital system. 
 
1.4.1.3 Intermediate mesoderm 
Fate mapping experiments have been performed to identify the location of early 
embryo cells that are destined to form the intermediate mesoderm. Smith et al. 
(1994) have tracked the migration of cells after injections of a labelling reagent in 
different positions of the mouse primitive streak. These experiments determined that 
cells located at intermediate positions in the E7.5 mouse blastocyst contribute mainly 
to the lateral plate and intermediate mesoderm (Smith et al., 1994). Furthermore, it 
was reported that cells from the posterior streak also seemed to contribute to the 
intermediate mesoderm. The cells were observed to migrate first bilaterally from the 
injection site and then anteriorly. 
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Although little is known about the signalling molecules that specify its formation, 
some processes in the formation of intermediate mesoderm are starting to be 
understood better. The transcription factor Osr1 is one of the genes expressed earliest 
in the intermediate mesoderm. In mice, transcripts can be seen as early as E7.5 in the 
regions of presumptive nephrogenic tissue, but also in the lateral plate mesoderm 
(James et al., 2006). Mugford et al., (2008) have demonstrated that descendants of 
Osr1+ cells contribute to many intermediate mesodermal derivatives, such as the 
adrenal gland, gonad and metanephric kidney. Further studies have provided 
evidence that Osr1 expression is activated by Bmp signalling (James et al., 2005). 
James et al. (2005) have also proposed a mechanism for the role of Bmp signalling in 
trunk mesodermal pattering, where low levels of Bmp are able to inhibit repressors in 
the medial mesoderm, therefore activating intermediate mesodermal gene expression, 
but high levels of Bmp are able to repress both medial and intermediate mesoderm 
gene expression at the expense of lateral plate genes.  
 
Much more information would need to be collected to understand the specification of 
the intermediate mesoderm. The interplay of gene expression patterns and molecule 
gradients becomes increasingly complex with the progress of embryo development 
and will probably require taking into account the global processes, which steer 
embryo patterning. The idea that there is global and local positional information that 
patterns the embryo increases in popularity (Burke, 2000; Barak, 2005). The global 
positional information determines timing, major developmental events and 
patterning, while local positional information might be responsible for the final 
specification of a cell type. More evidence towards this idea might prove key for a 
new approach to studying development. 
 
1.4.2 Kidney development 
The previous sections of this chapter present only a short overview of embryo 
development, mesoderm and intermediate mesoderm formation. Although a much 
larger body of literature would have to be summarised for a complete overview, the 
information presented hitherto provides the developmental sequence of events 
leading to the development of the kidney from intermediate mesoderm. In mammals, 
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nephrogenesis progresses through three stages - the pronephros, mesonephros and 
metanephros, which develop in a temporal and spatial sequence. The pronephros and 
mesonephros are temporary and degenerate, while the metanephros remains 
functional throughout the life of the organism. In order to understand the 
development of the metanephros, we would need to look at the development of the 
preceding two stages, first.  
 
1.4.2.1 The nephric duct 
One of the first steps towards the formation of the urogenital system starts with the 
formation of the nephric duct. The morphogenetic processes and changes that the 
intermediate mesoderm undergoes to form the nephric duct have been studied in the 
development of a large variety of organisms, which include teleosts, amphibians, 
birds and mammals (Drummond et al., 1998; O’Connor, 1938; Davies, 1950; Fraser, 
1920). The nephric (pronephric) duct has received so much scientific attention, as it 
is a central component of the excretory system throughout development. It is a result 
of one of the first mesenchymal-to-epithelial transitions (MET), which occur in 
embryogenesis and has been mapped to the intermediate mesoderm (Bouchard et al., 
2002).  The duct is derived from a thickening localised in the pronephric region 
(Fraser, 1950). Early observations in Amblystoma tigrinum and Triton taeniatus  
have reported that the pronephric duct comes from “an independent outgrowth of the 
first nephric rudiment” (O’Connor, 1938). Furthermore, evidence has been 
demonstrated that the first nephric rudiment is derived in a segmental manner, where 
the cranial portion forms the pronephros, and the caudal portion forms the pronephric 
duct (O’Connor, 1938). Similar observations have been made in the cat - discrete 
vesicular structures along the length of the posterior part of the intermediate 
mesoderm were thought to fuse to form the rostral parts of the duct (Fraser, 1950). 
Nephric duct progenitors are thought to migrate caudally as a cord of mesenchymal 
cells and then transform into a tubule with a central cavity possessing a nephron-
inducing ability (O’Connor, 1938; Obara-Ishihara et al., 1999). After extension, in 
later developmental stages, the pronephric duct is called the mesonephric or Wolffian 
duct. It is an essential component for later morphogenetic events, which give rise to 
the urogenital system (Torres et al., 1995). It induces the neighbouring intermediate 
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mesoderm to give rise to the mesonephric tubules. The nephric duct functions as a 
drainage channel of the functional pronephros and mesonephros and is key for the 
development of the metanephros as it gives rise to the ureteric bud - an epithelial 
duct continuous with the WD, which will branch and develop into the collecting duct 
system of the adult kidney (Saxen, 1987). 
 
Several genes implicated in nephric duct specification have been identified. One of 
them encodes for the homeobox gene lim1. Shawlot and Behringer (1995) have 
reported that a targeted disruption of the gene results in a complete loss of duct 
formation. Retinoic acid (RA) has been identified as another important component 
for duct morphogenesis - in Xenopus, treatment with retinoic acid leads to ectopic 
lim1 expression (Taira et al., 1994), while deletion of the RA synthetic enzyme, leads 
to an absence of nephric duct formation (Niederreither et al., 1999). These studies 
have also demonstrated that the action of RA might be to mediate lim1 expression, 
which in turn supports initiation of nephric duct formation. Obara-Ishihara et al. 
(1999) reported that BMP signalling is important for the maintenance of duct 
markers, although evidence for its role in initiation of the duct has not been 
demonstrated. Surface ectoderm and BMP4 have been shown to be essential for 
Figure 1.3 - Development of the pronephros, mesonephros and metanephros 
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nephric duct formation from the intermediate mesoderm. The importance of paraxial 
mesoderm for differentiation of the intermediate mesoderm has also been shown in 
the chick (Mauch et al., 2000). In the initial stages of development Pax2 mutants 
show a normal formation of the nephric duct, but subsequently it fails to extend 
caudally and degenerates (Torres et al., 1995). 
 
1.4.2.2 The pronephros 
The complexity and fate of the pronephros varies from species to species. Entirely 
developed and functional pronephroi are found in all embryonic fish and all larval 
amphibians and they are also essential for their survival (Howland, 1921). In fish for 
example, although pronephroi function transiently, they are essential for maintaining 
water balance. Due to their habitat, freshwater fish larvae are subject to a constant 
water influx, which means that huge amounts of dilute urine have to be excreted, 
while maintaining a very high efficiency in recovering solutes to retain osmotic 
balance. There is some evidence that functional pronephroi are also molecular filters 
efficient in recovering solutes from the filtrate and can contribute to the regulation of 
blood pH (reviewed by Drummond and Majumdar, 2003). There is much more 
variation in complexity in reptiles, where the less advanced species have more 
advanced pronephroi. Birds and mammals do not have well-developed pronephroi 
and the latter persist only during embryonic development. In mice, pronephric 
tubules are rudimentary and exist only for a short period of time (Sainio et al., 1997).  
 
The pronephros develops from the intermediate mesoderm around E9.0 of mouse 
development (Kaufman, 2001). The pronephric ridge is first formed as a thickening 
of the somatic wall and as described in the previous section is closely associated with 
nephric duct formation. The pronephros consists of three main components - the 
glomus (external glomerulus), or the filtration unit of the organ; the tubules, which 
are responsible for resorption and excretion; and the duct, which drains the urine 
(Vize et al., 1995). The organ has a very simple structure, which produces filtrate 
similarly to metanephric glomeruli with the difference that the liquid is expelled in a 
coelom rather than in Bowman’s space (Davies, 1950). In Bufo viridis tadpoles there 
are two cranial and two caudal pronephroi, each of which consists of an external 
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glomerulus and a single convoluted tubule (Møbjerg et al, 2000). The pronephric 
tubule opens into the coelom via three nephrostomes and consists of three proximal 
tubule branches, a common proximal tubule and a distal tubule (Møbjerg et al, 2000). 
The nephrostomes are thin epithelial ciliated tubules of the nephron, which collect 
the filtrate from the coelom and channel it to the proximal tubule which functions in 
solute resorption and waste secretion. After water is resorbed when the filtrate passes 
through the distal tubule, the urine is passed down the pronephric duct to the cloaca 
(reviewed by Vize et al., 2003). 
 
1.4.2.3 The mesonephros 
The mesonephros is the second excretory organ that appears in embryonic 
development. It starts to appear posteriorly to the pronephros and is also derived 
from the nephrogenic cord mesenchyme (Fraser, 1920). Mesonephric tubules have a 
more complicated structure and unlike pronephric tubules might be functional during 
the embryonic life of mammals (Torres et al., 1995). Even though mesonephroi 
degenerate in mammalian development, they form functional adult organs in 
amphibians and teleost fish (Zhou et al., 2010; Haugan et al., 2010). The most cranial 
renal vesicles of the mesonephros appear at about E9.0 in the mouse (Vetter and 
Gibley, 1966) and the maximal number of tubules is 18-26. It is also interesting to 
note that there are two types of mesonephric tubules. The 4-6 anteriormost are 
connected to the nephric duct and have a short distal segment that might be partially 
derived from it. Most mesonephric nephrons are located posteriorly and can be seen 
“hanging” next to the WD, but never fused to it (Sainio et al., 1997).  
 
In mesonephros development, the nephric duct has a role in inducing nephrons in the 
mesonephric blastema. The cells of the mesonephric blastema condense to form renal 
vesicles and S-shaped bodies, which fuse with the WD and this process concludes in 
the maturation of a nephron with a small glomerular-like structure with primitive 
endothelial tufts (Lawrence, 1992; de Matino and Zamboni, 1966). Diverticulae of 
the mesonephric tubules of reptiles have been described, as well as forking of these 
in avian and mammalian embryos (Friebova-Zemanova and Goncharevska, 1982 and 
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the references therein). Mesonephric branching has also been described in a review 
by Sainio (2003). 
  
Relatively few genes implicated in mesonephros development have been described. 
Not surprisingly many of them are also involved in metanephros development, as 
will be detailed in section 1.5. An example is the transcription factor Pax2 (Dressler 
et al., 1990). Other genes important for mesonephros development include Wt1 
(Kreidberg et al., 1993), Emx2 (Miyamoto et al., 1997), Foxc1 (Kume et al, 2000) 
and Gata3 (Labastie et al., 1995; Grote et al., 2006). 
  
1.4.2.4 The metanephros 
The metanephros is the functional kidney in adult mammals and is formed last in the 
triad of embryonic kidneys (Bremer, 1916 and references therein). Its function and 
adult structure have been described earlier in this chapter (section 1.3). The 
development of the metanephros starts by the reciprocal inductive interactions of two 
progenitor tissues - the ureteric bud (UB) and the metanephric mesenchyme (MM; 
Grobstein, 1953). Evidence for these inductive interations and more information 
about the inductive properties of various tissues has been provided by experiments, 
in which the MM and UB have been surgically separated and cultured separately, re-
combined in culture, or cultured with heterologous tissues (Grobstein, 1953; 
Grobstein, 1955; Saxen, 1987). It was first determined that the UB was the natural 
inducer of the MM in embryonic development (Grobstein, 1953). Later, it was 
discovered that other heterologous tissues were also able to induce the formation of 
renal tubules in isolated MMs (Grobstein, 1955). Experiments showed that an 
impressive number and variety of embryonic tissues were able to induce 
tubulogenesis in E11.0 mouse metanephric mesenchymes. In addition to the UB, 
embryonic neural tissues (spinal cord, medulla, brain) and neural teratomas, 
embryonic mesenchymes (salivary, jaw, head, and bone), and submandibular 
embryonic epithelium were found to have inductive abilities on combination with 
MM (reviewed by Saxen, 1987).  
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Figure 1.4 - Development of the metanephros 
The schematic drawing shows invasion of the UB in the MM, induction of 
condensation, formation of the renal vesicle, formation of S-shaped body and fusion to 
the UB, and formation of a nephron with a glomerulus, PT, limbs of the loop of Henle, 
DT and collecting duct 
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 In development, the MM and UB are formed in two distinct developmental 
processes and originate from two different descendents of the intermediate 
mesoderm (Fraser, 1920; Vetter and Gibley, 1966). The UB starts to form at about 
E10.0 in the mouse as a diverticulum of the WD. Its formation is induced by the cells 
of the metanephric blastema, which secrete GDNF (Sainio, 1997). Experiments have 
shown that the UB fails to form upon removal of the adjoining MM.  In embryo 
development, upon evagination, the UB grows laterally towards the MM and projects 
into the metanephric blastema (also known as the metanephric anlage). Multiple 
bifurcations of he UB create a branching tree, which will become the collecting duct 
(CD) system of the adult kidney (reviewed by Saxen, 1987). 
 
The MM or blastema is composed of a few thousand mesenchymal cells that will 
give rise to stromal cells and all renal epithelia, but the collecting duct (CD). 
Although this is not the favoured hypothesis, some studies have suggested that cells 
from the MM are also able to contribute to UB structures (Qiao et al., 1995). There 
has been a lot of debate about the nature of the cells of the MM and whether there is 
a single stem or progenitor cell able to give rise to all types of cells present in the 
adult kidney including neuronal and endothelial cells (Herzlinger et al., 1992). A 
second hypothesis proposes that the metanephric blastema might consist of a 
heterologous cell population that might contain progenitors of the different kidney 
lineages. 
 
At E10.0 - E10.5 in the mouse, the metanephric blastema is visible as an 
accumulation of cells at the posterior end of the urogenital ridge, at the region of the 
intermediate mesoderm (Vetter and Gibley, 1966). The loose MM cells respond to 
the inductive signals from the UB by condensation and aggregation. The cells start to 
show signs of epithelisation and undergo MET to form a renal vesicle. As the 
ureteric bud grows and undergoes dichotomous branching, the renal vesicles remain 
associated with the UB at the side (Saxen, 1987; Georgas et al., 2009). The MET 
induces the expression of new cadherin genes and the formation of a basement 
membrane on the outside of the renal vesicle (Ekblom, 1980; Cho et al., 1998). 
Morphological shaping of the vesicles results in the formation of a structure called a 
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comma-shaped body (due to the formation of a cleft on one side of the vesicle), 
which then progresses to an S-shaped body (after the acquisition of a second cleft; 
Jokalainen, 1963). After the initial growth phase of cells, the first diversification can 
be noticed at the comma-shape stage. The proximal cells of the forming nephron 
elongate, their nuclei change position and cells at different positions become funnel-
shaped (reviewed by Saxen, 1987). At the stage of an S-shape, the nephron is already 
compartmentalised with a proximal and distal part. The most distal cells establish a 
contact with the cells of the UB, and both of these structures undergo morphogenetic 
changes to form a continuous lumen between the nephron and the UB (Georgas et 
al., 2009). The cleft positioned away from the UB forms the glomerular epithelium, 
consisting of visceral epithelium (podocytes) and the parietal epithelium of 
Bowman’s capsule (reviewed by Saxen et al., 1987).  At this stage, the presumptive 
podocytes can already be distinguished from the rest of the cells by their reactivity to 
the lectins - peanut agglutinin (PNA) and soya bean agglutinin (Laitinen et al., 1987). 
A functional glomerulus is formed only after the invasion of endothelial cells, which 
form the glomerular tuft and nephron maturation continues thereafter (reviewed by 
Daniel and Abrahamson, 2000).  
 
Although this process describes how a nephron is formed, it does not give an account 
of how more than 20,000 nephrons in the mouse kidney arise from the 12,000 cells in 
the metanephric mesenchyme (Karner et al., 2011). The generation of nephrons does 
not occur in a single burst of epithelialisation of MM cells, but rather proceeds 
continuously throughout embryo development. This implies that the progenitor 
population of cells should be replenished or that a population of cells with the ability 
to proliferate and differentiate to all cells of a nephron should be present in the MM. 
Recently these cells have been identified as Six2+ progenitors in the mesenchyme 
adjacent to the UB tips (cap mesenchyme; Kobayashi et al., 2008; Karner et al., 
2011; Self et al., 2006). Kobayashi et al. (2008) have demonstrated that the Six2+ 
cap mesenchyme contains multipotent progenitor cells, which seemed to have the 
ability to self-renew and to give rise to all cell types within the main body of the 
nephron. With the progression of kidney development, Six2+ cells are no longer seen 
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in the inner parts of the kidney where nephrons have already formed, but only at the 
periphery where nephrogenesis proceeds (Kobayashi et al., 2008). 
 
1.5 Important genes expressed during embryonic kidney 
development and nephron formation 
Although a thorough review of all signalling molecules would need many more 
pages, the aim of this chapter section is to give sufficient information about some of 
the main genes and molecular mechanisms governing early or later developmental or 
morphogenetic processes for kidney development. The expression profiles and 
functional importance of these genes are described here with two aims; 1 – to further 
describe the signals driving renogenesis in embryo development; and 2 – as some of 
them will be referred to in future chapters, as markers of renal progenitor cells. 
 
As it is relevant to one of the first processes defining metanephric development, I 
would like to go back to the mechanism by which the UB evaginates from the WD 
and invades the neighbouring MM. As shortly previously mentioned, this process is 
mediated by c-Ret-GDNF signalling (Vega et al., 1996; Sainio et al., 1997). c-Ret is 
a receptor tyrosine kinase localised on the membrane of WD cells. It is a receptor for 
glial cell line-derived neurotrophic factor or GDNF, which is secreted by the MM. 
GDNF is already expressed at low levels by the uninduced MM, but is highly 
upregulated in the cap mesechyme (Hellmich et al., 1996; Sainio et al., 1997). GDNF 
has been implicated in ureteric bud evagination and branching. On WD cells, GDNF 
binds to and activates a receptor complex, consisting of namely the Ret receptor 
tyrosine kinase and the GDNF family receptor α1 or GFRα1 (Sainio et al., 1997).  
Sainio at al. (1997) have shown that beads soaked in GDNF are able to induce the 
formation of supernumerary diverticula from the WD, which project towards the 
source of the chemical. A recent study by Kuure et al. (2005) has demonstrated that 
another major pathway, the Jagged1/Notch, is also implicated in the initiation of UB 
sprouting. They report a co-expression of molecules from both pathways starting 
immediately after the specification of intermediate mesoderm. Jagged1 (a ligand for 
Notch) colocalises with both GDNF receptors on the WD and Gdnf expression in the 
cap mesenchyme. GDNF seems to upregulate Jagged1 through Ret/GFRα1 
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signalling. The Ret/GFRα1/Gdnf system might coordinate UB growth acting together 
with other secreted factors, for example, pleiotrophin (Ptn) and bone morphogenetic 
protein 4 (Bmp4). Pleiotrophin expression has been detected in the MM and can 
stimulate the branching of explanted UBs in vitro, together with Gdnf, indicating that 
these two factors are sufficient for branching (Sakurai et al., 2001). Bmp4 has also 
been found important for UB branching by an indirect mechanism related to MM 
differentiation (Raatikainen-Ahokas et al., 2000). Bmp4 is expressed by the 
mesenchymal cells, which surround the WD and UB stalks, and might be involved in 
supporting their growth. Bmp4 heterozygous mutants form cystic kidneys (Dunn et 
al., 1997). It seems like there are some differences between observations in organ 
culture and in vivo studies, where in the latter situation gene regulation of UB growth 
and branching might be considerably more complex (reviewed by Vainio and Lin, 
2002). 
 
Another whole group of proteins important for kidney development (and more 
particularly for the formation of nephrons from MM) are adhesion molecules. 
Condensation of the MM is associated with an increase in intercellular adhesion 
(reviewed by Ekblom, 1989). Proteins, which were reported to be involved in the 
epithelialisation of the MM are the extracellular matrix components collagen I and 
III, fibronectin and tenascin, as well as the adhesion proteins laminin, E-cadherin 
(uvomorulin), N-CAM, as well as P- and N-cadherin. During MET, N-CAMs, 
interstitial collagens and fibronectin (common for mesenchymal cells), gradually 
disappear to be replaced by molecules characteristic of epithelial cells, such as 
laminin and E-cadherin (reviewed by Ekblom et al., 1989).  Also, it should be 
mentioned that some of the signals driving MET have already been identified. 
Experiments in the rat confirmed that the UB secreted factors that drive the 
epithelialisation of the MM and also identified that one of these factors was the IL-6 
type glycosylated cytokine LIF (leukemia inhibitory factor, Barasch et al., 1999). LIF 
activated STAT3 in rat MMs and induced a program of epithelial gene expression in 
precursors maintained or expanded by FGF2. The epithelialisation of the MM could 
also be induced by other IL-6 type cytokines (cardiotrophin, ciliary neurotrophic 
factor and oncostatin M). LIF was further found to cooperate with TGFb2 (in 
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addition to FGF2) to enhance and accelerate renal tubule formation in rat 
metanephric explants through a Wnt-dependent mechanism (Plisov et al, 2001). 
 
I would like to give a little more attention to another gene that has proven absolutely 
essential for early kidney development and will be frequently referred to in later 
chapters of this work - Pax2. Pax2 is frequently described together with another 
gene, Pax8, as it is another closely related member of the Pax-family sequence-
specific transcriptional regulators (reviewed by Chi and Epstein, 2002). The reason 
for this is that Pax2 and Pax8 are thought to have redundant functions at E9.5 of 
mouse embryonic development (reviewed by Dressler, 2011). Pax2 is expressed 
primarily in embryogenesis and - more specifically - during excretory system and 
central nervous system development. In the nervous system, it localises to the 
hindbrain, spinal cord, the otic vesicle and the optic cup (Dressler et al., 1990). In 
kidney development, Pax2 expression has been reported both in the ductal and 
mesenchymal components (Torres et al., 1995). Dressler et al. (1990) have reported 
that in mesoderm-derived tissues in the mouse, Pax2 starts to be expressed in the 
pronephric tubules and the nephric duct at about E9.0 whereas no expression is 
detected in the renogenic intermediate mesoderm prior to pronephros formation. In 
contrast, another study suggests that Pax2 expression starts earlier, being already 
detectable in the intermediate mesoderm at E8.5, before the nephric duct has been 
formed (Torres et al., 1995). Nevertheless, both studies agree that gene transcripts 
have been seen in the mesonephros, as well as the metanephros. Pax2 expression is 
characteristic of the UB, renal vesicles after they have started to condense from 
mesodermal cells and acquire epithelial properties, and the subsequent epithelial 
components of the nephron (Dressler et al., 1990; Narlis et al., 2007). On the other 
hand, the similar Pax8 starts to be expressed at the renal vesicle stage and continues 
to be maintained, together with Pax2, until the end of nephron differentiation (Narlis 
et al., 2007). It is interesting to note that Pax2 expression declines with the 
maturation of renal tubules. At embryonic day 17, Pax2 expression is discontinued in 
the glomerular crevices, but still seen in the perimeter of the growing kidney, and can 
no longer be detected in adult kidneys (Dressler et al., 1990).  
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The expression of Pax2 is essential for formation of pronephric, mesonephric and 
metanephric tubules. It has been reported that Pax2 is not only expressed, but also 
required for multiple steps in metanephros development (Torres et al., 1995; 
Bouchard et al., 2002). Pax2 homozygous mutants fail to form metanephroi (Torres 
et al, 1995). Although the nephric duct forms normally at E9.0-E10.0, it fails to 
extend caudally and no initiation of UB formation takes place. The MM of these 
animals does not undergo mesenchymal-to-epithelial transformation, which results in 
renal agenesis. It has also been demonstrated that Pax2 is necessary for the 
expression of Gdnf (Brophy et al., 2001). 
 
In kidney development, Pax2 and Pax8 participate in interconnected and extremely 
complex genetic networks, which still remain to be clarified. Mouse embryos lacking 
both Pax2 and Pax8 are not able to form pronephroi or later kidney structures due to 
an arrest of the MET that normally happens in the intermediate mesoderm to produce 
the nephric duct (Bouchard et al., 2002). Failure to initiate Lim1 and c-Ret expression 
occurs, accompanied by apoptotic loss of the nephrogenic intermediate mesoderm, 
one day after failed pronephric induction. At the same time, forced expression of 
Pax2 by retroviral vectors leads to the production of ectopic nephric structures in the 
intermediate mesoderm and genital ridge of chick embryos (Bouchard et al., 2002).  
Recent studies have indentified signals both upstream and downstream of Pax2.  The 
c-Jun N-terminal kinase (JNK) was found to activate Pax2 by phosphorylation. There 
is some evidence that Pax2 causes changes in methylation to establish renal epithelial 
fate (reviewed by Dressler, 2011) 
 
Data showing that double Pax2/8 mutants have a much more severe phenotypic 
effect than single mutants, suggests that there is a functional redundancy between 
those two genes (Bouchard et al., 2002). Heterozygous Pax2/8 mutants show a 
significantly reduced nephron number in correlation with a decrease in expression of 
the key developmental regulator Lim1, as well as an increase in the apoptotic index 
of nephron progenitor cells. Downregulation of Pax2/8 in mature nephrons results in 
differentiation defects of the distal convoluted tubules and UBs display branching 
defects associated with a downregulation of Wnt11 gene expression (Narlis et al., 
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2007). Narlis et al., 2007 have suggested a model, in which Fgf8 and Pax genes act 
in consort to activate Lim1 in renal vesicles, thereby allowing the differentiation of 
nephrons to proceed. Pax2 might also act by activating signalling via Wnt4 in the 
cells of the MM (Torban et al., 2006). These findings suggest that in kidney 
development Pax genes are important regulators for differentiation and branching 
morphogenesis. 
 
Another gene important for kidney development is the tumour-suppressor Wt1 
(Wilms’ tumour). It encodes a zinc-finger transcription factor, which has at least 24 
different isoforms resulting from combinations of alternative splicing, alternative 
start codons and RNA editing (Hohenstein and Hastie, 2006). Wt1 is expressed at 
low levels in the metanephric blastema at E10.5, but its expression increases in 
aggregates, comma-shaped bodies, and persists at high levels in podocyte precursors 
and epithelia of the Bowman’s capsule (Self et al., 2006; Pritchard-Jones et al., 
1990). Wilms’ tumour is an embryonic kidney neoplasia, which is characterised by 
undifferentiated mesenchymal cells and disorganisation of the renal epithelia and 
surrounding stromal cells (reviewed by Davies et al., 1999). Wilms’ tumours have 
provided a lot of insight into kidney development as the genes responsible for it are 
thought to control early kidney development. Studies have suggested that Wt1 is 
absolutely required for renogenesis (Kreidberg et al., 1993). Homozygous mutants 
had a complete absence of a UB and although a metanephric blastema was present it 
underwent apoptosis leading to a renal agenesis.  Since MM apoptosis could not be 
rescued in vitro, the authors concluded that Wt1 is important for MM survival and 
early differentiation.  
 
The function of Wt1 is extremely complex and information in the literature is 
contradictory. The Wt1 promoter has been described as a target of Pax2 (Dehbi et al., 
1996; McConnell et al., 1997), while on the other hand Wt1 appears to be a regulator 
of Pax2 (Hartwig et al., 2010) and repressor of Pax2 and Wt1 (Rupprecht et al., 
1994; Ryan et al., 1995).  A recent large-scale study identified 1663 genes bound by 
Wt1, which is only an example of the complexity and significance of this gene 
(Hartwig et al., 2010).  
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At the start of metanephric kidney development, the metanephric blastema acts as an 
accumulation of kidney progenitor cells that will proliferate and differentiate to form 
all structures essential for the formation of a functional kidney. In this respect, the 
MM could be regarded as a site where multipotent renal progenitors or stem cells are 
contained. Many groups are currently working on isolating putative stem cells from 
embryonic kidney rudiments (Herzlinger et al., 1992; Maeshima et al., 2003; Oliver 
et al., 2002; Lusis et al., 2010). Evidence is accumulating that the transcription factor 
Six2 might be central for multipotent kidney cells (Self et al., 2006; Kobayashi et al., 
2008; Lusis et al., 2010). Six2 is a homeobox gene, which is expressed throughout 
the development of the excretory system, including in the nephrogenic cords and 
metanephroi. At around E10.0 of mouse embryonic development, expression can be 
detected in the metanephric blastema before UB invasion (Oliver et al., 1995). At 
E10.5, Six2 expression localises to the mesenchyme surrounding the UB tips and at 
E11.5 it is found in the cap mesenchyme - the induced MM surrounding UB tips. It 
has been described that Six2 is expressed at different levels in different 
compartments - high levels were observed on the dorsal side of the UB and lower 
levels were found on the ventral side, near the ureteric stalk, where renal vesicles are 
formed. Six2 expression is shut down in epithelialised nephrons, but remains 
expressed in the nephrogenic zone (at the periphery of the kidney) while the kidney 
develops (Self et al., 2006). Self et al. (2006) have also demonstrated that in Six2-
null mice, ectopic renal vesicles form on the cortical side of the ureteric bud, rather 
than on the medullary as expected in a normally developing metanephros. The 
authors have shown that there is a depleted progenitor pool, which is progressively 
lost leading to a termination of nephrogenesis after induction of only a few nephrons. 
It has been proposed that Six2 might at least in part act by blocking the action of 
Wnt9b thus permitting self-renewal of uncommitted nephron progenitors (Kobayashi 
et al., 2008). It has also been suggested that Six2 might act by activating Gdnf 
expression and that it is able to auto-activate its own promoter (Brodbeck et al., 
2004). 
 
Wnts are a large family of secreted proteins that regulate key steps in kidney 
development and in embryogenesis, in general. When separated from the UB, MMs 
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usually die in cultures. In series of experiments, it has been determined that 
heterologous tissues, such as spinal cord, were able to rescue isolated MMs from cell 
death and induce nephron formation. Wnt1, for example, has been identified as the 
factor, which has the effect of spinal cord to induce nephron formation in isolated 
MMs (Herzlinger et al., 1994). Interestingly, it is not normally expressed in kidney 
development indicating that it must have a redundant function with another Wnt 
protein (also Kispert et al., 1998). Wnt4, for example, is expressed in the condensates 
of the induced MM. In double Wnt4 mutants, the ability of the MM to condense upon 
induction is retained, but MET fails and no tubules are formed (Stark et al., 1994). In 
experiments with Wnt4-producing cells and spinal cord, it has been found that these 
signals are sufficient to initiate ex vivo tubule formation, which pinpoints Wnt4 as an 
important tubule-inducing factor (Kispert et al., 1998). These studies of the role of 
Wnts in nephron induction have also provided insight about the ability of spinal cord 
to induce nephrons in explanted MMs. Other Wnts are also important for kidney 
development. Two examples are Wnt9b and Wnt11. Wnt9b is required for 
differentiation of the condensed mesenchyme via FGF8 and Fgflr1. Wnt11 seems to 
promote GDNF expression and therefore survival and branching of the UB (reviewed 
by Hendry et al., 2011). 
  
Although many more genes are involved in and important for different aspect of 
early or late kidney development, it would not be possible to cover all of them in the 
current work. The information in the text about genes important for kidney 
development and some additions are been given in Table 1.1.  
 
1. 6 Embryonic stem cells 
1.6.1 The biology of embryonic stem cells 
One of the two major foci of this thesis is embryonic stem cell differentiation to renal 
cells with two aims – to obtain a model system for studying renal lineage 
specification, and to obtain ESC-derived kidney cells for testing the usefulness of 
cell replacement therapies in treating kidney disease or testing the efficacy of drugs. 
To be able to discuss these concepts in subsequent chapters successfully, several 









in Phenotype References 
Transcription factors 
Emx1 UB, MM 
Kidneys, UB, genital tract completely 
missing 
Miyamoto et al., 
1997 
Eya1 MM 
Absence of UB growth and failure of 
MM induction Xu et al., 1999 
Foxc1 MM Two kidneys and double Ubs Kume et al., 2000 
Foxd1 S 
Mutant kidneys are small, few 
nephrons fused longitudinally Hatini et al., 1996 
Pax2 UB, MM 
Deficient UB outgrowth, MM not 
induced 
Brophy et al., 
2001 
Rara, Rarb UB, S, MM Hypoplasia, agenesis 
Mendelsohn et al., 
1999 




MM undergoes unrescuable 
apoptosis 
Kreidberg et al., 
1993 
Six2 MM 
Premature and ectopic differentiation 
of MM cells, depletion of the 
progenitor pool Self et al., 2006 
Pod1 MM 
abnormalities in epithelial branching 
and morphogenesis, podocyte 
defects 
Quaggin et al., 
1999 
Growth factors 
Bmp4 (het) MM 
Hypoplasia, dysplasia, hydroureters, 
ectopic uterovesical junction, double 
collecting duct 
Miyazaki et al., 
2000 
Bmp7 UB, MM 
Severe hypoplasia, few nephrons 
and collecting ducts 
Dudley et al., 
1995; Dudley and 
Robertson, 1997 
Fgf7 S 
Small kidneys, less UB branches 
and nephros Qiao et al., 1999 
Gdnf MM No kidney as UB evagination fails 
Moore et al., 1996; 
Sanchez et al., 
1996; Pichel et al., 
1996 
Wnt4 MM Failure of kidney tubule formation Stark et al., 1994 
Growth factors/receptors 
Gfra1 UB, MM 
Agenesis of the kidney as in Ret and 
Gdnf 
Enomoto et al., 
1998 
Notch2 MM** Glomerular defects 
McCright et al., 
2001 
Ret UB Failure of UB outgrowth 
Schuchardt et al., 
1994 
Nephrin podocytes 
Foot process effacement, 
proteinuria, early postnatal death 
Putaala et al., 
2001 
Table 1.1 - A summary of some mutant genes, which show a kidney phenotype 
The expression profile is not given in detail. UB-ureteric bud; MM-metanephric 
mesenchyme; S- s-shaped body 





absence of glomerular tufts and 
mesangial cells 
Leveen et al., 
1994 
Integrin α8 MM 
reduced UB growth and branching, 
defective epithelialisation of MM cells Muller et al., 1997 
Integrin 
α3β1 UB, glom 
decreased branching, proximal 
tubular epithelia contain excess 
lysosomes or become microcystic, 
podocytes do not form mature foot 
processes 
Kreidberg et al., 
1996 
Proteoglycans and their biosynthetic enzymes 
Hs2st UB, MM 
Renal agenesis due to lack of UB 
branching and mesenchymal 
condensation 
Bullock et al., 
1998 
Gpc3 UB, MM 
Selective degeneration of medullary 
collecting duct 
Cano-Gauci et al., 
1999 
Others 
Laminin α5 UB, MM 
absence of normal GBM, disarrayed 
glomerular epithelial cells, absence 
of vascularised glomeruli Miner and Li, 2000 
Pkd1 UB, MM enlarged cystic kidneys Lu et al., 1997 
Pkd2 UB, MM cyst formation Wu et al., 2000 
 
the history, biology and use of embryonic stem cells is provided together with the 
key players in regulating pluripotency. Then, ES cell differentiation is discussed with 
a focus on literature reports for the derivation of renal cells from ES cells. Other 
types of stem cells are mentioned briefly to illustrate their limited differentiation 
potential in comparison to ESC or other pluripotent cells. 
 
1.6.1.1 Characteristics of embryonic stem cells 
Embryonic stem cells are pluripotent cells derived from the inner cell mass of a 
blastocyst-stage embryo (Evans and Kaufman, 1981; Martin, 1981). These cells have 
attracted the interest of the scientific community with their abilities to self-renew 
indefinitely and to differentiate into all derivatives of the three germ layers - the 
endoderm, mesoderm and ectoderm (Evans and Kaufman, 1981). The true 
pluripotent stem cell has to fulfil a number of requirements to be considered 
pluripotent (reviewed by Smith, 2001). These have been summarised in Figure 1.5. 
The characteristics of ESCs are very different from these of adult stem cells or other 




1.6.1.2 The discovery of embryonic stem cells  
The first publications, reporting successful attempts to isolate and maintain in culture 
murine ESCs have been published in two independent studies by Martin Evans and 
Matthew Kaufman (Department of Genetics, University of Cambridge) and Gail 
Martin (Department of Anatomy, University of California, San Francisco) in 1981 
(Evans and Kaufman, 1981; Martin, 1981). Also, Martin was the first person to use 
the term “embryonic stem cell”. Evans and Kaufman used the term “EK” cells to 
distinguish the blastocyst-isolated pluripotential cells from EC cells or embryonal 
carcinoma cells. The potential of ESCs to form embryoid bodies (EBs), to 
differentiate into a multitude of cells and to form teratomas when injected in mice, 
has been reported together with their discovery (Evans and Kaufman, 1981). 
 
It is important to note that pluripotency and the ability to form chimeric animals is 
not a property exclusive to ESCs. Cells derived from teratocarcinomas of germ cell 
or embryonic cell origin also have shown such properties. These cells, known as 
embryonal carcinoma (EC) cells or teratocarcinoma stem cells, have demonstrated an 
ability to differentiate to the three germ layers (McBurney, 1976) and to form 
chimeric animals (Brinster, 1974; Papaioannou et al., 1975, 1978). 
 
Scientists spent a lot of years trying to isolate the human equivalent of mouse ES 
cells. Finally, the breakthrough happened when researchers led by James Thomson 
(University of Wisconsin-Madison) were able to prove a technique for the isolation 
and maintenance of human ESCs in culture (Thomson et al., 1998).  This was an 
important event in stem cell biology, as it introduced the possibility of using hESC 
for differentiation and subsequent application in the treatment of disease by cell 
replacement therapies or other more indirect medical applications. Such a use of 
hESCs harboured many challenges, both scientific and ethical. The ethical debate 
about hESC is based on the fact that they are derived from the blastocyst stage of an 
embryo, which involves its destruction. To solve this, scientists have been looking 
for other sources of pluripotent cells. This led to the cornerstone discovery of 4 key 
factors, which were able to induce pluripotency in somatic cells (Takahashi and  
Yamanaka, 2006). This has rekindled many efforts for future developments in the 
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Figure 1.5 - The characteristics of a true embryonic stem cell 
After Smith, 2001 
 
field of regenerative medicine. 
 
Takahashi and Yamanaka (2006) showed that the genes Oct4, Klf4, c-Myc and Sox2 
can induce pluripotency when introduced into a terminally differentiated cell. The 
resulting cells are thus called induced pluripotent stem cells or iPS cells. Although 
direct therapeutic results by means of cell transplantation of iPSC-derived cells are 
not yet possible for safety concerns, iPS cells have proved of a great significance for 
the creation of models of human disease and provided us with an invaluable tool to 
study the molecular mechanisms of some pathologies and to test for potential 
therapeutic targets, in vitro and on human tissue. This means that once methods for 
the differentiation of ESCs have been established, they could also be transferred to 
the differentiation of iPS cells to renal cells. 
 
 
1.6.1.3 How is pluripotency maintained? 
The two properties of ES cells, which make them extremely interesting, are their 
abilities to differentiate to all germ layers and to self-renew indefinitely. At the dawn 
of embryonic stem cell research, there was no scientific evidence of what governed 
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pluripotency and managed to maintain these cells undifferentiated in in vitro culture. 
ES cells were first cultured on STO feeders and in conditioned medium obtained 
from teratocarcinoma cell lines (Martin, 1981). The unknown factor, which could be 
obtained from STO mouse fibroblasts or from buffalo rat liver cells, was shown to 
maintain embryonal carcinoma cells and embryonic stem cells in an undifferentiated 
state (Smith and Hooper, 1987; Koopman and Cotton; 1984). Thus, it was referred to 
as DIA, or differentiation inhibitory activity (Williams et al., 1988). Williams et al. 
(1988) noticed a structural similarity between partially purified DIA and myeloid 
leukaemia inhibitory factor (LIF). They managed to prove that supplementing 
cultures of mouse ESCs with LIF was able to maintain them in pluripotent state, as 
shown by chimera formation. Nowadays, it is possible to culture mESCs without 
feeders in LIF-containing medium (Smith et al., 1988; Williams et al., 1988). 
Furthermore, the pathways governing pluripotency start to be understood much better 
than before, which has led to the development of a chemically defined medium based 
on inhibitors, which is not only able to maintain the undifferentiated state of mESCs, 
but proves to be better than conventional methods (Silva et al., 2008). In mouse ES 
cell culture, LIF and serum (BMP) block differentiation by activation of STAT3 and 
inhibition of differentiation proteins. However, these pharmacological inhibitors 
(CHIR99021, PD184352 and SU5402) were sufficient for maintenance of 
pluripotency in mESCs (Ying et al., 2008). They act upstream of LIF/Stat3 by 
blocking phospho-Erk-mediated signalling from the FGF receptor and inhibition of 
GSK3 to enhance ES cell proliferation and survival (Ying et al., 2008). These studies 
have also led to the theory that ESCs do not require external signals to remain 
pluripotent and will do so as long as differentiation signals are absent, which was 
named the “ground state of pluripotency”. 
 
Further aspects of the major regulatory pathways implicated in the maintenance of 
pluripotency have also been described. It has been reported that Stat3 activation by 
gp130 (glycoprotein 130, which interacts with the LIF receptor) is essential for 
maintenance of pluripotency (Niwa et al., 1998). It is also dependent on the intrinsic 
activity of the octamer-binding transcription factor Pou5f1 (Oct3/4). Chambers et al. 
(2003) have also further indentified that Stat3/Oct4 can be bypassed by the 
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overexpression of the transcription factor Nanog to sustain pluripotency. At the same 
time, Oct4 and Sox2 (which belongs to the SRY-related HMG-box family 
transcription factors) have been shown to act in consort to regulate pluripotency and 
to participate in a complex regulatory network, where they cross-activate and auto-
activate their own promoters (Chew et al., 2005). The Oct4-Sox2 complex has been 
proven to bind to the Nanog promoter, as well (Rodda et al., 2005). Interestingly, it 
seems like Nanog is dispensible for inducing pluripotency, or lies downstream of 
Oct4 and Sox2, as it is not among the 4 genes, which were used for the generation of 
iPSCs (Takahashi and Yamanaka, 2006). 
 
Although all these genes are important for the maintenance of pluripotency and are 
therefore considered as ES cell markers, it is important to note that they are not 
expressed only in the ICM in the short span of time when embryonic stem cells are 
isolated. Oct4 expression is also maintained in the epiblast and persists in primordial 
germ cells throughout development. Similarly to Oct4, Sox2 is first expressed in the 
blastomeres of the 4-cell stage embryo and persists in the ICM and then epiblast 
(Avilion et al., 2003; Chew et al., 2005). Nanog transcript first appears in the ICM of 
the morula prior to blastocyst formation (Mitsui et al., 2003; Chambers et al., 2003). 
It seems like Nanog is switched off after implantation, but then reappears in the 
proximal epiblast at about E6.0 (Avilion et al., 2003). 
 
1.6.1.4 Other types of stem cells 
To illustrate the difference between pluripotent stem cells (ESCs and iPSCs) and 
other types of stem cells, a short overview of the latter is also given. Another class of 
stem cells are the adult or tissue-specific stem cells. They are found in already 
formed organs in the adult organism and are believed to function in the body as its 
natural mechanism to constantly repair itself. Interest in these cells grows and 
together with research and the number of reports, the notion that almost every organ 
contains stem cells is also becoming increasingly popular. Similarly to a pluripotent 
stem cell, a single (clonal) adult stem cell can both self-renew and differentiate to 
multiple lineages usually associated to the organ it came from (reviewed by 
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Weissman, 2000; Gage, 2000). Though unlike pluripotent stem cells, adult stem cells 
cannot make all cells of the body, but only a very limited number of cells types.   
 
The discovery of stem cells, which are able to replenish tissues, dates back to the 
1960s when experiments with radiational ablation of bone marrow cells in mice were 
performed (McCulloch and Till, 1960; Till and McCulloch; 1961; Siminovitch et al., 
1963; Becker et al., 1963; Till et al., 1964). Till et al. (1964) were the first to describe 
some of the basic processes related to haematopoietic stem cells (HSCs). Since then, 
stem cells in various organs have been reported. Some of the more prominent studies 
include - intestinal, skin, neural, uterine, mesenchymal and haematopoietic cells 
(reviewed by Gage, 2000; Weissman, 2000; Barker et al., 2010). Scientists still 
disagree about the true stemness of some proposed types of adult stem cells, for 
example, putative kidney stem cells.  
 
The classes of stem cells are not even limited to embryonic and adult stem cells. It 
has been found that stem cells are present in extraembryonic tissues and 
compartments. For example, umbilical cord blood stem cells are found in the 
placenta after a baby is born (reviewed by Dovat and Feig, 1997). Although, they are 
isolated from extraembryonic tissue, and indeed from a very unique source, they 
have been characterised as hematopoietic stem cells and other abilities that they have 
been suggested to possess remain disputable. Amniotic fluid stem cells have also 
been discovered and their properties are also of a large scientific interest (Prusa et al., 
2003; Prusa et al., 2004; Tsai et al., 2005). 
 
In summary, over time, there have been multiple discoveries that many types of 
explanted cells have the ability to replenish themselves, which has increased the 
hopes that potential cell-based therapies for regeneration of diseased tissue might be 
possible. The fact that the differentiation abilities of adult cells are 
 limited has made ESCs a very attractive source for obtaining virtually unlimited 
numbers of the necessary tissue-specific differentiated cells. The discovery of iPS 
cells has also initiated numerous discussions about their regenerative potential. On 
one hand, their ESC-like pluripotency (and therefore wide differentiation potential) 
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makes them a highly attractive source of differentiated/progenitor cells. iPS cells 
have even demonstrated at least two advantages over ES cells - their derivation is not 
ethically controversial; and they are donor - specific, which makes them a potential 
advanced autologous therapeutic product that does not require immunosuppression. 
Still, the properties of induced pluripotency have not been fully characterised, so a 
direct substitution of ESCs with iPSs is not yet possible and proof-of-principle 
studies should be first performed with ES cells.  
 
1.6.2 Embryonic stem cell differentiation to a renal lineage – a 
literature review 
Unlike many other types of cells that have been produced in vitro from ES cells, the 
generation of kidney cells remains relatively refractory to directed differentiation. 
Spontaneous ES cell differentiation or the use of strictly defined protocols has 
efficiently generated other mature cells, for example, beating cardiomyocytes or 
mature neurons (van Laake et al, 2007 and Brüstle et al., 1997). Unlike these cells, 
which are recognisable by a beating activity or a very particular morphology (in a 
combination with molecular, histochemical and functional methods), renal cells are 
difficult to detect. Another level of complexity to recognising kidney cells is the lack 
of a single renal marker for committed progenitor cells. All these setbacks have made 
it very difficult to study the derivation of renal progenitors from ES cells and later - 
iPS cells. A few groups have used various differentiation methods or transplantation 
to look for mES cell-derived renal cells (Kim and Dressler, 2005; Steenhard et al, 
2005; Kramer et al., 2006; Vigneau et al., 2007; Bruce et al, 2007; Morizane et al., 
2009; Ross et al., 2009; Ren et al., 2010). An overview of these studies is given in 
Table 1.2.  
 
Due to the difficulty of finding a single early kidney cell marker, these studies have 
frequently used a combination of genes to look at the mRNA profile of differentiated 
embryoid bodies on the basis of reverse transcription PCR. The limitation of this 
method is that it detects gene expression in a pool of cells rather than single cells and 
is therefore not indicative of the co-expression patterns of a combination of genes in 
individual cells. Furthermore, in the process of ESC differentiation in general, 
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pluripotency markers like Oct4, Nanog, AP, telomerase are progressively 
downregulated, while all genes specific for more differentiated states and specified 
populations of cells increase by default. When analysing the influence of chemicals 
on the differentiation potential of ES cells, usually a control (untreated) and an 
experimental (treated) groups are present (an untreated group has not always been 
provided). Noting a downregulation of pluripotency genes and upregulation of the 
gene of interest in the experimental sample, though, might have two interpretations. 
Indeed, more cells might have differentiated to the cell type of interest, but also - 
more cells might have differentiated in general. The latter possibility might mean that 
the provision of specific molecules might be responsible for speeding up the process 
of differentiation, rather than forcing cells down a certain lineage. Secondly, when 
looking for kidney cells, which cannot be traced by a single marker molecule, but 
require detection by a combination of genes, upregulation of two genes of interest in 
the sampled pool of cells does not directly mean that one population of cells co-
expressing the genes exists; there might be two other distinct populations of cells 
which have upregulated either gene A or gene B. Only a few of these studies have 
tried to address the presence of non-kidney cells in the differentiated EBs by 
screening for a limited number of non-kidney related genes (Bruce et al., 2007; 
Vigneau et al., 2007; Mae et al., 2010). Furthermore, although scientists have 
revealed a lot of information about gene expression patterns in living organisms and 
their development, it is important to note that these patterns can be altered by in vitro 
manipulations. This might be especially relevant for ES cell differentiation, as during 
ex vivo procedures, these ICM-like cells do not receive the correct signals present in 
development. There have been no reports to disprove the possibility for cells being 
arrested at a partially programmed stage in their differentiation or expressing a 
combination of genes, which would not normally be seen in development, therefore, 
virtually creating a cell existing only in vitro, or possibly in malignancies, might not 
be impossible.  
 
In addition to conventional differentiation by supplementation with small molecules 
and growth factors, transgenic lines have also been created to test for the in vitro 
nephrogenic potential of ES cells. Kobayashi et al. (2005) have genetically 
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engineered mESCs to express Wnt4 before differentiating them via the EB method. 
They reported that the water transport transmembrane protein Aquaporin2 was 
upregulated when the transfected cells were treated with a combination of HGF and 
Activin A (Aquaporin2 is a water channel regulated by anti-diuretic hormone and is 
critical for water absorption in the kidney; Takata et al., 2008). Although, tubular 
structures were formed in teratomas, a very careful examination would be necessary 
to understand more closely what the properties of these tubules are.  
 
Other growth factors have also been used for induction of renal genes in wild-type 
cells - a combination of activin A, bone morphogenetic protein 7 (BMP7), BMP4 and 
retinoic acid (Kim and Dressler, 2005); activin alone (Vigneau et al., 2007); BMP4 
alone, both in serum and serum-free medium (Bruce et al., 2007) or the sequential or 
combinatorial use of three small molecules and retinoic acid (Mae et al., 2010). 
Kramer et al. (2006) have tested the intrinsic potential of ES cells to give rise to 
kidney cells spontaneously when differentiated via the EB method without the 
addition of growth factors. 
 
Only quite recently were iPS cells tested for their ability to differentiate to renal cells 
(Morizane, 2009). Gene expression studies, based on PCR suggested that iPS cells 
have a potential very similar to ES cells, but exhibited attenuated expression of 
kidney markers. Recently, a few groups have reported work on differentiation of 
human ES cells to a renal lineage (Batchelder et al., 2009 and Dolt, personal 
communication), also with limited success.  
 
Despite the fact that there have been several studies on the in vitro renogenic 
potential of ES cells, unfortunately the information obtained is still not thoroughly 
comprehensive and robust.  These studies have not yet been expanded further in 
additional reports to clarify some of the mechanisms and processes of differentiation 
and improvements of already reported methods have not been suggested. Unlike 
other branches of directed differentiation, the renal lineage seems to be only in its 
dawn and many more studies are necessary. In order to solve some of the potential 
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differentiated via the 
EB method and 
treatment with HGF 
and Activin A 
reverse transcription 
PCR; quantitative PCR; 
western blot for Aqp2; 
immunocytochemistry 
for kidney markers; 3D 
assay for tubule 
formation 
reported expression 
of Aqp2 by PCR, 









mESC injected into 
kidney rudiments 
assessment of cell 
integration into kidney 
tubules by β-Gal+ and 
electron microscopy; 
immunohistochemistry 
of injected kidney 
rudiments for kidney 
markers 
integrate into kidney 
structures as 
assessed by β-Gal, 
electron microscopy 
and adenovirus 






ROSA26 ESCs - 
derived EBs treated 
with a combination of 
retinoic acid, Activin 
A and Bmp7 
western blotting and 
reverse transcription 
PCR of EB extracts; 
immunohistrochemistry 




kidney markers; EBs 
show co-expression of 
E-cadherin and Pax2 
and respond to 
induction with spinal 
cord; EB-derived cells 
integrate into kidney 
rudiments 
Bruce et al., 
2007 
mESC genetically 
modified to express 
kidney-specific Pax2 
reporters were 
differentiated via EBs 
and treatment with 
Bmp2, 4 and 7 
real-time PCR for 
kidney-specific genes, 
presence of reporter 
positivity in EBs; 
immunocytochemistry; 
FACS 
upregulation of kidney 
markers over time and 
after some of the 
treatments; suggest a 
spontaneous kidney 
differentiation 
program in EBs grown 
in serum or serum-
free conditions when 
supplemented with 
BMP4 





GFP mESCs were 
differentiated via the 
EB method, sorted 
for Brachyury, treated 
with Activin A and 
injected into kidney 
rudiments 
FACS selection for 
Brachyury+ cells after 
treatment with Activin 
A; gene expression 
studies by reverse 
transcription PCR and 
immunohistochemitry of 
the resulting EBs; 
integration studies in 
kidney rudiments 
upregulation of kidney 
progenitor genes after 
FACS selection and 
treatment with Activin 
A; decrease of neural-
specific genes; 
incorporation of the 
derived cells into 
priximal tubules and 





mESC and iPS were 
differentiated via the 
EB method, by the 
addition of Activin 
and in some cases 
other factors 
(Gremlin, Wnt4, 
Gdnf, Gdf11, LIF and 
BMP7 
real-time PCR upregulation of kidney 
genes after 
differentiation as 
detected by real-time 
PCR (Pax2, WT1, 
KSP, Nephrin, Ngn2) 
Ross et al., 
2009 
eGFP-labelled mESC 
were examined for 




differentiate to kidney 
cells 
tracking the ability of 
cells to repopulate the 
decellularised organ 
and differentiate by 
microscopy; kidney 
gene expression by 
immunohistochemistry 
and real-time PCR 
migration of cells and 
repopulation of the 
decellulrised matrix; 
positivity for Pax2 and 
Ksp-cadherin after 
long-term culture by 
immunohistochemistry 
and PCR 
Ren et al., 
2010 
mESCs differentiated 
with the EB method 
by an initial treatment 
of retinoic acid and 
Activin A and a 
subseqent treatment 
with conditioned 





ESC derived cells 
transition through 
mesoderm to give rise 
to cells expressing 
kidney markers 
Mae et al., 
2010 
mESC differentiated 
by small molecules 
and retinoic acid 
gene expression by 
reverse transcription 















detect marker co-expression in individual cells should be employed to study in vitro 
ESC differentiation to renal progenitors. Such an approach would help scientists 
circumvent at least one of the caveats of studying kidney development - or the 
frequent inconclusiveness and possible misinterpretations based on reverse 
transcription studies of mixed populations of cells. Single-cell and three dimensional 
studies of kidney structures would help confirm without any doubt that transplanted 
cells localise in renal tubules and very careful and stringent co-expression studiesand 
in situ hybridisation for multiple markers should confirm the identity of the cells in 
question.   
 
As the results from in vitro differentiation studies need significantly more 
improvement, it might be necessary to approach the problem from two sides and add 
the dimension of developmental biology with a particular reference to ES cell 
differentiation. Up to now no developmental studies have been performed to directly 
translate to stem cell differentiation. Paradoxically, at the same time, almost all of the 
outlined studies have made use of information related to the normal processes of 
kidney development that would happen in embryogenesis - transition to primitive 
streak and mesoderm, acquisition of intermediate mesodermal properties and the 
influence of nephrogenic factors. This reveals that careful experiments with early 
embryos have to be performed to obtain some missing links in these areas. For 
example, it would be particularly interesting to address the following scientific 
problems: 1 – the timing of acquisition of renogenic potential in development; 2 - the 
position and characteristics of these early renocompetent cells; 3 – the question of 
whether a transition through mesoderm and intermediate mesoderm is required for 
differentiation or whether it is possible to generate kidney cells via alternative routes. 
Another more general, but fundamental, issue remains to be clarified as well. In spite 
of the existence of a number of publications reporting the differentiation of ES cells 
to a renal lineage, 5 years after the first reports, no improvements to these protocols 
were reported and the studies have not been taken further. Also, no attempts for the 
isolation and purification of ES cell - derived kidney cells have been reported. This 




Figure 1.6 - Interconnectedness between embryonic stem cell research, kidney 
development and potential clinical applications 
In yellow - connections between ES cell research and kidney development 
In pink - potential applications of ES cell research to clinical studies 
In blue - potential relevance of kidney development to clinical studies 
Two-headed arrows denote a potential bidirectional transfer of information 
KD - kidney development 
1.7 Perspectives 
In this section, I would like to discuss briefly the possible impact of this scientific 
work by drawing the connections between two different scientific areas and add the 
additional aspect of their potential application in clinical practice. Some of the 
relationships between these three pivotal foci are illustrated in Figure 1.6. First, the 
interconnectedness between kidney development and ES cell biology is much more 
direct. For instance, experiments examining early kidney development in 
embryogenesis might provide important insight for improving ESC differentiation to 
kidney cells and vice versa – understanding early embryonic development and 
kidney development would pave the path to understanding how cells take lineage 
decisions and make fate commitments. Although, some information is available 
about the signals that might be involved in various steps (as described earlier in this 




cells and whether passing through developmental stages sequentially (for example, 
mesoderm and intermediate mesoderm) is indispensable or a sufficient condition in 
the process. Solving this question is of great significance to understanding kidney 
development, but even more so to understanding cell behaviour and specification in 
vitro. Evidence indicating that cells can leap across their developmental chronology 
of fates would lead to radical changes in the current concept of commitment.  
Understanding normal development is a prerequisite for understanding the cellular 
and molecular basis of disease, which then reflects into the development of methods 
for treatment. At the same time, if the knowledge accumulated by studying kidney 
development could be applied to generating ESC-derived renal cells the possibilities 
for clinical improvements will be highly increased. ESC-derived renal cells could be 
immediately used for large-scale drug screening experiments. In addition, the 
possibility to use iPS-derived renal cells would be even more exciting as this would 
allow screening of the influence on drugs on particular diseased renal cells in 
unlimited quantities. In addition to drug screening, ESC or iPSC-derived renal cells 
might prove useful in medical devices to improve the quality of life of patients on 
dialysis. As mentioned earlier in the chapter, the function of the kidneys is not only 
limited to excretion of urine. They are important in maintaining a healthy water-salt 
balance and are a part of the endocrine system producing essential hormones. 
Bioartificial hemofilters containing human proximal epithelial cells have already 
been designed to address this problem and clinical trials are underway (Humes et al., 
1999; Humes et al. 2004). The possibility of using functional and responsive ESC- or 
iPSC-derived kidney cells could provide an unlimited number of proximal tubular 
cells for these devices. 
 
In addition to their potential use for developmental studies, modelling disease, and 
drug screening, ESC- or iPSC-derived renal cells might find a place in cell 
replacement therapies to substitute for cells lost in damaged organs. Although this is 
not yet possible due to safety and ethical (in the case of ESCs) concerns, in vitro-






Materials and methods 
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2.1 Mice and Mating 
2.1.1 Mouse strains 
All animals were maintained and sacrificed in compliance with the Animals 
(Scientific Procedures) Act (1986) and the appropriate Home Office guidelines on 
the Act.  Animals were obtained from and maintained under the care of BRR, CIP, 
University of Edinburgh. CD1 mice were used for isolation of wild-type tissues. 
TgTP6.3 transgenic mice (Pratt et al., 2000) were used for isolation of GFP+ tissues. 
These were a kind gift from Dr. Thomas Pratt, University of Edinburgh. TgTP6.3 
mice express a Tau-GFP fusion protein under the CAG promoter and therefore show 
GFP-positivity at comparable levels in most cells and tissues.  
 
Timed matings were carried out according to the standard for the animal facility 
procedures. Two females and one male were set up in a single cage in the evening 
and plugging was monitored on the following morning. The morning of discovery of 
the vaginal plugs was designated E0.5. Stock TgTP6.3 mice were kept in 
Individually Ventilated Cells (IVCs). Breeders were maintained in conventional 
cages. 
 
2.1.2 Genotyping  
CD1 wild type females and TgTP6.3 transgenic males were mated for the generation 
of GFP-positive embryos. As reported by Pratt et al. (2000), homozygosity of the 
transgene (TgTP6.3+/+) leads to lethality in early embryonic development. 
Hemizygotes are GFP-positive and survive without any noticeable phenotypic 
differences from wild type (WT) mice. When breeders (hemizygotes for the 
transgene - TgTP6.3+/-) were mated with WT female CD1s, the possible resulting 
phenotypes were only TgTP6.3+/- (GFP-positive) and TgTP6.3-/- (i.e.WT). In that 
case, it was possible to determine the genotype of pups born (ear clips) and embryos 





Figure 2.1 – Genotyping of tauGFP mice 
A and B - ear clips of GFP-negative pups resulting from a cross between a WT female and a 
hemizygous for the transgene male showing no fluorescence. Fur is slightly autofluorescent; C 
and D - micrographs showing the easily distinguishable phenotype of hemizygous pups (with 
black and white coat, respectively A and B). All micrographs were taken at the same exposure 
time 
2.2 Tissue culture 
2.2.1 Isolation of E11.5 kidney rudiments 
Embryos were removed from the mouse uteri with the help of forceps and a surgical 
blade. 25 gauge needles (BD Microlance) attached to 1mL syringes were used for all 
finer dissections. The embryos were decapitated and all tissues rostral to the 
developing hind limb buds were removed in one single incision with the needles. The 
caudal parts of the embryos were bisected along the midline to allow access to the 
kidney rudiments, located dorsally to the hind limb buds and WD. The rudiments 
were carefully dissected out and cultured in Complete Kidney Culture Medium 
(CKCM) consisting of Minimal Essential Medium (MEM) with non-essential amino 
acids (Sigma), 10% fetal calf serum (Biosera), 100units Penicillin and 100µg/mL 
Streptomycin (Sigma). All kidney cultures were kept at 37°C in a humidified 
incubator with 5% CO2. Caudal parts that were not required for immediate use were 
A                              B
C                              D
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Figure 2.2 – Isolation of tissue from E9.5 embryos 
 A - a typical E9.5 mouse embryo: B - a micrograph of an E9.5 bisected caudal part, the tissue 
isolated for experiments has been showed by a red dotted line 
A                               B
preserved in Bijoux bottles containing dissecting medium at 4ºC for up to 2 days 
(Davies, 2006). 
 
2.2.2 Isolation of tissues from E10.5 embryos 
The embryos were carefully removed from the uterus by an incision in the amniotic 
sac and decapitated. Caudal halves were collected for tissue dissection.  
Before dissection, the bisected caudal parts were carefully examined to identify the 
correct stage of kidney development progression. Only embryos, which showed a 
slight enlargement of the Wolffian duct, but no formation of a UB invading the 
neighbouring uninduced MM were used for experiments. 
 
2.2.3 Isolation of tissues from E9.5 embryos 
Embryos were obtained by a quick scalpel incision cutting the uterus and amniotic 
sac.  The embryos were teased out by gently squeezing the surrounding tissues with a 
pair of forceps. Embryos were examined and staged. E9.5 embryos from the same 
uterus were found in stages ranging from E9.0 to E10.25. Whenever possible, only 
embryos at Theiler stage 15 were selected for tissue harvesting. In this case, the 
number of somite pairs (21-29) and absence of hind limb buds were used for 
determining the stage. Due to the scarcity of embryos in some experiments, embryos 
with initiated hind limb buds, but without visibly formed metanephric anlagen (early 
Theiler stage 16) were used. Needles were used for embryo decapitation and the 
dissection of the nephrogenic region, shown on Fig. 2.2 by a red dotted line.  
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Figure 2.3 – Isolation of tissue from 
E8.5 embryos 
A typical E8.5 mouse embryo; scale 
bar: 100µm 
Figure 2.4 – Typical E7.5 embryos 
Micrograph of E7.5 embryos isolated from 
the same uterus, showing different size and 
stage of development 
2.2.4 Isolation of tissues from E8.5 embryos 
The obtained mouse uterus was cut into pieces containing one implantation site each 
by forceps dissection. Embryos were obtained by a sufficiently large incision with a 
scalpel in the individual pieces of uterus. Only embryos at approximately Theiler 
stage 13 were selected for use in experiments. 
These typically contained 7-12 formed somite 
pairs and some showed initiated development of 
the mandibular component; neural tube closure 
had taken place only until the proximal part of 
the tail. An example is shown on Figure 2.3. The 
tissue dissected for experiments is indicated by a 
red dotted line. The incision to separate the 
caudal from the rostral part was always made 
after the last fully formed somite pair. 
 
2.2.5 Isolation of E7.5 embryos  
The two uterine horns were separated and 
surrounding fat was removed. At this 
embryonic stage, the embryo implantation 
sites were still visible as distinct bulges on 
the uterus. They were segmented by 
forceps dissections and embryos were 
carefully extracted by opening the decidua 
from the implantation side. All 
extraembryonic tissues were removed and 
whole embryos were used for the 
experiments. Embryos obtained from the 
same uterus showed a great variation in size and development (Figure 2.4). Embryos 
selected for experiments had to fulfill the following criteria: 1 - were in the pre-
somite stage and 2 - exhibited neural plate in the stage of head fold formation. 
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2.2.6 Isolation of mesonephroi from E11.5 mouse embryos 
Embryos were obtained as described for E11.5 kidney rudiments. The embryos were 
sacrificed by decapitation. Tissues rostral to the forelimbs were removed, as well as 
tissues ventral to the fore- and hind-limb buds (inner organs), including the limb 
buds. The remaining portion of the trunk was bisected along the spinal cord, 
exposing the meta- and mesonephroi. The whole gonad-mesonephros region was 
dissected out, followed by removal of the gonad.  
 
2.2.7 Isolation of spinal cord 
E11.5 mouse embryos were used for the isolation of dorsal spinal cord. After 
sacrificing the embryos, caudal parts were kept for kidney isolation and the rest of 
the body was used for spinal cord isolation. First, the anterior limbs and viscera were 
removed. A thin dissecting needle was inserted in the anterior opening of the spinal 
canal and a second dissecting needle was used to rupture the dorsal spinal cord along 
the midline, by stroking movements along the first needle. The bisected spinal cord 
was opened to the side (as shown on Figure 2.6) and the clear parts (dorsal spinal 
cord) were excised leaving the ventral spinal cord and the somites.  
Figure 2.5 – Isolation of mesonephroi 
Light micrographs of a gonad-mesonephros region from an E11.5 mouse embryo. The gonad, 
mesonepros, mesonephric tubules and mesonephric duct are shown by arrows. The red dotted 






tubules Line of dissection 
Mesonephros 
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Figure 2.6 - Isolation of spinal cord 
After sacrificing the embryos by decapitation, the caudal parts and viscera were removed leaving 
the dorsal portion of the trunk containing somites and spinal cord (as shown on the diagram). The 
dissected tissue was placed on its ventral side and by inserting a needle in the spinal canal, the 
dorsal spinal cord was cut along the midline. Unfolding it to the side allowed removal of a 
longitudinal piece of dorsal spinal cord 
 
 
2.2.8 Tissue culture on filters 
The obtained kidney rudiments or other tissues were cultured on sectioned 5µm 




Sample on filter paper 
Sample on filter paper 
Trowell metal screen 
CKCM 
Cell culture dish 
Air-medium interface 
Figure 2.7 – Tissue culture setup 
A diagrammatic representation of conventional tissue culture, showing a 3.5 cm cell culture dish 
with a sample cultured on a piece of polycarbonate filter placed on a Trowell metal screen at the 
medium-air interface 
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2.2.9 Co-culture of tissues and dorsal spinal cord 
Tissues were harvested as described in previous sections and placed on filters. Long 
stripes of dorsal spinal cord were dissected as previously described and placed within 
physical contact with the sample, encircling it. Small square pieces of spinal cord 
were used for inducing isolated MMs. 
  
2.2.10 Disaggregation of tissues into single cells 
Tissues (e.g. E11.5 kidney rudiments or nephrogenic regions from earlier embryos) 
were obtained by a mechanical dissection in serum-free medium, as previously 
described. During long waiting periods, the samples were kept in dissecting medium 
at 37ºC and 5% CO2 in a humidified incubator until used. Tissues were transferred to 
a 3.5cm dish with pre-warmed 1x Trypsin-EDTA solution (containing 0.25% 
Trypsin and 0.1% EDTA in Hank’s Balanced Salt Solution) with the help of a flame-
polished Pasteur pipette. The enzymatic treatment was carried out for 2min at 37ºC. 
The samples were collected with a glass Pasteur pipette and moved to a new tissue 
culture dish containing CKCM for 5 min to stop the trypsinisation. After being 
placed in a 1.5mL microcentrifuge tube, in 200µL of Advanced Dulbecco’s Modified 
Eagle’s Medium (DMEM), the clumped treated tissue was disaggregated by vigorous 
trituration until a single-cell suspension was obtained. An adjustment to this 
procedure was made for treating E7.5 embryos, where the incubation time in 
Trypsin-EDTA was increased to 3min.  
 
2.2.11 Reconstruction of kidney-like rudiments from mixtures of 
single-cell suspensions 
First, single cell suspensions were generated from either tissues or adherent cells and 
the numbers of cells were counted. In the case of adherent cells or disaggregated 
embryoid bodies, the cells were passed through a 40µm cell strainer to make sure 
that no clumps of attached cells were present, interfering with the production of fine 
chimerism with the kidney rudiment cells. Althought the 40µm strainer generates 
mainly single cells, occasional aggregates were also present. In most cases 100,000 
embryonic kidney cells (host cells) were mixed with 10,000 or 15,000 test cells in a 
0.5mL microcentrifuge or a PCR tube. The suspensions were mixed immediately 
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before centrifugation at 3,000rpm for 2min. The pellets were detached from the tubes 
by careful flushing with a 200µL pipettor set to 100µL and transferred to filter 
culture with a flame-polished glass Pasteur pipette. Pellets were cultured in CKCM 
supplemented with ROCK inhibitor (as described in section 2.5) for 24h and only 
CKCM thereafter. 
 
2.3 Fixation and immunohistochemistry (IHC) 
2.3.1 Methanol fixation 
Tissues were fixed by replacing the culture medium with ice cold methanol (-20°C) 
by gentle pipetting and incubation for 10min at room temperature. Before 
immunostaining, the pieces of filter with rudiments immobilised on them were 
placed in Bijoux bottles with PBS. Two short washes with PBS were followed by a 
wash for 30min at RT. The PBS solution was then directly replaced with 400µL of 
primary antibody solution. 
 
2.3.2 Paraformaldehyde fixation 
Tissues were fixed by replacing the medium with 4% Paraformaldehyde (PFA) in 
PBS and incubated for 30min. The samples were then rinsed two-three times with 
PBS, left to wash in PBS for 30min and permeabilised with 0.1% Triton-X in PBS 
for 30min. Both incubations were performed at room temperature. The final solution 
was then replaced by primary antibody solution. 
 
2.3.3 PFA-methanol co-fixation of pelleted cell mixes or tauGFP cells 
Samples we fully immersed in PFA and incubated for 30min at room temperature. 
They were then rinsed 2 times with PBS and incubated in PBS at room temperature 
for another 30min. Tissues were post-fixed with ice-cold methanol for 10min and 
then stored in methanol at -20ºC in light-protected Bijoux bottles.  
 
2.3.4 Immunostaining 
Freshly fixed tissues or tissues stored in methanol at -20°C were stained as follows: 
the samples were rehydrated and washed in PBS for at least 30min prior to staining;  
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Table 2.2 – List of secondary antibodies 
A list of secondary antibodies (used in different combinations for double- and triple - labeling 
experiments) with details about dilutions and purchasing information 
Table 2.1 – List of primary antibodies 
A list of primary antibodies (used in different combinations for double- and triple - labeling 










Antibody Company Dilution Catalogue No 
mouse anti-human WT1 (monoclonal) Dako 1:50 M3561 
mouse anti-Calbindin (monoclonal) Abcam 1:100 ab82812 
rabbit anti-Laminin Sigma 1:100 L9393-5mL 
rabbit anti-Six2 Lifespan 1:200 LS-C10189 
rabbit anti-Pax2 (polyclonal) Covance 1:100 PRB-276P 
mouse anti-E-cadherin  
BD Trasduction 
Labs 1:100 610181 
rabbit anti-Calbindin D-28K Chemicon 1:100 AB 1778 
goat anti-megalin (P-20) (polyclonal) Santa Cruz 1:50 sc-16478 
Mouse anti-Oct3/4 BD Biosciences 1:150 611202 
Antibody Company Dilution Catalogue No 
goat anti-mouse IgG - FITC Sigma 1:100 F0257-2ml 
goat anti-mouse IgG - TRITC Sigma 1:100 T5393-1ml 
goat anti-rabbit IgG - FITC Sigma 1:100 F9887-.5ml 
goat anti-rabbit IgG - TRITC Sigma 1:100 T5268-1ml 
donkey anti-mouse IgG - AlexaFluor 647 Invitrogen 1:100 A31571 
goat anti-rabbit IgG - AlexaFluor 647 Molecular Probes 1:100 A21244 
chicken anti-goat IgG-FITC Santa Cruz 1:100 sc-2988 
chicken anti-goat IgG-Rhodamine Santa Cruz 1:100 sc-2860 
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Table 2.3 - List of fluorescently conjugated lectins used for IHC 
primary antibody incubations were done at 4°C overnight, followed by 2 short 
washes in PBS and an incubation in PBS for 3-6h; samples were left in secondary 
antibody overnight at 4°C and washed for at least 1h at RT before mounting for 
microscopy. As the immune system in mouse embryos is not yet developed 
(reviewed by Landreth, 2002) there are no immunoglobulins and Fc receptors, which 
allows the use of mouse primary and secondary antibodies raised without non-
specific staining or problems with background. 
 
2.3.5 Antibody/lectin co-staining 
Lectins were commercially available already conjugated to fluorophores and were 
therefore applied to samples together with secondary antibodies. All samples that 
were co-stained with antibodies and lectins were blocked with 1% milk (dried 





2.3.6 Oct4 staining of mouse ES cells  
Oct4 staining of WT or tauGFP+/- ESC was performed as follows: cells seeded on 
cover slips were washed in PBS for 30-60min prior to staining; primary antibody 
(mouse anti-Oct3/4, BD Biosciences) was applied for 2h at RT; cells were rinsed 
with PBS 2x and incubated in PBS for a further 1h at RT; the cells were incubated in 
secondary antibody for 2h at RT, washed with PBS for 30-60min and the cover slips 




Lectin Company Concentration Catalogue No
DBA Lectin - FITC Sigma  10µg/mL L9142-1MG 
DBA Lectin - TRITC Sigma  10µg/mL L9658-2MG 
LTL Lectin - fluorescein  Vector 1:100 FL-1321 
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2.3.7 Nuclear staining with DAPI 
DAPI was obtained from Invitrogen, reconstituted to a stock concentration of 
10.9mM and used at a final concentration of 300nM. For tissue counter-staining 
DAPI was applied together with the secondary antibody solution and incubated 
overnight at 4°C to allow for even penetration. Monolayers of cells were stained with 
DAPI for 5min at RT. 
 
2.4 Cell culture 
2.4.1 Counting cells 
After disaggregation to single cells, the cells were resuspended in a known volume of 
medium and mixed well by pipetting. 10µL cell suspension were aspirated and 
mixed with 10µL Trypan Blue. 10µL of this mixture were applied onto a Neubauer 
counting chamber and 5 squares were counted. The number of cells per mL was 
calculated by averaging the number of cells obtained from the 5 squares, multiplied 
by the dilution factor (2) and the chamber factor (10,000). 
 
2.4.2 Routine culture of mouse embryonic stem cells 
Mouse embryonic stem cells (mESC) were kept in ESC medium (Advanced DMEM 
(12491-015, GIBCO), 10% ESC-grade fetal calf serum (PAA), 1000U/mL LIF, 
2mM L-glutamine, 5µM 2-mercaptoethanol, 100U/mL Penicillin and 100µg/mL 
Streptomycin.  
tauGFP+/- ESC were kept under Puromycin selection at all times, where ESC medium 
was supplemented with Puromycin (Sigma) to a final concentration of 2µg/mL. 
Oct4-GFP ESCs were cultured in medium, supplemented with 400µg/mL G418 
(Sigma). ESC lines were cultured on gelatinised cover slips and supplied with fresh 
medium every 2 or 3 days. 
 
2.4.3 Passaging of mouse embryonic stem cells 
The adherent cells in 6-well plates were washed once with pre-warmed PBS and 
incubated in 1mL 1x Trypsin-EDTA solution for 5min at 37°C. The enzymatic 
treatment was stopped with 1mL ESC medium, the cells were collected, triturated to 
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generate a homogenous single cell suspension and centrifuged. The pellet was 
resuspended in 1-3mL of ESC medium, mixed well and a few droplets of cell 
suspension were added to freshly gelatinised 6-well plates containing 2mL ESC 
medium. 
 
2.4.4 Thawing of cells 
Vials were kept on ice after being removed from liquid nitrogen, until thawed rapidly 
by immersing their bottom half in a 37°C water bath for 1-2 min. The cell suspension 
was aspirated with a pipette containing 1mL normal culture medium, directly 
transferred to a 15mL conical tube and centrifuged at 1000rpm for 5min. The 
medium was removed, cells were resuspended in 2mL fresh culture medium and 
applied to gelatinised culture dishes.  
 
2.4.5 Freezing of mouse cells 
Cells were frozen in cryovials in 1mL Recovery cell-culture freezing medium 
(12648010, Invitrogen) or 1mL home-made medium containing 10% DMSO, 40% 
Advanced DMEM and 50% ES cell-grade serum. The cells were first enzymatically 
detached from the cell culture dishes, then centrifuged at 1000rpm for 5min, 
resuspended in freezing medium and placed in a -20°C freezer. After 1h, the 
cryovials were transferred to a -80°C freezer for 24h and stored in liquid nitrogen or 
at -80°C if needed for use within a couple of weeks. 
 
2.4.6 Gelatinisation of culture dishes 
0.1% sterile Gelatin from porcine skin (Fluka) in PBS was pipetted in culture dishes: 
1mL for 3.5cm, 3.5mL for 6cm and 5mL for 10cm dishes and incubated for at least 
15min at room temperature. The liquid was aspirated and replaced with cell culture 
medium right before adding cell suspension. 
 
2.4.7 Depleting fibroblast-mESC co-cultures from fibroblasts 
As mouse embryonic fibroblasts (MEFs) are significantly bigger and heavier than 
ESCs, they sediment at the bottom of the cell culture dish (and adhere to it) much 
more quickly than do stem cells allowing for separation. Upon trypsinisation, the 
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mixed suspension of MEFs and ESCs was pipetted in a fresh culture dish and left in 
an incubator for 45min – 1h. The medium (which contains mostly unattached stem 
cells) was aspirated and transferred to a gelatinised culture dish.  
 
2.4.8 CellTracker staining of cells 
Cells were either detached from cell culture dishes or obtained from primary tissue 
by dissection and trypsinisation, and pelleted by centrifugation at 1000rpm for 5min. 
The pellet was resuspended in 4μM CellTracker solution in dissecting medium and 
kept in an incubator at 37°C for 45min. Cells were harvested by centrifugation and 
washed two times with serum-free medium before finally resuspending them in 
CKCM for counting and use in experiments. 
 
2.4.9 EB formation from mESC 
ES cells were trypsinised and centrifuged at 1000rpm for 5min. The cells were 
resuspended, counted with a Neubauer chamber (as described), adjusted to the 
desired number of cells and plated on 10cm bacteriological-grade dishes in 
differentiation medium (DMEM (Sigma), 2mM L-Glutamine (Sigma), 1mM sodium 
Pyruvate (Sigma), 1x non-essential amino acids (Invitrogen) and 5µM 2-
mercaptoethanol). Wherever indicated, the differentiation medium was supplemented 
with DMSO (control, as diluent) or DAPT. Medium was changed on day 3 of EB 
formation (to allow cells to aggregate) and every second day thereafter. EBs were 
used for either isolation of RNA and gene expression studies, or disaggregated into 
single cells for use in cell mixing experiments. In the latter case, the EB - derived 
single cell suspension was passed through a 40µm cell strainer to ensure that no 
clumps of cells were present, interfering with the experiment. 
 
2.4.10 Monolayer differentiation of mESC 
ESCs were harvested from adherent culture as previously described and counted with 
a Neubauer chamber. For differentiation 6 x104 cells/cm were plated in 
differentiation medium containing 4µM DAPT (γ-secretase inhibitor) or an equal 
amount of diluent (DMSO). 
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2.4.11 Culture of hESC 
The cells were cultured on Matrigel-coated culture dishes or flasks in mTESR Basal 
medium containing 1x mTESR supplement (both from Stem Cell Technlogies). The 
cell culture containers were coated with Growth Factor Reduced Matrigel at a 
concentration of 328µg/mL (diluted in KO-DMEM, Invitrogen) for 1h at RT. For 
transfected hESC, G418, Fungizone and Penicillin/Streptomycin were also added to 
the culture medium. Fresh medium was supplied every day. 
 
2.4.12 Passaging of hESC with Collagenase 
Cells were washed once with PBS and incubated in Collagenase IV (Invitrogen), 
diluted to 200U/mL in KO-DMEM, for 5-10min at 37°C until the colonies started to 
lift around the edges. The Collagenase was the aspirated and cells washed once with 
PBS before being removed from the dish with a cell scraper and gently disaggregated 
by trituration. Human embryonic stem cells (hESC) were usually subcultured 1:2. 
 
2.4.13 Freezing of hESC 
Cells were detached from tissue culture flasks and dishes, as previously described, 
centrifuged at 1000rpm for 5min and resuspended in 1mL cold (4°C) Cryostor  
freezing medium (CS10, Biolife Solutions). The cell suspension was aliquoted into 1 
or 1.5mL cryovials, which were then placed in a “Mr. Frosty” isopropanol cell 
freezer, loaded with isopropanol at 4°C, and left at 4°C for 10min, before being 
transferred to -80ºC. 
 
2.5 Protein inhibitors 
Protein inhibitors for treatment of kidney cultures, tissue cultures, adherent cells or 
EBs were supplied by directly diluting them in the respective culture medium at the 
desired concentrations. Y-27632 (Y0503, Sigma) was reconstituted in dH2O to a 
stock concentration of 5mM and used at a concentration of 10µM. Glycyl-H1152 
dihydrochloride (2485, Tocris) was reconstituted in dH2O to a stock concentration of 
5mM used at a concentration of 1.25µM. DAPT was reconstituted in DMSO and 
used at a final concentration of 4µM. 
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2.6 Molecular Biology 
2.6.1 RNA extraction (spin column) 
RNA from tissues and cells was extracted using the SV total RNA isolation system 
(Promega) according to the protocol supplied by the manufacturer. Several small 
modifications were made to improve the quantity of RNA isolated and to collect the 
sample at a higher concentration. These were as follows: at the lysis step, the sample 
was incubated for 5min at 70°C, not for 3min, as suggested by the manual; at the 
elution step, 100µL of nuclease-free water were used to collect the RNA from the 
spin column; furthermore, the resulting 100μL were reapplied to the spin column 
membrane, incubated for 5min and eluted a second time. The secondary eluate was 
stored at -80°C.  
 
2.6.2 RNA extraction (TRIzol) 
The RNA isolation was performed according to the manufacturer’s instructions 
(Invitrogen). Centrifugations were performed at 4°C. At the final step, in some cases 
the ethanol needed more than 30min to evaporate. 
 
2.6.3 Reverse transcription (cDNA synthesis) for semi-quantitative 
PCR 
For semi-quantitative PCR, the concentrations of obtained total RNA were measured 
with a Spectrophotometer Ultrospec 4000 (Pharmacia Biotech), Nanodrop or 
Agilent. 200ng RNA from each sample were used for the synthesis of cDNA. One 
reaction (total volume 20µL) contained a final concentration of 10U/µL MLV 
Reverse Transcriptase (M170A, Promega), 1x MLV Buffer, 1U/µL rNasin RNAse 
inhibitor (N251A, Promega), 1mM dNTPs, 200nM Random Primers (C118A, 
Promega), 200ng DNA and nuclease-free water. After mixing, the reaction was 






In the cases where the obtained total RNA concentration was too low, it was 
necessary to combine several equivalent reactions into one. For example, in a 20µL 
reaction, the maximum possible amount of RNA and water combined is 11.5µL. If 
the RNA concentration in the original stock required a larger amount of solution than 
11.5µL to be accommodated, all reagents in the reaction were multiplied by 2x, 3x, 
etc. to get a final RNA content of 200ng RNA. Respectively, 2x, 3x, etc times more 
cDNA mix was then used for PCR. 
 
2.6.4 Primer design 
Primers were designed with the online tool Primer3 version 0.4.0, located at 
http://frodo.wi.mit.edu/primer3/. The default settings of the program were used, 
together with the option “rodent mispriming library”.  mRNA information was 
obtained from NCBI Entrez Gene and the mRNA sequence was extracted in FASTA 
format from the “Genomic regions, transcripts and products” link. Primers with a 









M-MLV Reverse transcriptase 200U/µL 1.0 10U/µL 
M-MLV Reverse transcriptase 5x 4.0 1x 
rRNasin RNase inhibitor 40U/µL 0.5 1U/µL 
dNTPs 10mM 2.0 1mM 
Random Primers 100µM 1.0 200nM 
RNA Varies 
RNA adjusted 
with water, max 
11.5µL combined 
200ng 
nuclease free water Varies Varies 
 
Table 2.4 - Reagent list and concentrations for cDNA synthesis from isolated total RNA 
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Table 2.5 – List of primers 
 A list of forward and reverse primers used for transcript detection of the respective genes, based on 
cDNA synthesis; the expected product size is also provided in base pairs 
selected primers were checked for unspecific binding to undesired mRNA sequences 
and genomic DNA with BLASTn. 
 
A list of primers for the experiments in this work is given in Table 2.5. 
 
2.6.5 PCR for gene expression studies 
For PCR, a master mix with all reagents was prepared and 24µL were aliquoted in 
each thin-walled PCR reaction tube. The PCR master mix was prepared as shown. 
GoTaq polymerase and green GoTaq buffer were obtained from Promega and the 
dNTP mix was purchased from Invitrogen. The following settings of the Thermal 
Cycler were used: step 1 - 4min denaturation at 94°C; step 2 - 60s at 94°C, 60s at 56 
to 61°C, 90s at 72°C (depending on the optimal melting temperature for the primer 
pair) and step 3 - final elongation for 10min at 72°C. Step 2 was performed for 25-35 
cycles and the reaction was kept at 4°C after completion. The whole product was 
loaded on a 1% agarose gel for analysis. A negative control was performed for every 
set of reactions to confirm the absence of contaminants in the reagents, where no 
cDNA was added to the reaction. Wherever necessary, a positive control was also 
performed. 
Gene Forward Primer Reverse primer 
Product 
size [bp] 
Oct4 CACGAGTGGAAAGCAACTCA AGATGGTGGTCTGGCTGAAC 246 
Nanog AAGTACCTCAGCCTCCAGCA GTGCTGAGCCCTTCTGAATC 163 
Brachyury CCGGTGCTGAAGGTAAATGT CCTCCATTGAGCTTGTTGGT 248 
Osr1 CTGCCCAACCTGTATGGTTT GCGAGGCTTGGTCTTAAGTG 237 
AFP AAACATCCCACTTCCAGCAC CTTCCGGAACAAACTGGGTA 218 
AchE CCTGGGTTTGAGGGTACTGA GGTTCCCACTCGGTAGTTCA 234 
αSMA CTGACAGAGGCACCACTGAA CATCTCCAGAGTCCAGCACA 160 
GAPDH AACTTTGGCATTGTGGAAGG ACACATTGGGGGTAGGAACA 223 
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2.6.6 Agarose gel electrophoresis 
1% gel was prepared with UltaPure agarose (Sigma) ant TAE buffer. GelRed 
(Biotium) was added for visualisation of DNA at a final concentration of 1x. The gel 
was set for 30min, wells loaded with the whole content of the PCR reaction and the 
electrophoresis was run in a BioRad chamber at 80 to 100V. The size of the 
fragments was determined on the basis of a 100bp DNA ladder (G210A, Promega) to 
confirm specificity of the product.10µL DNA ladder were mixed with 2µL 
Orange/Blue Loading Dye (Promega). The DNA was visualised with a UV 
transilluminator (UVP) and Visi Doc It Processor (UVP), and images were printed 
with a VideoGraphing printer (Sony, UP_890 CE). The images were digitalised by 
scanning. 
 
2.6.7 DNA extraction from freshly isolated and cultured kidney 
rudiments 
Dissected kidney rudiments were placed in a 1.5mL microcentrifuge tube and 
pelleted by centrifugation at 3000rpm for 2min. The medium was removed and 
replaced by lysis buffer. Cultured kidney rudiments were first removed from the 
Component 1 reaction [µL] Final concentration 
GoTaq DNA polymerase 0.125 1.25U 
5x GoTaq reaction buffer 5.00 1x 
dNTPs 0.50 0.2mM 
forward primer 1.00 1.0µM 
reverse primer 1.00 1.0µM 
cDNA 1.00 Varies 
water  16.375  - 
total 25.00  - 
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isopore membrane filters by gently detaching them with dissecting needles and then 
placed in lysis buffer.  
 
DNA isolations were performed with a DNeasy Blood and Tissue kit (69504, 
Qiagen), according to the protocol provided by the manufacturer. Proteinase K 
(EO0491, Fermentas) was used for the protein degradation step. The 1.5mL 
microcentrifuge tubes with samples were incubated in a water-loaded heat block at 
56ºC for 40min - 1h and vortexed every 20min to ensure effective proteolysis. When 
the solution was clear and no fragments or particles were visible on inspection, the 
following step of the protocol was performed. The optional step of RNase treatment 
was also performed. Ribonuclease A from bovine pancreas (R4642, Sigma) was used 
at the concentration suggested by the manufacturer. Incubation time was increased to 
5-6 minutes at RT. The obtained DNA was eluted from the spin-column in 200µL 
buffer AE (provided by the manufacturer) and the elution was performed twice with 




2.7.1 Preparation of samples for microscopy 
Upon completion of IHC, the samples were washed in PBS for at least 1h at RT. For 
mounting tissue samples, two 22x22mm cover slips (VWR International) were glued 
with nail varnish at the two opposite sides of a 22x64mm large rectangular cover slip 
(VWR International) leaving a space in between. The former were used as spacers. 
Samples was transferred to dried cover slips and fully immersed in hard-set or 
conventional Vectashield before mounting them with a second 22x64mm cover slip 
and sealing them with nail varnish. All slides were labelled and stored in light-
protected chambers at 4°C until imaged. 
 
2.7.2 Microscopes 





Table 2.8 – Fluorophores, lasers and excitation wavelengths 
 A table of excitation wavelengths and lasers used for imaging samples labelled with different 
fluorophores 
 
Table 2.7 – List of microscopes 
A comprehensive list of equipment used for fluorescence and light microscopy with details 






























Microscope Camera Software 
Zeiss Imager. A1 AxioCam MRm AxioVision Rel 4.7 
Zeiss Observer D1 AxioCam MRm AxioVision Rel 4.7 
Leica Ortholux II Leica DC 350F Leica IM50 v 1.20 Release 19 
HUND Wetzlat Wilovert MiniVid LW Scientific 
IrfanView version 3.91 (pictures)
amcap DirectShow Video 
Capture version 8.12 (video) 
Zeiss Axioskop 2 FS mot 
confocal  
Zeiss LSM 510 Zeiss LSM 510 
Zeiss Axiovert confocal Zeiss LSM 510 Zeiss LSM 510 






Artificial colour of 
channel 
Alexa Fluor 647 633 Helium Neon dark blue 
GFP            
FITC 
488 Argon Crypton green 
TRITC    
Rhodamine 
543 Helium Neon red 
DAPI 760 Ti:sapphire multiphoton cyan 
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The excitation wavelengths for confocal microscopy were set as shown in Table 2.8, 
lasers and fluorophores have been used as indicated. A 40x Plan Neofluar oil-
immersion lens was used for all confocal sections for counting cells.  
 
2.7.3 Image processing 
Image manipulations, including channel merges, image adjustments, measurements, 
quantification, counting, averaging, production of movies from stacks was done with 
the NIH program ImageJ version 1.43 with the MBF collection of plugins compiled 
by Tony Collins, both freely available from http://rsbweb.nih.gov/ij/download.html. 
Speckles on confocal sections were enhanced by the “smooth” function of the 












The aim of this chapter is to evaluate the possible methods for integrating test cells 
into kidney rudiments for functional quantitative studies to be applied in testing the 
renogenic potential of cells.  Furthermore, it serves to clarify why the method of 
disaggregation and reaggregation of kidney rudiments has been selected for 
experiments in later chapters and to provide experimental evidence that the selected 
method is suitable for both qualitative and quantitative studies to assess the potential 
of different types and sources of cells to become part of kidney tubules. Figures 
resulting from this study, which are not essential for further chapters, were marked as 
supplementary and shown only for reference at the end of this thesis. 
 
3.1.1 Why is it necessary to devise an assay for studying acquisition 
of renogenic capacity? 
As discussed in Chapter 1, studying the acquisition of renogenic capacity in ES and 
early embryo cells is difficult, as no single robust marker for early kidney 
progenitors is available. ES cell studies have addressed this problem by using a 
combination of genes for reverse transcription PCR detection and injection of cells 
into kidney rudiments for visual analysis (Kim and Dressler, 2005; Steenhard et al, 
2005; Kramer et al., 2006; Vigneau et al., 2007; Bruce et al, 2007). Although cell 
injection is a good method for qualitative assessment, it might pose limitations to 
quantitative studies due to possible variabilities of the procedure. At the same time 
performing only reverse transcription analysis does not give sufficient information 
about the identity of differentiated cells as it detects the expression profiles of the 
whole mixture of tested cells rather than that of a single cell. This is a serious 
limitation when using heterogeneous systems such as EBs or primary tissues 
consisting of many cell types, as it does not provide information for the co-
expression of markers in a single cell. Therefore, for accurate analysis, a combined 
system that allows studying the functional abilities of cells to make kidney-like 
tubules and their gene expression on the basis of various markers is necessary. 
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First, the most suitable method for introducing the tested cells in a developing kidney 
rudiment to allow for analysis of the ability of the tested populations of cells to 
localise in forming kidney tubules had to be identified. In such a system, the tested 
cells would be exposed to the signals from the developing rudiment necessary for 
early metanephric development. This presents the additional advantage of using the 
embryonic kidney rudiment as a niche for providing the right differentiation signals 
potentially improving the process. 
 
3.1.2 The importance of a quantitative system for introducing cells 
into kidney rudiments 
As discussed in Chapter 1, the development of functional systems for studying the 
renogenic potential of various types of cells, such as different types of stem, 
progenitor or adult cells, is essential. In addition to the possibility of screening 
different cells, there is a necessity for screening the same type of cells, for example 
embryonic stem cells, but after treatments with different combinations of factors and 
molecules. The non-quantitative version of the disaggregation-reaggregation method 
gives a great opportunity to screen cells and treatments on the basis of the presence 
or absence of the ability of certain cells to integrate in re-forming ureteric bud 
structures and nephrons and their marker expression patterns. Once populations of 
cells with renogenic capabilities have been identified, a quantitative method would 
allow for comparing the efficiency of different treatments or abilities of different cell 
types to contribute to the structure of developing organotypic kidney cultures.  
 
3.1.3 The ideal assay for studying renogenic potential 
The ideal assay for the purposes detailed above would offer a repeatable method for 
introducing the same number of cells in kidney rudiments (1), a homogeneous 
distribution of the test cells (2), and their accurate quantification (3). The technique 
would optimally allow for the integration of cells in both the developing nephrons 
and the extending ureteric bud (4). It should offer a possibility to incorporate a high-
resolution detection by confocal microscopy (5) and allow the assessment of multiple 
cell markers simultaneously (6).  
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One of the most important tools in this assay would be an extremely robust method 
for tracing cells (7). The danger of tracer transfer and other requirements for good 
cell and lineage markers have been discussed elsewhere (McLaren, 1976; West, 
1984; MacKay et al., 2005).  The 6 most important conditions for an ideal marker 
have been presented in a contemporary perspective by MacKay et al. (2005), who 
have suggested that such markers should be:  
 
 -  retained within cells 
 -  not transferred between cells 
 -  widely expressed 
 -  easy to detect in fresh and fixed material 
 -  stable and expressed uniformly throughout development 
 -  and developmentally neutral.  
 
In the following sections several different approaches for cell delivery have been 
discussed to determine which one would fit the seven criteria for a good assay most 
closely. 
 
3.1.4 Methods for introducing test cells into developing kidney 
rudiments 
3.1.4.1 Microinjection 
A method for introducing exogenous cells into a tissue could be a direct injection of 
cells into the region of interest. This technique has been used in the first studies 
reporting the injection of cells into the mouse blastocyst (Gardner, 1968; 
Papaioannou et al., 1975). Microinjection of cells has also been used for cell delivery 
into embryonic kidney rudiments (Steenhard et al., 2005; Kim and Dressler, 2005). 
Vigneau et al. (2007) have microinjected EB-derived cells into both explanted 
embryonic kidney rudiments and the kidneys of live newborn mice. The latter 
method is reported to generate a high number of ESC-derived cells integrated into 
renal tubules over long-term grafting and would therefore be an attractive approach 
for studying the potential of cells to differentiate to renal cells. Nevertheless, a 
quantitative assessment of cells integrating in various kidney compartments will be 
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more difficult due to large amount of tissue to be screened (an adult kidney versus an 
embryonic kidney). 
 
Preliminary studies were performed as a part of this thesis to test the possibility of 
injecting cells in E11.5 kidney rudiments manually, by conventional or mouth-
pipetting. Kidneys often developed poorly due to the damage or did not show kidney 
localisation of the injected cells (results not shown). Occasionally, labelled cells were 
detected in the treated rudiments, but they were localised only at the injection site. 
The viability of these cells was not confirmed as pilot studies showed that the 
injection procedure was very difficult to reproduce. 
 
Labelled MMs were also tested for their ability to integrate into developing kidney 
rudiments, without injection. The labelled MMs and a single kidney rudiment were 
placed in a hanging droplet for 24h to allow adhesion and cultured in the 
conventional kidney culture system thereafter. Results showed that MM cells were 
unable to invade the kidney and therefore failed to enter nephrons (Supplementary 
Figures 1 and 2). Inducing mechanical injury to the kidney rudiments before 
incubation with labelled MMs in a hanging droplet did not improve the results 
(Supplementary Figure 3). None of these approaches showed promising results for 
providing a convenient and reproducible method for introducing test cells into kidney 
rudiments. 
 
3.1.4.2 Intravenous injection of cells 
Another possible method for delivery of cells into kidneys is injecting the cells 
systemically. Various groups have reported success with this method, for example, 
for the introduction of mesenchymal stem cells (MSC) and amniotic fluid stem cells 
(AFSCs) into the kidneys of adult mice after injury (Morigi et al., 2004; Herrera et 
al., 2007; Hauser et al., 2010). Importantly, Herrera et al. (2007) have reported that 
the process of stem cell homing to the kidney after injury might be due to the 
presence of the surface molecule CD44 in MSCs. It is known that the proteoglycan 
CD44 is a substrate for hyaluronate (Aruffo et al., 1990), which is upregulated in 
kidneys subjected to ischemic injury (Johnsson et al., 1996). Studies with anti-CD44 
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blocking antibodies show that cells lacking this extracellular molecule stopped 
migration of MSCs to glycerol-injured kidneys. CD44 expression was also reported 
in AFSCs (Hauser et al., 2010). The extensive evidence suggesting that stem cell 
homing to injured kidneys is CD44 - mediated is a significant limitation to assessing 
the properties of primary cells, which are non-homogeneous populations and might 
lack the expression of CD44. For this reason, the method of systemic injection of 
cells in mouse models of kidney injury did not provide a convenient tool for the 
intended studies. 
 
3.1.4.3 Disaggregation of kidney rudiments to single cells and reformation of 
kidney structures in culture 
There have been already many proofs-of-principle for disaggregation and 
reaggregation of tissues. It has been reported that various cell or tissue explants can 
be dissociated and reaggregated to form organotypic cultures - retina (Watanabe and 
Raff, 1990; Bytyqi et al., 2007), aorta-gonad-mesonephros region (Sheridan et al., 
2009), thyroid (Bell et al., 1984), skin (Bell et al., 1983), pancreatic islets (Halban et 
al., 1987; Matta et al, 1994), liver (Takezawa et al., 2000; Mizumoto et al., 2008) etc. 
The MM of kidney rudiments has also been disaggregated and its ability to reform a 
limited number of nephrons has been shown (Auerbach and Grobstein, 1958). Very 
recently, Unbekandt and Davies (2010) reported a high-efficiency method that allows 
the disaggregation of whole E11.5 kidney rudiments (both MM and UB) to single 
cells by enzymatic treatment. The suspension of single embryonic kidney cells can 
be pelleted and the pellet cultured in complete kidney culture medium (CKCM) 
supplemented by ROCK inhibitor (ROCKi) for the first 24h and only CKCM 
thereafter (as described in Chapter 2). When the pelleted embryonic kidney cells are 
cultured for 4 days or more, they form structures typical of developing kidney 
rudiments. Fragments of UB are formed throughout the pellet, as can be seen on 
Figure 3.1.1. In developing kidney rudiments, Calbindin is a marker for the ureteric 
bud (Mounier et al., 1987; McIntosh et al., 1986; Brun et al., 1987; Liu et al., 1993; 
Davies, 1994). The cells also retain their competence to respond to nephron-
inductive signals and nephrons form, as visualised by the component of basal lamina, 
Laminin (see Figure 3.1.1 and Unbekandt and Davies, 2010). As reported by the 
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authors and confirmed by my experiments (see results section), the procedure is very 
robust, as development of structures takes place in every properly executed 
experiment. Also, the major benefit of using this system is the presence of a single 
cell suspension stage, which is extremely convenient for homogeneously mixing 
other populations of cells with embryonic kidney cells without the need for injection. 
Importantly, it also allows for the integration of cells in both the developing 
nephrons and the extending ureteric bud. Preliminary studies in this thesis and the 
authors’ report have shown that the disaggregation-reaggregation system might be 
extremely suitable for cell mixing experiments. 
 
3.1.5 Possible sources of error in a quantitative application of the 
disaggregation system  
A system for quantification of integrated cells would require that a known number of 
cells be mixed with kidney cells in a known proportion. Although, these cells might 
have different properties and therefore show different potential to integrate into 
kidney structures, or a lack of such ability, we would expect to find a comparable 
number of cells localising in reaggregated kidney rudiments after repetition of the 
same procedure. At the same time, the reaggregation method is technically 
Figure 3.1.1 – Comparison between reaggregated and conventional kidney cultures 
 A - reaggregated embryonic kidney cells after 3 days of culture showing formation of UB fragments 
(arrows) and induction of nephrons (arrowheads); B - an embryonic kidney rudiment, explanted at 
E11.5 and cultured for 4 days, showing a continuous collecting duct system and nephrons positioned 
mainly at the periphery of the rudiment; green - Calbindin, red - Laminin 
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demanding and experiments and preliminary tests have shown that various steps in 
the procedure might introduce a significant bias into potential attempts for 
quantification. Based on preliminary studies, the factors that could contribute to 
variation were identified and detailed in the following sections. 
 
3.1.5.1 The developmental stage of the mouse embryos 
For the reaggregation system, kidney rudiments are explanted from a significant 
number of embryos at an approximate embryonic age - E11.5. Although timed 
matings deliver embryos at approximately the desired stage, they do not always 
maintain the precision necessary for some mixing experiments (Downs and Davies, 
1993). There is a lot of variation between embryos coming from the same uterus and 
there might be an even larger gap in the development of embryos coming from two 
or more uteri in experiments requiring a large number of rudiments. In this context, 
kidney rudiments have two main attributes with the potential to influence the 
outcome of experiments - the size of the rudiments themselves and the 
developmental maturity of both UB and MM cells. The size difference between 
rudiments can be corrected for by counting the number of cells after disaggregation 
and by always using the same number of host and disaggregated cells for quantitative 
studies. The differentiation state of UB and MM cells presents a more subtle 
challenge, as it cannot be corrected for. In the initial stages of kidney development, 
the cascade of reciprocal inductive signals between the MM and UB brings about 
very rapid changes in the “potency” of cells - UB cells start do divide rapidly and 
UBs to branch, while the MM undergoes MET to form nephrons. Cells that have 
already been initiated to progress through these differentiation processes might have 
the ability to recover from disaggregation more quickly as they have already been 
“induced” or committed to develop and might thus form larger structures more 
quickly. This will not be relevant to reconstituting tissues from a single population of 
cells, but might have a certain impact when two or more populations of cells are 
mixed. For example, in our case, where the two populations of WT and tauGFP cells 
are being mixed, more mature WT cells might result in more WT structures being 
reformed biasing the proportion of WT/tauGFP cells in structures, in comparison to 
the theoretical expectation. Also less developed cells might show an initial lag phase 
 76
necessary for their induction, before they could start to participate in morphogenetic 
processes. 
 
3.1.5.2 Preservation of tissues 
It is a routine procedure to preserve caudal parts of E11.5 embryos for several days 
in Minimal Essential Medium at 4°C, after sacrificing the embryos (Davies, 2006). 
Although, no significant differences were reported when the tissue was used within 
48h in whole kidney rudiments, a bias in experiments with disaggregated cells could 
not be excluded. Preserved cells could be either more sensitive to enzymatic 
treatment or have a decreased response to ROCKi - mediated survival. Also, 
preserved tissues might have a normal potential, but might also undergo an initial 
lagging phase of recovery from cold storage before starting to develop normally. 
 
3.1.5.3 Counting errors 
For cell mixing experiments cells were counted before mixing at the single-cell stage 
to ensure accurate proportions of cells before pelleting. Counting with a Neubauer 
chamber in solution of Trypan blue contains bias at several levels. The more obvious 
potential source of error is counting the number of cells itself. Counting only one cell 
more results in a difference of 20,000 cells per mL of cell suspension. This comes 
from the fact that the average number of cells counted per square is multiplied by the 
dilution factor (2 in that case) and the chamber factor (determined by the volume 
accommodating cell suspension in the chamber) - 10,000. So, for one more counted 
cell this gives: 
 
1x 2 x 10,000 = 20,000 
 
The second source of error is also related to the enzymatic treatment, in combination 
with calculating the numbers of available cells. Trypan blue is a dye, which is taken 
up by dead or dying cells and allows excluding them from the count. In some cases 




3.1.5.4 Pipetting error  
Pipetting error might occur when aliquoting the counted cells for pelleting. This 
could lead to a significant error, especially in the tested cells, as the cell suspension 
used for mixing was often in volumes close to 20µL. In this case, a pipetting error of 
only 2µL would actually mean a whole 10% of the target cell number. 
 
3.1.5.5 Pelleting efficiency 
Due to their size, shape and weight, different cell populations might have different 
pelleting rates (might apply to both UB cells versus MM cells, which come from the 
same organ rudiment and “host” cells versus tested cells, which might come from 
different tissues and might belong to earlier or later stages of development). Pelleting 
is also dependent on the centrifuge tubes, as experience has shown that different 
types and brands lead to different results (observations, data not shown). In general, 
after centrifugation, some cells, together with cell debris, are always left out of the 
pellet and form a characteristic vertical trail of cells, which can be traced from the 
pellet to the hinge of the tube. This can lead to variation between samples as none of 
the cells in the trail will be transferred with the pellet. If a certain cell type shows a 
higher tendency to localise in this thin strip of excluded cells, a minor bias for a 
certain cell type would occur. 
 
3.1.5.6 Placing the pellet in culture 
Some cells are frequently lost in the process of placing the pellet on top of a slice of 
polycarbonate filter. Sometimes, a small portion of the pellet might break off. 
 
3.1.5.7 Repelleting 
When during the procedure the pellets completely break apart, cells have to be 
resuspended and re-pelleted, in the process of which cells might be lost. 
 
3.1.5.8 Shape and size of the pellet  
In the case of thicker pellets, the positioning of certain cell types might be biased. 
Although the same procedure is followed every time, sometimes the experiments 
resulted in a smaller pellet, a very small pellet (which cannot be transferred) or even 
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no pellet at all. In the former case, the ratio of host-tested cells should still be 
preserved, but this has not been tested separately. In the latter two cases, this does 
not affect these experiments in particular (as they never reach being placed into 
culture), but is indicative that there might be another unknown (and therefore 
unpredictable) factor influencing pellet formation. 
 
3.1.6 Final comments 
In this section, the characteristics of an ideal quantitative assay and the possible 
sources of error have been identified. On the basis of this information, sets of 
experiments could be designed to test the robustness of the disaggregation-
reaggregation system and detect whether these errors would allow for using it 
quantitatively to assess renocompetence in different cell populations. These are 
presented in the following section. First, two cell labeling methods have been tested. 
Next, an experimental setup for quantitative analysis was designed and two 
approaches of quantitative assessment were compared. Finally, the potential 
differences between labelled and unlabelled cells were addressed.  
 
To develop a method for quantification of cells potentially integrating in renal 
epithelia, as a proof-of-principle, it would be necessary to test how cells already 
proven to have this ability behave in the reaggregation system. This control 
population of cells should have the same mixing properties as embryonic kidney 
cells. For this reason labelled and unlabelled embryonic kidney cells from E11.5 




3.2.1 CellTracker Green is not a suitable staining reagent for 
quantification of cells in mixed-cell organotypic cultures 
Preliminary studies were performed to investigate whether embryonic kidney cells 
stained with the commercially available dye CellTracker Green will be traceable in 
cell-mixing experiments.  
 
E11.5 kidney rudiments were isolated, disaggregated and stained with CellTracker, 
as described in the Materials and Methods chapter. Stained and non-stained cells 
were mixed in a ratio 1:1 (50% of all cells in the mixture were green). Pellets were 
cultured for 5 days, which is the maximum recommended incubation time for 
CellTracker-stained cells and, co-fixed with PFA and Methanol (as described). 
Samples were stained to visualise tubular structures and imaged. 
 
Micrographs indicated a relatively weak and non-uniform CellTracker staining 
(Figure 3.2.1, A and C). Green cells were found in both ureteric buds and nephrons 
(arrowheads), but their identification was very difficult, as is obvious from the 
images. Non-epithelialised cells in the interstitium also showed a weak staining, but 
counting numbers of cells with certainty was not possible. Interestingly, in some 
cases CellTracker-positive cells in UBs showed a weaker Calbindin staining 
indicating that the dye might be toxic to cells or interfere with their normal 
development and gene expression (Figure 3.2.1, A and C, marked by stars).  
 
As exemplified by Figure 3.2.1, it was not possible to determine the percentage of 
green cells in the mix. These observations, together with the difficulty to treat cells 
with the dye before every experiment, and the limitation of incubating stained 
samples in culture for only 5 days, makes CellTracker an unattractive tool for 




Figure 3.2.1 – Reaggregated organotypic rudiments containing CellTracker-stained E11.5 
embryonic kidney cells 
A and C - reaggregated embryonic kidney cells after 5 days of culture showing formation of 
UB fragments (blue arrows) and induction of nephrons (red arrows); stars indicate regions of 
the UB, which do not express (or express lower levels of) Calbindin, possibly as a result of 
the CellTracker treatment; B and D - schematic representations of the micrographs given in 
A and C, showing UB structures in blue, nephrons in red, and the condensing mesenchyme 
in pink;  
green - CellTracker Green-labelled E11.5 kidney cells, red - Laminin, blue – Calbindin; the 
mixes contain 50% CellTracker-labelled cells 
 
3.2.2 Characterisation of kidneys explanted from 
TgTP6.3tauGFP+/tauGFP- mice 
As the quality of the CellTracker staining was not sufficiently high for the intended 
experiments, another method for tracing cells had to be sought. It was predicted that 
using genetically, rather than transiently, labelled cells would allow for a much better 
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cell traceability. In addition, the possibility of culturing cell mixes for longer periods 
of time would maximise the number of structures formed and hence reveal more 
about the potential for cell integration. Therefore, tissues from mice expressing GFP 
in virtually all of their cells were tested, as described below. 
 
TgTP6.3tauGFP+/tauGFP- transgenic mice were kindly provided by Thomas Pratt, Centre 
for Integrative Physiology, University of Edinburgh. The transgene consisted of a 
tau-GFP fusion and puromycin resistance gene, linked by an internal ribosome entry 
site (IRES). The expression of both was driven by a human cytomegalovirus 
immediate early enhancer (HCMVIEE), coupled to the chicken β-actin promoter and 
first intron (Figure 3.2.2, A). Mice hemizygous for the transgene exhibit GFP 
fluorescence in all of their tissues, while homozygous mice die early in embryonic 
development (Pratt et al., 2000; MacKay et al., 2005). Upon mating, 
TgTP6.3tauGFP+/tauGFP- males crossed with wild type (WT) CD1 females would 
generate only WT embryos and hemizygotes (viable), Figure 3.2.2, B. By 
fluorescence microscopy it was determined that indeed approximately 50% of all 
embryos resulting from the matings carried the transgene.  
 
Next, experiments to test whether transgenic freshly isolated unfixed tissues can be 
identified by fluorescence microscopy were performed.  For embryonic kidney cell 
isolation, caudal parts and E11.5 kidney rudiments were dissected as described in the 
Materials and Methods section. GFP expression was detected by fluorescence 
microscopy of freshly isolated living tissue. tauGFP-positive kidney rudiments were 
clearly distinguishable from non-transgenic ones by their bright green fluorescence. 
All transgenic kidneys were very highly fluorescent (Figure 3.2.2, E and F), while 
WT rudiments were clearly negative for GFP (Figure 3.2.2, C). Even after increasing 
the exposure time for imaging WT kidneys 20 times above original levels, WT and 
transgenic kidneys were still clearly distinguishable (compare Figure 3.2.2, D taken 
at 884ms with Figure 3.2.2, E and F, taken at 43ms) allowing for a rapid and accurate 
microscopy-based determination of genotype. 
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Figure 3.2.2 - Characterisation of GFP expression in TgTP6.3tauGFP+/tauGFP- 
transgenic mice: 
A - a schematic representation of the pTP6.3 construct used for transfection of 
mouse ES cells and generation of transgenic animals (from Pratt et al., 2000). The 
construct encodes a tau-GFP fusion and puromycin resistance gene, linked by an 
internal ribosome entry site (IRES). The expression of both is driven by a human 
cytomegalovirus immediate early enhancer (HCMVIEE), coupled to the chicken β-
actin promoter and first intron; B - illustration of matings between wild-type CD1 
females and TgTP6.3 males for the generation of tauGFP+ embryos for 
experiments. 50% of resulting conceptuses are expected to be transgenic; C - 
bright-field and GFP fluorescence merge of micrographs of wild type kidney 
rudiments. Fluorescence channel exposure time 43ms; D - bright-field and GFP 
fluorescence merge of micrographs of wild type kidney rudiments. GFP channel 
was captured at 884ms; E and F - bright-field and GFP fluorescence merges of 
micrographs of wild type kidney rudiments, 43ms; GFP in green 
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3.2.3 Cells from TgTP6.3tauGFP+/tauGFP- embryonic kidneys show some 
variation in fluorescence intensity 
After successfully verifying the accuracy of transgenic kidney rudiment 
identification based on fluorescence microscopy, it was necessary to observe mouse 
kidney rudiments derived from tauGFP+ animals at a cellular level to monitor the 
differences of GFP-positivity in different types of kidney cells. At E11.5, there are 
only two or three main types of cells in a developing embryonic kidney - the cells of 
the UB, the uninduced MM and potentially some induced MM cells. Monitoring only 
those three cell types, especially before the epithelialisation of nephrons had taken 
place, does not give useful information about the variability of GFP fluorescence 
between cell types. For this reason, kidney explants from a later embryonic stage 
were used for characterisation. E14.5 rudiments were dissected as described for 
E11.5 rudiments and disaggregated by incubation with 1x Trypsin-EDTA for 5min at 
37°C. Cells were plated on 22x22mm cover slips in 6-well plates and fixed with 4% 
PFA after 24h of culture to let the cells attach. 
 
Microscopic observations of 3 samples, obtained from 5 pairs of plated kidney cells, 
showed that GFP fluorescence levels were sufficient for detection in all observed 
cells (Figure 3.2.3, B, C and D). At the same exposure time, control cells obtained 
from WT E14.5 kidneys did not exhibit any autofluorescence and were virtually 
undetectable. (Figure 3.2.3, A).   
 
In the cell, the function of the protein tau is to stabilise microtubules and it is 
therefore localised cytoplasmically (Weingarten et al., 1975). Similarly to the native 
protein, the tau-GFP fusion protein has also been detected in the cytoplasm and is 
excluded from the nucleus (Pratt et al, 2000). During cell division, the GFP signal is 
detected co-localising with the mitotic machinery, suggesting that fusion protein 
localised as reported for endogenous tau (Pratt et al., 2000; Weingarten et al., 1975).  
 
Although cells were detectable in all cases, the observed primary E14.5 kidney cells 
had somewhat different fluorescence levels (figure 3.2.3, B, C, D). For example, 
Figure 3.2.3, C shows phenotypically similar epithelial cells showing lower 
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Figure 3.2.3: Characterisation of GFP fluorescence in transgenic kidney cells.  
A - control showing wild-type kidney cells derived from wild-type E14.5 embryos; B, C 
and D - tauGFP expression of E14.5 kidney cells derived from TgTP6.3tauGFP+/tauGFP- 
transgenic embryos; B and D - show kidney cells with several different morphologies, 
which express high (arrows) or lower (arrowheads) levels of tauGFP; C - shows 
differences in GFP intensity between cells with a similar morphology. Arrows point at 
examples of brighter cells, while arrowheads indicate cells with lower levels of GFP; 
GFP in green 
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(arrowheads) or higher (arrows) levels of GFP fluorescence. Differences in 
fluorescence levels were detected both between morphologically similar and 
morphologically different embryonic kidney cells. 
 
3.2.4 tauGFP cells are easily detectable in cell disaggregation-
reaggregation experiments 
WT and genetically labelled with tauGFP kidney cells were mixed and pellets of 
reaggregating organotypic cultures were prepared. After 6 days of culture, the pellets 
were fixed and stained for Laminin, Calbindin and DAPI to investigate detectability 
of tauGFP cells. GFP-positive cells could be clearly seen in the three renal 
compartments - nephrons (arrowheads, Figure 3.2.4), ureteric bud reaggregates 
(arrows, figure 3.2.4) and the interstitium (the regions surrounding renal epithelia, 
green cells not indicated). As integration into renal epithelia rather than the 
interstitium will be the focus of the following chapters, the presence of cells in the 
interstitium was not extensively examined.  
 
This preliminary analysis of tau-GFP kidney cells confirmed that genetic marking of 
cells is significantly superior to using the transient label CellTracker (compare to 
images on Figure 3.2.1). In addition, cell mixing experiments with CellTracker - 
stained cells suggested that carry-over of dye is possible and label transfer from 
grafted cells to host cells might occur (unpublished data, Davies lab; Supplementary 
Figure 4). This is also inconsistent with the requirements that have been suggested 
for good cell and lineage markers described in the introduction of this chapter 
(McLaren, 1976; West, 1984; MacKay et al., 2005).  In contrast to CellTracker, the 
tauGFP-tagged primary cells seemed to fulfil all conditions with the only limitation 
of variable fluorescence in some cells. The variation of fluorescence between 
different types of cells might anyway be unavoidable due to the different cell sizes, 
shapes and function. On the basis of the tests performed, it could be concluded that 
tauGFP-tagged cells are an excellent and very suitable tool for cell mixing 
experiments with embryonic kidney cells. 
 
 86
Figure 3.2.4 - Disaggregated E11.5 mouse kidney rudiments containing a mixture of WT 
and tauGFP+ cells, shown after reaggregation and a 6-day culture 
A – tauGFP+ cells (GFP, green) were easily detectable by confocal microscopy when 
integrated into the structure of both nephrons (Laminin, red) and UBs (Calbindin, blue). 
They were also well-visible in the interstitium (space around renal epithelia); B – the same 
confocal section as in A, showing nuclear DAPI staining in cyan, in addition to Calbindin 
(blue), Laminin (red) and GFP (green); C – a schematised version of the micrograph in A, 
outlining the nephrons in red and ureteric buds in blue, surrounded by red. GFP+ cells are 
clearly visible when integrated in both types of structures, as well as when localising in the 
interstitium.  
Arrowheads show GFP+ cells integrating in nephrons. Arrows show GFP+ cells 
integrating in UBs. 
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3.2.5 Quantitative studies and a comparison between two methods of 
analysis for assessing the integration of control GFP-tagged cells 
provide proof that experiments are robust and repeatable 
After a robust method for tracking integrating cells was found, the possibilities for a 
quantitative use of the disaggregation-reaggregation system had to be tested. For 
quantitative studies, E11.5 WT embryonic kidneys cells were used as host cells, and 
tauGFP+ E11.5 kidney cells as control test cells. For every experiment, a defined 
ratio of green/non-green cells was used for assessment. At the single cell suspension 
step, the numbers of cells in both suspensions were counted and 15,000 tauGFP+ 
cells were added to 100,000 WT kidney cells for the formation of pellets. This is a 
ratio of 1:7.67 tauGFP: WT cells, which is respectively 13 and 87 percent. Assuming 
that WT and tauGFP+ cells behave in the same way, after 6 days of culture, we 
would expect to see a proportional rate of integration in the three early renal 
compartments - UB, nephrons and stroma and comparable results between different 
experiments. 
 
Pellets for quantification were prepared and treated, as follows. After centrifugation, 
the pellets were cultured in CKCM supplemented with 1.25µM ROCKi.  The 
medium was replaced with conventional CKCM after 24h to remove the inhibitor.  
Pellets were grown for 6 days and co-fixed with PFA and methanol. Samples were 
triply stained for the UB-maker Calbindin, the component of the basal lamina - 
Laminin, and DAPI for nuclei. As previously demonstrated, Calbindin appears as a 
uniform staining throughout the cell. Laminin is detected in the basal laminae of both 
UB structures and nephrons and therefore appears as an outline of both UB structures 
and nephrons. Therefore, when analysing images of kidneys, a Calbindin+ Laminin+ 
epithelial structure was identified as a UB, while a Calbindin- Laminin+ - as a 
nephron.  
 
The integrated cells were detected by GFP expression. Assessing the numbers of 
cells in the renal compartments was performed on the basis of the DAPI staining. 
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In addition to a repeatable and robust procedure for producing pellets containing the 
same number of GFP+ cells, an appropriate and statistically relevant method had to 
be designed for acquisition and assessment of the data. A common procedure for data 
collection and analysis was therefore devised to screen organotypic cultures rapidly 
and accurately by confocal microscopy. At least 6 pellets resulting from at least 3 
separate experiments obtained by reaggregation-disaggregation were analysed by 
confocal microscopy. For each experiment, multiple kidney rudiments were isolated 
and disaggregated to obtain enough cells for the generation of cell mixes. For each 
pellet, 15 confocal micrographs were made, each showing a single confocal section. 
The areas of sample to be micrographed were selected by visual inspection of the 
Laminin staining, which is only indicative of the presence of structures, but gives no 
information about the presence or localisation of tauGFP+ cells. Areas containing 
any structures were selected at random. It was necessary to control for micrographing 
areas containing kidney epithelial structures, as otherwise, no useful information for 
the integration of these into test cells would have been extracted. 
 
Only 10 of the 15 confocal sections were used for cell counting analysis. It was 
noticed that thicker pellets are more difficult to stain in their central areas in 
comparison to peripheral ones. That is why 5 of the 10 sections taken were used as 
spares, in case the quality of some images was not sufficient for quantification.  
 
In the test stainings, penetration problems were more apparent in the DAPI channel, 
where nuclei in the core of the pellets were almost indistinguishable. Including DAPI 
in the secondary antibody mix for an overnight incubation, rather than at the end of 
the staining process, improved the outcome sufficiently for cell counting. 
 
Two methods were devised for screening the pellets for integrating tauGFP+ cells. 
Method 1 used for analysis assesses the percentage of green cells (tauGFP+ cells) 
localising in each of the three different embryonic kidney compartments - UB, 




- the total number of cells on a section which includes the number of WT cells and 
tauGFP+ cells - TC 
- the total number of green cells on a section - TGC 
- the total number of all cells localising in all UB structures on a section - UBC 
- the number of green cells localising in UBs on the same section - GCUB 
- the total number of all cells localising in all nephrons on a section - CN 
- the number of green cells localising in nephrons on the same section - GCN 
 
The total number of stromal cells (TSC) has been calculated by subtracting the 
number of cells in nephrons and UBs (CN + UBC) from the total number of cells 
(TC).  
 
TSC = TC - (CN + UBC) 
 
The total number of green cells in the stroma (GCS) has been calculated by 
subtracting the green cells in UBs and nephrons (GCUB + GCN) from the total 
number of green cells on the section (TGC). 
 
GSC = TGC - (GCUB + GCN) 
 
Cell integration was assessed according to the criteria described below.  Nuclei were 
counted on the basis of DAPI staining. A structure was identified as a UB fragment 
when it was both Calbindin+ and Laminin+. A second supporting criterion was used 
in addition due to differences in staining intensity of UBs, which made the 
identification of some UB fragments difficult.  Unlike nephrons, which have a more 
complex morphology, the UB normally consists of a single-layered epithelium with 
regularly arranged cells. Observing the positioning of nuclei on the basis of DAPI 
staining therefore gives additional information about the identity of the structure. In a 
nephron, the basal lamina component - Laminin marks the basal (outer) side of the 
nephron. At the same time no Calbindin expression is observed. A Laminin+ 
Calbindin- structure was assigned a nephronal identity. A morphological criterion for 
identification of nephrons was also used in addition to the histochemical information 
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- nephrons appear much more convoluted, may appear multilayered and contain cells 
with different nuclear shapes and sizes.  
 
On the basis of these counts, the following proportions were calculated:  
 
- the percentage of cells in UB that are green 
- the percentage of cells in nephrons that are green 
 
First, the issue of calculating the minimum number of sections necessary for 
accurate analysis was addressed, by plotting the trend of the mean number of green 
cells and the mean standard deviation for every additional section count. The 
running mean of total green cells and the running standard deviation were analysed 
for 40 separate sections. As can be seen on Figure 3.2.5, the running mean fluctuates 
severely in the initial counts, up to 7 sections counted, then decreases to about 170 
cells per section at section 30 and maintains a relatively constant level thereafter. A 
similar effect was noticed for the running standard deviation, which is high in the 
first few counts, but then decreases and starts maintaining a constant level. On the 
basis of this analysis, it could be concluded that counting 30 sections per experiment 
gives a sufficient level of accuracy for the quantitative analysis of integrating cells. 
 
Second, it was determined whether a minimum of three biological replicates was 
sufficient for accurate data representation of the proportion of green cells integrating 
in nephrons and UBs.  The results are shown for each one of three separate 
experiments, as well as after pooling all counts (Figure 3.2.6 A, B and C). The 
values shown are the GFP+ cells localised in UBs or nephrons, as a percentage of 
the total number of cells in either type of renal epithelia. The data is presented as 
95% confidence intervals for the mean number of cells localising into either UBs or 
nephrons ± the margin of error in percent. The normal theory approximation of a 
confidence interval of a proportion was used. It is known as the Wald interval and 





(Wald and Wolfowitz, 1939) where  is the proportion of successes in a Bernoulli 
trials process, estimated by the statistical sample. Z is the z1-α/2 quantile or the 1-α/2 
percentile of a standard normal distribution and n is the sample size. For a 95% 
confidence interval α = 0.05, so z1-α/2  = 1.96.  
 
The analysis of 90 sections obtained from three separate experiments for cells 
localising into either UBs or nephrons showed that the efficiency of integration in 
these two compartments can vary between experiments (Figure 3.2.6, A, B and C). 
Integration in UBs ranged from 17.23 ± 0.91% to 30.92 ± 1.23% in the three 
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Running mean Standard Deviation
 Figure 3.2.5 - Determining the minimum number of sections necessary for accurate cell 
quantification by examining the behaviour of the running mean and running standard 
deviation 
 
This analysis was based on reaggregated pellets containing approximately 13% tauGFP+ 
cells mixed with WT cells. Pellets were cultured for 6 days, fixed and stained for counting 
of green cells. The mean number of green cells and the mean standard deviation for every 
additional section count are shown on the graph. The running mean of total green cells 
per section and the running standard deviation were analysed for 40 separate sections. 
The running means (blue diamonds) fluctuate severely in the initial counts, up to 7 
sections counted, then decrease to about 170 cells per section at section 30, and maintain 
a relatively constant level thereafter. A similar effect was noticed when plotting the running 
standard deviation, which is high in the first few counts, but then decreases and also 
starts to maintain a constant level. After section 30, additional measurements did not 
change the trend of the running mean or running standard deviation, which indicated the 
minimum number of sections required for quantification.
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different experiments, while integration in nephrons ranged from 11.86 ± 0.96% to 
19.41 ± 0.62%. Pooling the data for all three experiments resulted in obtaining very 
similar efficiencies of integration - 22.78 ± 0.50% for UB cells and 19.41 ± 0.52% 
for nephron cells (Figure 3.2.6, A, B and C, pooled). A two-tailed student’s t-test for 
these populations showed that the difference in efficiencies of integration is not 
significant (p = 0.25). These results suggest that for standardised quantitative 
studies, pooling the results from at least three separate experiments is sufficient for 
decreasing the experimental error of the variation in different biological samples. 
 
In addition, it was interesting to observe that presenting the data as an average of the 
GFP+ cells integrating in both types of renal epithelia resulted in correcting the 
proportions of cells - the same percentage of green cells was calculated for all three 
individual experiments (Figure 3.2.6, D). In addition, comparing the graphs on 
Figure 3.2.6, A and B, it can be noticed that the mean percentage of green cells in 
UB decreases from Experiment A to Experiment C, while the mean percentage of 
green cells integrating in nephrons increases proportionally at the same time. The 
average of both types of renal epithelia approximates 21% in all experiments 
(Experiment 1, Experiment 2 and Experiment 3), as well as in the pooled data set 
(Figure 3.2.6, D). As the proportion of total GFP+ cells in both types of renal 
epithelia seems to be constant in all three experiments, the variation of green cells in 
nephrons versus ureteric buds, seems to be due to variation in the homogeneity of 
cells in the starting populations used for mixing. More precisely, it is possible that 
the 15,000 green cells mixed into Experiment 1 contained more UB cells than the 
15, 000 cells mixed into Experiment 3. Therefore, the variation that is observed is 
not due to an error in the method of analysis, but is due to the natural variation of 
cells in the starting population. On the contrary, these results suggest that the 
combination of experimental method and method of analysis gives an accurate, but 
also a sensitive, representation of small differences in the starting populations of 
cells. These results suggest that the quantification method is indeed a very useful 
tool for comparing two populations of cells with very similar renogenic potentials. 
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The similar integration rates of GFP+ cells, together with the recurrent percentage of 
green cells integrating in renal epithelia in individual experiments was a good 
indication that in spite of the large variance that can occur between different 
experiments, a sufficiently large number of samples and repeats makes this method a 
robust way for comparing the integration potential of different types of cells. In 
particular, the results in this chapter have identified that analysing at least three 
separate experiments (biological replicates) with three technical replicates each, 10 
sections each, gives an excellent basis for comparing the ability of cells to integrate 
into renal epithelia. 
 
Furthermore, an alternative method for analysis was applied to confirm the results 
obtained by Method 1. Instead of calculating percentages of cells, the number of 
cells per unit area of a certain renal compartment was used as an indicator. 60 
sections were analysed by both methods to allow for comparable results. For 
quantifying the proportion of cells in each compartment that are green, analysis was 
performed as described for Method 1. For assessing the number of green cells per 
unit area, the following were calculated for the same set of data: 
 
- the number of green cells localising in nephrons per unit area 
- the number of green cells localising in UBs per unit area 
- the  number of green cells localising in the stroma per unit area (the number of 
green cells in the stroma was calculated by subtracting the green cells in 
nephrons and UB from the counted total number of green cells on a section; the 
area of stroma was quantified by subtracting the area of nephrons and buds on 
the confocal section from the total area of kidney tissue captured on the same 
section) 
- the total number of green cells on a section per unit area (in this instance, the 
total area taken up by the reaggregated kidney rudiment on a section) 
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GFP+ cells in UB            
[percent of total UB cells ± 
margin of error] 
GFP+ cells in nephrons      
[percentage of total cells in 
nephrons ± margin of error] 
Experiment A 30.92 ± 1.23 11.86 ± 0.96 
Experiment B 21.71 ± 0.95 20.17 ± 1.04 
Experiment C 17.23 ± 0.91 24.79 ± 1.15 


























































Figure 3.2.6: Quantification of the percentage of GFP+ cells integrating in renal 
epithelia  
A - illustrates the GFP+ cells localising in UB structures as a percentage of total UB 
cells; Experiment A showed that 30.91±1.03% of all UB cells were green, expressed 
as a percentage of total cells ± the margin of error as calculated for a 95% 
confidence interval; 21.71±0.80% of all UB cells in Experiment 2 were green in 
comparison with 17.23±0.77% in Experiment C. The average percentage of UB 
cells that were GFP+ was calculated by pooling all data and was 22.78±0.50%. 
 
B - illustrates the GFP+ cells localising in nephrons as a percentage of the total 
number of cells in nephrons; Integration of GFP+ cells in Experiment A is 
11.86±0.80%, Experiment B - 20.17±0.87% and Experiment C - 24.79±0.97%. The 
pooled data shows integration 19.41±0.52% when calculated for all data sets. 
The percentages in both A and B rounded to a whole number are shown above 
each bar. 
 
C - A table summarising the values obtained from counting experiments, 
represented as a percentage of cells in two types of renal epithelia that are GFP-
positive ± the margin of error based on a 95% confidence interval experiments are 
shown separately and as a pooled set of data 
 
D - the bar chart shows the integration of green cells in both types of renal epithelia 
(nephrons and UBs), collectively without discriminating for a particular type. The 
data sets for the bar chart were generated by averaging the data from A and B. The 
margins of error were calculated by following the rules for error propagation after 
mathematical operations on the basis of the values from A and B. The percentages 
of cells integrating in renal epithelia in experiment A, B and C, as well as the pooled 
data from all experiments, are shown above the bars. 
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Area measurements were made on the basis of visual inspection of Calbindin and 
Laminin staining (as previously described) and manual selection of the relevant areas 
in ImageJ. To avoid scaling errors, the results were obtained in pixels from the raw 
data. As the number of green cells per pixel gave a very small and inconvenient for 
representation value, the data was therefore converted to cells per kilopixel (1000 
pixels = 1 kilopixel). It must also be noted that the error for Method 1, which was 
previously given as a 95% confidence interval has now been converted to SEM for 
two reasons - the data were given as a proportion, not in percent; to be able to 
compare the analyses obtained by Method 1 and Method 2 (measuring cells per unit 
area doesn’t result in a binomial distribution as it is not a “yes/no” event). As 
calculating the proportions of green cells required division of measured values, 
mathematical operations were used to calculate the propagation of uncertainty, while 
obtaining these values. 
 
A comparison between the two methods for data analysis of integration is shown in 
Figure 3.2.7 A, B and C. As can be seen from the bar graphs and table, both methods 
show extremely similar results. For simplicity in describing the comparison between 
the two methods, the value obtained by dividing the number of green cells per renal 
compartment by the total number of cells in the same compartment (for Method 1) or 
by the area of the compartment in kilopixels (for Method 2) will be referred to as 
Integration Coefficient. The values used to generate Figure 3.2.7 A and B are given 
in Figure 3.2.7. It can be seen that in both methods, very similar proportions of GFP+ 
cells were observed in nephrons (0.14 ± 0.02 for Method 1 and 0.13 ± 0.01 for 
Method 2) and the stroma (0.18 ± 0.01 and 0.17 ± 0.01). Although for UB cells, the 
mean Integration Coefficient for Method 1 was slightly higher than the value 
obtained for Method 2 (0.29 ± 0.04 versus respectively 0.22 ± 0.03) that difference 
was still accommodated for by taking into account the standard errors. The 
cumulative Integration Coefficients for all renal compartments taken together were 
essentially the same - Method 1 showed tauGFP+ cell integration of 0.19 ± 0.01, 
while Method 2 indicated a number of 0.18 ± 0.01. This analysis provides proof that 
both the experimental approach allowed an estimation of the ability of cells to 
integrate into renal epithelia, but also that the analysis methods provided for a good  
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Coefficient Method 1 
± SEM  
Integration 
Coefficient Method 2 
± SEM 
Nephron 0.14 ± 0.02 0.13 ± 0.02 
UB 0.29 ± 0.04 0.22 ± 0.03 
Stroma 0.18 ± 0.01 0.17 ± 0.01 




Figure 3.2.7 - Comparison of two methods for analysis of cell integration 
 
A - shows analysis Method 1, based on estimating the proportion of cells green cells 
in each compartment (by dividing the number of GFP+ cells by the number of GFP- 
cells in each compartment). 
B - the same set of data analysed by Method 2, which measures the average 
number of green cells found in a particular compartment per unit area. Values are 
shown as the number of cells per kilopixel area of the confocal section. 
 
C - illustrates the raw data for generating the bar graphs in A and B and compares 
the integration coefficients of Method 1 and Method 2. The integration coefficient of 
Method 1 was formed by calculating the proportion of green cells (from total cells) in 
a compartment. The integration coefficient in Method 2 is the number of green cells 
per kilopixel area of the respective renal compartment. Error bars were calculated by 
following the mathematical operations for propagation of uncertainty based on the 
SEM. 
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and accurate interpretation of the results. It was concluded that using either method 
for quantitative studies would offer an accurate method for assessment of the 
integration potential of different types of cells. 
 
3.2.6 Quantification studies could not reject the possibility that the 
tauGFP+ cell population might grow faster than the WT population 
After having considered the suitability of the disaggregation-reaggregation system 
for quantitative studies and compared two possible methods for data analysis, I 
investigated whether the experimentally obtained values correspond to the theoretical 
numbers of cells expected to be found in renal structures. As previously mentioned, 
15,000 GFP+ cells were mixed with 100,000 WT cells for pelleting. Therefore, we 
would expect the pellets to contain about 13% of GFP+ cells. By Method 1 it was 
determined that 18.90 ± 0.32% of all cells in pellets were green. This is 5.90% ± 
0.32% more green cells than expected. As even the largest error calculated for a 95% 
confidence interval could not accommodate the difference, it either came from 
uncertainty that wasn’t accounted for or the observation was not a random event. If 
the increased numbers of cells were not observed by chance, the possible reasons 
could be - tauGFP cells proliferate faster than WT cells; fewer tauGFP undergo cell 
death in embryonic kidney development; tauGFP cells survive manipulations and 
enzymatic treatment better; tauGFP cells respond more to treatment with ROCKi, 
which inhibits cell death. To address whether there are such differences between WT 
and tauGFP cells, a protocol for monitoring the change of cell numbers was devised. 
Although cells are largely different in size, shape and protein content, their DNA 
content should be the same for all types of cells. Therefore, the amount of DNA 
extracted from a population of cells could serve as an indicator of relative cell 
number. This method was employed to detect whether tauGFP cell numbers 
increased more than WT cell numbers, as described below. 
 
An equal number of tauGFP+ and WT kidneys was isolated from E11.5 mouse 
embryos. Half of the freshly isolated rudiments were used for immediate DNA 
isolation (time point 0) and the other half - after 6 days of culture. To minimise 
variability between the pools of rudiments used at the two different time points, the 
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pair of kidneys isolated from the same embryo was always divided between the two 
groups. Quantifying the amount of DNA in the starting culture would allow 
correcting for cell number differences between the two tested populations at the 
beginning of each experiment.  
 
The second half of isolated kidneys was cultured for 6 days in a conventional culture 
system, as consistent for the mixed-cell pellets characterised earlier in this chapter. 
The DNA content in the second half of rudiments was quantified after 6 days of 
culture. Dividing the DNA content at D6 by the value from D0 would provide 
information about the relative increase in cell number after 6 days of culture or how 
many times the population has increased from D0 to D6. As the growth of a whole 
population of cells is a balance of cell proliferation and cell death, such a comparison 
will provide insight only about the cumulative effect of both, which will be referred 
to as “growth”. As cell proliferation and cell death were not a particular focus of this 
thesis, they were not pursued individually. 
The results of 5 independent experiments are summarised on Figure 3.2.8. Figure 
3.2.8, A shows a comparison between the increases of the DNA content in wild type 
(extracted from CD1 mice) kidneys and tauGFP+ kidneys. From the bar chart we see 
that the population of cells in the CD1 pool has increased 2.62 times from D0 to D6, 
while the population of cells in the tauGFP pool has increased 3.09 times. The data 
given are averages on the basis of 5 individual experiments. Error bars are standard 
errors of the mean (SEM). Although, tauGFP cells indeed showed a higher increase 
in cell number, it was found that this difference was not significant. A two-tailed 
student’s t-test assuming unequal variance gave a p value of 0.43. Even if we 
postulate that it is not possible to measure a higher than the real DNA concentration 
at any point and therefore perform a one-tailed student’s t-test, the p value drops only 
to 0.22, once again failing to reject the null hypothesis. Although the data from these 
experiments did not show a significant difference in the relative growth of WT and 
tauGFP+ rudiments, it was interesting to observe that the value for tauGFP cells was 
consistently higher than that of WT cells in all five separate experiments (Figure 
3.2.8, B). In addition, Figure 3.2.8, B demonstrates that the increase in DNA content 
between cultured CD1 and tauGFP kidneys was significant in two of the five 
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experiments performed. This suggests that the number of experiments performed 
might not have been sufficient to pinpoint potential differences in population growth. 
A second method for analysis was used to test whether different treatments of data 
give the same results. Rather than comparing the times increase in DNA 
concentration, the change of DNA concentration, or Δ[DNA], was expressed as the 
difference of the DNA concentration at D6 and the DNA concentration at D0. The 
main specificity about using this approach is that the number of kidneys used in each 
experiment was also taken into account to calculate Δ [DNA] per kidney, unlike in 
the first method. For the first method, expressing the results per kidney does not 
change the result as the ratios of [D6]/[D0] for one kidney or all kidneys remains the 
same as an equal number of kidneys were used at both time points and the 
components cancel each other. The results obtained using the second approach, 
recapitulated the initial analysis. TauGFP+ kidney cells showed a larger difference of 
DNA content between D6 and D0 (the average increase observed per kidney was 
536ng, in comparison to CD1 cells (384ng). Although, the difference was quite large, 
a student’s t-test showed that it was not significant. Similarly to the previous 
approach, looking at every experiment separately, demonstrated that tauGFP tissues 
generated a higher concentration of DNA from the same number of rudiments.  
Two other independent studies also showed that there was a larger increase in 
tauGFP cells, as compared to wild-type cells. In the first test, numbers of cells were 
counted, instead of quantifying DNA. Cell counts were performed with a standard 
Neubauer chamber. To correct for inaccuracies in pipetting and counting, each 
sample was pipetted onto the counting chamber 4 individual times and the same 
pipetting was counted thrice. The increase of cells from D0 to D6 was expressed as a 
ratio of the number of cells at D6 divided by the number of cells at D0 (similarly to 
the DNA quantification experiments). These cell counts showed a once again higher 
proportion of tauGFP+ cells in comparison to WT cells (Figure 3.2.9). The final 
difference between the cell numbers obtained from CD1 and tauGFP kidneys was 
significant when analysed with a two-tailed student’s t-test assuming unequal 
variance (p<<0.01). These results could not be treated as conclusive as only one 
experiment was performed. 
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Comparison of DNA content between CD1 
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Figure 3.2.8 - Comparison of the DNA content of CD1 and tauGFP embryonic kidneys 
after 6 days of culture 
 
A - shows the times increase of the DNA content of both types of kidneys from D0 to D6. 
The data is based on 5 separate experiments. The DNA content measured on the basis of 
DNA extraction from all right kidneys of embryos at D6. Differences in the starting 
concentration of DNA were corrected for by an initial quantification of the DNA content of 
all left kidneys at D0. The error bars are standard deviation. The difference between CD1 
and tauGFP kidneys is non-standard on the basis of a two-tailed unpaired student’s t-test. 
 
B - Shows the results obtained from all 5 individual experiments separately. 2 out of the 5 
experiments showed a significant difference between the increase in DNA concentrations 
of tauGFP and CD1 kidneys. Bars are standard deviation. Ns - non-standard; * = p < 0.05; 
** = p < 0.01 
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Comparison of the changes in cell 
numbers in CD1 and tauGFP kidneys 































Similar results were obtained when DNA was isolated from cultured pellets made 
from the same number of tauGFP+ and tauGFP- cells. DNA yield for GFP+ cells 
was higher after 6 days of culture. 2.21µg DNA were obtained from CD1pellets, 
while 2.85µg were calculated for tauGFP pellets. Only one experiment was 
performed.  
 
The results from all experiments studying the possibility for differences between WT 
and tauGFP kidneys were not conclusive, but the possibility for such a difference 
Figure 3.2.9 - A comparison of the increase in cells numbers of CD1 and tauGFP 
kidney cells after disaggregation, reaggregation and 6D culture 
The number of CD1 cells increased 1.08 times, while the number of tauGFP cells 
increased 1.93 times. Cells were counted three times in 4 separate pipettings both at 
D0 and at D6. The error bars show standard deviation. Significance was estimate with 
an unpaired student’s t-test assuming unequal variance (p = 0.003). 
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could also not be rejected on the basis of the experimental analysis performed. On 
the contrary - results suggested that designing methods to decrease variation and 
performing a large number of experiments might demonstrate the existence of a 
potential difference between the two types of rudiments. A separate study would be 
needed to address this issue for obtaining more conclusive data. Importantly, this 
study has shown that there are either no significant differences in the growth of WT 
and tauGFP cell populations or the latter grow faster. This suggests that the detection 
of tauGFP cells will not be lost in experiments due to an overgrowth by WT cells. 
 
 
3.3 Summary and discussion 
In this chapter, I have described the development and testing of tools improving the 
available methods for studying kidney development and the renogenic potential of 
different types of cells. I have developed a robust quantitative method for assessing 
the potential of cells on the basis of their ability to contribute to the structure of 
developing ureteric buds and forming nephrons. In this section, I will shortly discuss, 
how the developed method satisfies the 7 conditions for a good assay for studying 
the renogenic potential of cells, on the basis of the experimental results from section 
3.2. 
First, the identification of a good method for tracking cells after mixing them with 
embryonic kidney cells has been described.  In these studies, the use of tauGFP+ 
mouse embryos for cell extraction and mixing studies has proven significantly better 
than transient labeling methods such as CellTracker. Some of the disadvantages of 
transient labelling are that the label is diluted out with cell divisions, which 
significantly decreases the permissible culture time of experiments. In addition, 
experiments have shown that although CellTracker labelling indeed worked robustly 
every time (based on microscopic verification after each staining procedure), at the 
end of the culture time the intensity of staining differed between experiments (results 
presented in Chapter 5). The staining of control embryonic kidney cells with 
CellTracker generated images, in which labelled cells were extremely difficult to 
distinguish. These micrographs would be very difficult to interpret in qualitative 
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studies and will not be useful at all for quantifying integrating cells. In contrast, the 
use of genetically labelled cells largely improved the quality of the images produced 
and made the detection of cells much easier. It fulfilled all 6 requirements for a good 
marker for cells, as described in section 3.1.3. The only limitation that could be 
detected was the slight variation of fluorescence levels between some cells. In later 
quantitative experiments including cell counts, it was determined that this does not 
have an impact on cell detectability. Then, the other criteria for a good assay, 
discussed in section 3.1.3 were tested. As required, it was determined that in control 
conditions the disaggregation-reaggregation system allowed for the integration of 
cells in both UB and nephrons (condition 4). It worked well in combination with 
confocal microscopy (condition 5) and allowed the assessment of at least two 
markers simultaneously, as demonstrated by Calbindin/Laminin co-staining 
(condition 6). Quantitative studies also confirmed that this method was suitable for 
introduction of a defined number of cells, a homogenous distribution of the tested 
cells and counts resulted in useful quantitative data (conditions 1, 2 and 3).  
 
Several limitations of the disaggregation-reaggregation system have also been 
identified. Experimental analysis showed that the proportion of cells integrating in 
the three early kidney compartments - nephrons, UBs and stroma, varied 
significantly between experiments. Experiments suggested that this was due to 
varying proportions of cells in the starting populations. Furthermore, quantitative 
data demonstrated that this problem can be solved by performing a sufficient number 
of biological repeats.  Another limitation of the assay was that the experimental 
percentage of tauGFP cells found in renal epithelia was higher than the theoretical 
value. As previously mentioned, tauGFP+ cells express a tau-GFP fusion protein 
under the CAG promoter. Pratt et al. (2000) have reported that the tauGFP fusion 
protein is very clearly distinguishable in the process of neurons carrying the 
construct, in contrast to other cells carrying a construct for GFP only. This leads to 
the conclusion that the tauGFP fusion helps the reporter protein to be transported to 
the processes of neural cells and that the tau component is functional. Tau is a 
protein essential for and a major regulator of microtubule assembly (Weingarten et 
al, 1975). It acts by a physical contact with microtubules. This means that the tauGFP 
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fusion protein might play a role in providing additional stability to microtubules due 
to the existence of the GFP moiety, thereby providing increased protection to the cell 
in conditions of stress, such as enzymatic treatment. To detect such a possible 
difference between tauGFP and WT cells, additional experiments were performed. 
DNA quantification experiments were used as an approach to monitor the change of 
relative cell number and therefore as an indirect indicator of growth (defined as the 
balance of cell proliferation and cell death in a population of cells). Experiments 
based on DNA quantification of cultured kidneys of both types showed a higher 
average increase in DNA content for tauGFP+ kidneys, but this effect was not 
significant. Supporting experiments confirmed these results, although did not provide 
any statistically assessable data. Although this study did not identify the reason for 
the higher than expected percentage of tauGFP positive cells, it was very important 
in providing an independent check that tauGFP cells did not grow slower than WT 
cells. In cell mixing experiments, a higher proportion of tauGFP cells would not 
affect the final conclusions from experiments, as it has been shown to reappear 
consistently in all experiments. It is essential, though, that the percentage of 
integrating green cells was not lower than the theoretical value. Such an outcome 
would have introduced the danger of failing to detect small numbers of integrating 
tauGFP cells, thereby obtaining a completely negative result for the respective 
population.  
Overall, experiments performed in this chapter determined that the embryonic kidney 
disaggregation-reaggregation system fulfills the criteria for a good assay system 
detailed in section 3.1.3 very well. Even though, several limitations of this method 
were detected, they could be circumvented by performing a sufficient number of 
repeats and careful analysis. The comparison of two methods of analysis of the 
quantifications showed extremely similar results suggesting that either one could be 
used for assessing the integration potential of different populations of cells, as 
convenient. The quantitative version of the disaggregation-reaggregation system 





Undifferentiated embryonic stem cells form chimeric 
structures with renal epithelia, but do not express kidney 




As outlined in Chapter 1, one of the aims of this thesis is to investigate acquisition of 
renogenic potential by studying in vitro differentiation of embryonic stem cells to 
kidney cells. Once a good qualitative method has been established, the quantitative 
assay developed in Chapter 3 could be used to evaluate what proportion of the tested 
cells are able to contribute to the structure of renal epithelia. In the current chapter, I 
investigate one particular approach to ESC differentiation. This is to test whether the 
microenvironment of the developing kidney rudiment is sufficient to induce renal 
differentiation in ESCs. I will start by first establishing some criteria and definitions, 
as a tool to explain the results from mixing ES cells into organotypic cultures. 
Second, I will discuss the advantages of using the disaggregation-reaggregation 
system as a potential niche for differentiation (also in comparison to previously 
published studies). Next, I will present experimental evidence that, although ESCs 
placed in the environment of reaggregating embryonic kidney rudiments are able to 
form chimeric structures with native renal epithelia, they fail to express renal 
markers. Finally, I will discuss how these results could fit the information currently 
available in the literature. 
 
4.1.1 Definitions for assessment of integration of test cells into 
reforming renal structures in reaggregated cultures 
Before results from the cell reaggregation/ESC-integration experiments can be 
presented, the terminology used in future parts of this thesis has to be defined. These 
definitions are necessary to describe the different possible behaviours of test cells, 
after they have been mixed with embryonic kidney cells and mixed in organotypic 
cultures. It has previously been demonstrated (Unbekandt et al., 2010; Chapter 3 of 
this thesis) that control labelled embryonic kidney cells have the ability to integrate 
into all renal compartments indistinguishably from non-labelled cells. Therefore, the 
ability of test cells to integrate into the structure of reforming nephrons and UBs is 
one of several criteria for being able to classify the investigated cells as renal. A 
summary of the terms commonly used in this thesis to characterise the behaviour of 
grafted cells is given in Table 2.1.1. Column one of the table shows the term most 
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commonly used to refer to cells exhibiting the properties described in column 3. 
Column two provides phrases that can be used synonymously with the terms found in 
column 1.  
 
4.1.2 Criteria for identifying cells as renal 
Many of the limitations and difficulties in determining whether ES cells have 
differentiated into kidney cells or not, have been discussed in Chapter 1. They have 
been summarised here to provide support for selecting the criteria for renal cell 
determination given below. 
 
Difficulties in the assessment of the derivation of kidney cells (in organotypic 
cultures): 
- the lack of a robust marker for tracking the grafted cells, without any risk of 
transfer of the labelling reagent 
- the lack of a single marker for the identification of kidney cells 
- the existence of many different types of renal cells, which express different 
combinations of markers 
- reverse transcription PCR is, by itself, inadequate in assessing gene expression 
in mixtures of cells, including embryoid bodies or organotypic cultures as it 
doesn’t provide resolution to the single-cell level 
- functional studies on the basis of soluble reagent incorporation are difficult to 
perform as other types of tubules with the properties to transport substances exist 
 
These limitations have made it necessary to look for a good analytical approach to 
screen for the generation of renal cells critically and define the requirements that 
cells must fulfil in the context of mixed organotypic cultures, in order to be 
considered as renal cells. These criteria should not be used individually, but should 
be fulfilled in conjunction: 
 
- the cells should be well-detectable 







to test cells 
Synonymous 
words/phrases 
Properties of the test cells after 
integration in reaggregates 




renal tubules; dispersed 
Unknown 
   
form structures  -   - form assemblies of more than 5 cells  
 - are enclosed by a basement membrane 
 - display some degree of organisation 




form/are within physical 
contact with host renal 
epithelia; associate with 
renal epithelia; are 
(found) (in the structure 
of) renal epithelia 
 - form structures of more than 5 grafted cells 
 - display some degree of organisation  
 - are within physical contact with host renal 
epithelia 
 - are enclosed by a basement membrane, 
continuous between grafted and host 
structures 
 - do not form fine-grained chimeras, but 
rather segregate from host renal epithelia 
 -  may or may not express renal markers 
 -  may display a different morphology from 
renal cells 
   
integrate into the 
structure of renal 
epithelia 
localise into renal 
epithelia 
 - individual cells or many cells found into a 
physical contact with renal epithelia 
 - enclosed by the same basal lamina as the 
host structure they are found in 
 - have a morphology indistinguishable from 
renal cells 
 - may or may not express renal markers 
   
integrate into the 




 -   - as above, but express renal markers 




- potentially renal cells integrated into the structure of developing renal epithelia 
should have a morphology indistinguishable from the surrounding host kidney 
tubular cells on the basis of several sub-criteria – overall morphology, shape, 
size, position in the native tubule with respect to neighbouring cells, consistent 
positioning of the nucleus with respect to the positioning of neighbouring nuclei 
- should co-express at least two kidney markers with sub-criteria – to express 
these markers in the correct cellular compartments, to co-express a marker 
combination consistent with the literature, should express these markers as 
above to match the location/function of the respective cells (for example, if a cell 
is found in a tubule, it should express tubular, but not stromal markers). 
 
After the tools necessary for testing the usefulness of using the kidney rudiment as a 
microenvironment for differentiation of ESCs to renal cells had been established, it 
was possible to proceed to description and analysis of the experimental results. In the 
following chapter section, tauGFP ESCs were first characterised for GFP expression, 
the ability to maintain in an undifferentiated state and the ability to give rise to cells 
from the three germ layers before their renogenic ability was examined. 
 
4.1.3 Advantages of using the kidney disaggregation-reaggregation 
method as an alternative approach to explanted kidney rudiments to 
provide a microenvironment for differentiation of embryonic stem 
cells  
Unlike many other cell types, which can routinely be produced from ES cells, 
methods for generating kidney cells are still in the first steps of their development. 
This being the case, the efforts for devising defined conditions for ES cell 
differentiation should first be focussed on finding one sufficiently effective method 
for generation of kidney cells, rather than many less efficient ones.  
 
Experiments studying aggregation of ES cells and cleavage-stage tetraploid embryos 
(Nagy et al., 1990; Nagy et al., 1993) have shown that, when re-introduced into 
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foster mothers and left to develop to term, embryonic stem cells are capable of 
generating all cells and tissues of the body. In contrast, in entirely in vitro conditions 
where no re-implantation is involved, the cells no longer receive the right signals to 
guide them to form a normally developing embryo. Still ESCs differentiate to a 
multitude of cell types, which includes mesodermal cells, spontaneously (Martin, 
1981; Li et al., 1998).  By the same token, it could be hypothesised that ESCs would 
behave the same way after being mixed with embryonic kidney cells in the 
disaggregation-reaggregation system. Once they have differentiated spontaneously to 
mesoderm or intermediate mesoderm, they could potentially acquire the ability to 
respond to the signals from the kidney microenvironment and progress to make renal 
cells (Figure 4.1.1). Furthermore, the reaggregation system has the important 
advantage of starting structure formation from a single-cell suspension. This allows 
for an additional criterion to assess the differentiation process on the basis of the 
cells’ abilities to integrate into the structure of developing renal epithelia and orient 
themselves correctly with respect to neighbouring kidney cells.  The small size of the 
organotypic cultures, as well as the existence of already available methods for three-
dimensional analysis of at least two different markers in addition to GFP, make this 
system a promising approach for studying the in vitro generation of kidney cells.  
 
Table 4.1.1 - The developmental steps from inner cell mass (ESC) to renal cells 
ICM - inner cell mass; IM - intermediate mesoderm; MM - metanephric mesenchyme 
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Up to now, there has been only one study that reported testing the ability of totally 
undifferentiated cells to respond to the signals provided by the microenvironment of 
a developing kidney (Steenhard et al., 2005). The authors reported that injection of 
mouse ROSA26 ES cells into E13 mouse kidney rudiments resulted in the formation 
of tubular-like structures within 5 days. These cells also seemed to express markers 
associated with renal cells such as WT1 and α1 Na+/K+ ATPase, and were able to 
bind Lotus tetragonolobus lectin. First, the results presented in this study suggested 
that use of the microenvironment of a developing kidney rudiment for the 
differentiation of ES cells might hold some promise as a method of directed 
differentiation. Second, it also provided valuable insight into the limitations of the 
method of injection and into potential ways to improve the results of similar 
experiments. One of the important findings that Steenhard et al., (2005) reported 
about the ESC-derived structures was that they did not observe any chimeric 
structures between the ROSA26 ES-derived cells and native kidney cells. The ability 
of ESC-derived cells to form chimeric structures with native kidney cells would be 
one of a few important criteria, which would contribute to the identification of these 
tubules as kidney tubules, both in normal development and in in vitro systems. This 
comes from our knowledge that in development dispersed MM cells aggregate to 
form renal vesicles, which develop into nephrons (Grobstein, 1955) and that 
disaggregated embryonic kidney cells reaggregate to form individual UB structures 
and nephrons (Unbekandt and Davies, 2010). Furthermore, if the potential of such 
cells to be used in cell replacement therapies in the future has to be considered, they 
would be useful for replacing lost kidney cells only if they possess the ability to form 
chimeric structures with them to replace cells that have been lost. With regard to 
these limitations of the currently available methods, it was concluded that the 
disaggregation-reaggregation culture system gives an excellent possibility to obtain 
more information about the ability of ES cells to respond to signals from the 
microenvironment of a kidney to differentiate to renal cells. Performing the 
experiments with E11.5 kidney rudiments rather than E13 ones would give ESC-
derived cells a better chance to demonstrate whether they could integrate into host 
kidney structures and allow for better analysis of the properties of these cells. 
Combined with the possibilities to study simultaneously the co-expression of several 
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markers in three dimensions, the described approach provides an extremely valuable 
tool for studying the potential of ES cells to generate renal cells in vitro in response 
to signals from the microenvironment. 
 
4.2 Results 
4.2.1 Optimisation of ES cell culture conditions 
To make sure that no contaminant cells were present in mixing experiments with 
kidney cells, all embryonic stem cell lines worked with and described in this chapter 
were depleted of mouse embryonic fibroblast feeder cells. To find the best conditions 
for culture of feeder-free ES cells, wild-type control E14 cells were plated in three 
different conditions: gelatinised tissue culture plates, where gelatine was washed 2 
times before cell plating; on gelatinised tissue culture plates where the gelatine was 
only aspirated after coating (without washes); and on gelatinised, ethanol-sterilised 
22x22mm glass cover slips placed in the wells of 6-well tissue culture plates.  
 
24h after seeding, the morphology of cells in the three different conditions was 
assessed by light microscopy. 5 wells per setup were characterised morphologically 
and all examined wells showed consistent results. In the wells where gelatine was 
washed with PBS prior to seeding cells, more flat cells were observed in comparison 
to the other two setups. This made controlling for unusually high percentages of 
differentiating cells very difficult due to the presence of flatter ES cells (Figure 4.2.1, 
A, B and C, arrows). In the sample where gelatine was not washed after coating, the 
flat cells decreased at the expense of more three dimensional colonies with light 
halos around them (as characteristic for mouse ES cells cultures on fibroblasts). ES 
cells on gelatinised glass cover slips were almost entirely three-dimensional and 
almost no flat cells were observed (Figure 4.2.1, G, H and I). This provided: 1- a 
good, morphology-based approach for controlling the cultures visually for unusually 
increased numbers of flattening cells; and 2 - a convenient tool for fixing and 
staining cells for fluorescence microscopy, where cells would be already attached to 
cover slips and could be mounted on glass slides for better imaging. Due to these 
advantages, cells were routinely cultured without a feeder layer on gelatinised cover  
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Figure 4.2.1 - The influence of substrates on the morphology of ESCs in culture 
A, B, C – ESCs cultured on gelatinised cell culture dishes, where the gelatine was 
washed twice with PBS before seeding; D, E, F – ESCs cultured on gelatinised cell 
culture dishes, where the gelatin was not washed with PBS before plating the cells; 
G, H, I – ESCs cultured on conventional gelatinised glass cover slips. 
The three columns contain representative images for three different wells (overall 5 






slips, which were not washed with PBS after treatment.  
 
Furthermore, a simple test was used to check whether the flat cells described in the 
paragraphs above (as shown on Figure 4.2.1, A, B and C) were the result of 
differentiation or whether they were an alternative morphology of still-pluripotent 
cells. For this purpose, flatter cells, cultured directly on the cell culture dish where 
gelatine was washed twice, were detached enzymatically and plated on gelatinised 
cover slips. The morphology of the cells after replating was indistinguishable from 
the cells shown on Figure 4.2.1, G, H and I indicating that the cells were not 
differentiating, but displayed different morphology when seeded on different 
substrates. 
  
4.2.2 Characterisation of tauGFP+ mouse embryonic stem cells 
4.2.2.1 tauGFP ES cells maintain transgene expression under selection and 
conditions favouring pluripotency 
tauGFP mouse embryonic stem cells were kindly provided by Dr. Jane Quinn, 
University of Edinburgh. The same line of embryonic stem cells had also been used 
for the production of the tauGFP mice characterised in the Materials and Methods 
Chapter and previous chapters (Pratt et al., 2000). These cells were cultured under 
continuous Puromycin selection to maintain selective pressure for the randomly 
inserted construct (construct, as shown on Figure 3.2.2, A). For using these cells to 
test differentiation to a renal lineage on the basis of mixing them in the cell 
disaggregation-reaggregation system described in Chapter 3, they first had to be 
characterised for GFP fluorescence, pluripotency and differentiation potential.  
 
Both control E14 ES cells (parent line) and tauGFP ES cells were plated at a low 
density on gelatinised glass cover slips, incubated for 24h to let them attach and fixed 
with PFA and methanol. They were then stained with DAPI to visualise the nuclei 
and mounted for microscopy. Micrographs of the control and GFP+ populations were 
taken at the same exposure times.  
 
The control E14 ESCs did not show any autofluorescence and were clearly 
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distinguishable from the tauGFP-tagged cells (Figure 4.2.2, A). As with the tauGFP 
kidney cells shown in Chapter 3, some differences in the intensity of GFP expression 
were observed (Figure 4.2.2, A-E). There were very intensely labelled with GFP 
cells (Figure 4.2.2, B) referred to as strongly positive cells. There were also cells, 
which exhibited a weaker GFP-fluorescence, termed “positive” (Figure 4.2.2, C, 
arrows). These were very clearly distinguishable from control cells, but had a weaker 
fluorescence intensity than strongly positive cells. Two other types of cells were also 
observed in the labelled population of cells – weakly positive cells and negative 
cells. The weakly positive cells had very low levels of fluorescence and were 
difficult to distinguish from control cells (Figure 4.2.2, D, arrow). Negative cells 
were not at all distinguishable from control cells and did not exhibit any detectable 
florescence (Figure 4.2.2, E, arrow).  
 
Too many weakly positive or negative cells could interfere with cell mixing 
experiments. To determine whether this was the case, the numbers of cells in 
different categories were quantified on the basis of 10 randomly taken fluorescence 
micrographs. Total cells were counted on the basis of DAPI staining. The results 
were presented as a percentage of the total number of cells ± the margin of error 
calculated for a 95% confidence interval. As can be seen on Figure 4.2.2, F and G, 
the percentage of cells that did not express the tauGFP fusion protein was very low. 
98.70 ± 0.61% were found to express detectable levels of the protein, while only 1.30 
± 0.61% were determined as negative. Such a small fraction of negative cells could 
not affect the results of cell mixing experiments. 
 
The distribution of the counted cells into the categories: strongly positive, positive, 
weakly positive and negative was also compared (Figure 4.2.2, H and I). Cell counts 
allowed concluding that strongly positive and positive for tauGFP cells were most 
frequent in the culture, representing respectively 76.74 ± 2.20% and 19.15 ± 2.05 of 
total cells. The difficult to detect weakly positive cells accounted for only 2.80 ± 
0.88% of the total population. These results confirmed that even if weakly positive 
cells were undetectable in organotypic cultures, this would not affect the data 
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Figure 4.2.2 - Characterisation of tauGFP ESC 
A - Micrographs showing tauGFP expression in the transgenic ES cell line and lack 
of GFP expression and autofluorescence in the parent E14 ES cell line at the same 
exposure time; B, C, D, E – details of tauGFP+ cells illustrating the different 
fluorescence intensities of transgenic cells, as defined in the text; B – strongly 
positive cells (arrow); C – positive cells (arrows); D – weakly positive cells (arrow); 
E – negative cell (arrow); F – pie chart showing the proportion of tauGFP+ and 
negative cells in the culture; G – bar graph showing the percentages of tauGFP+ 
and negative cells, error bars are SEM; H – pie chart showing the proportions of 
cells with different fluorescence intensities in the culture; I – bar graph showing the 
percentage distribution of cells with different intensities in the culture, error bars are 
SEM. 
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4.2.2.2 tauGFP ES cells retain expression of the GFP fusion protein at least 15 
days after removal of selective pressure 
Although, the quantification of tauGFP expressing cells demonstrated that expression 
of the fluorescence protein is maintained very well under selection and in conditions 
favouring pluripotency, it was also important to note that Puromycin would have to 
be removed in mixing experiments with wild-type kidney cells. Removal of selection 
in these experiments could significantly decrease the percentage of tauGFP positive 
cells over the course of the experiment, thereby rendering the grafted cells 
undetectable. Therefore, GFP fluorescence after a long-term differentiation culture in 
the absence of Puromycin had to be tested, as well. 
 
For this purpose, EBs from tauGFP and control E14 cells were formed and kept in 
suspension culture for 15 days. EBs were then stained with DAPI, sandwiched 
between two cover slips and imaged for nuclei and GFP fluorescence. The 
micrographs showed that due to the complex morphology of embryoid bodies it was 
not possible to quantify the number of GFP positive cells (Figure 4.2.3). The greatest 
difficulty was to assess the number of nuclei on the section, as cell death that 
naturally occurring during the morphogenetic processes in EBs made it very difficult 
to distinguish debris (possibly random fragments of nucleic acid) from nuclei (Figure 
4.2.3). Although this experiment did not generate any quantitative data, it was 
sufficient to show that GFP positive cells were still maintained even after 15 days of 
EB culture under conditions lacking selection, which was much longer than the 
timescale of cell mixing experiments. 
 
4.2.2.3 tauGFP ES cells express the pluripotency marker Oct4 
For examining the potential of ES cells to produce kidney cells in vitro it was next 
necessary to confirm that the starting population of cells to be used in cell mixing 
experiments contained mainly undifferentiated cells. Screening for the pluripotency 
marker Oct4 would also allow determining whether the tauGFP ES cell line, 
produced by a genetic modification expressed this marker as expected.  For these 
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Figure 4.2.3 - GFP expression of tauGFP EBs, 15 days after culture in Puromycin-
free medium 
Control E14 EBs shown in row 1 and 2 do not show GFP fluorescence when 
micrographed at the same exposure time as used for imaging tauGFP cells. The 
nuclear staining for DAPI shows that cells are present in the EBs. Images of 
tauGFP EBs (rows 3 and 4) show that GFP fluorescence is retained even after a 15 
day culture in Puromycin-free conditions. These images also illustrate the 
complexity of maturing EBs containing regions with cellular debris, which made 








purposes, control E14 and tauGFP ES cells were seeded at a low density on 
gelatinised glass cover slips, incubated for 24h to attach and fixed with PFA, 
followed by methanol. The fixed cells were stained for Oct4 and DAPI. Figure 4.2.4 
shows representative images of the staining for both secondary antibody controls and 
samples. Although, the controls for both types of cells show relatively high 
background fluorescence, a comparison to the Oct4-stained samples revealed that the 
staining was clearly distinguishable from negative cells. As can be seen from Figure 
4.2.4, background fluorescence is present fairly uniformly within the colony of cells, 
in contrast to the Oct4-stained cells, which showed a specific nuclear staining. 
Additionally, these experiments were used to confirm that Oct4 positive cells were 
also expressing tauGFP, as evident from the micrographs shown in Figure 4.2.2, 4th 
column with panels. 
 
While acquiring images for Oct4 quantification studies, the DAPI channel was used 
for selection of areas containing high number of cells for counting. The selection of 
areas was done blindly with respect to Oct4 as this channel was not observed in the 
process. 10 different micrographs of cover slips seeded with cells were taken for both 
the control E14 cells and tauGFP cells. The Oct4 positive cells in the two groups 
were quantified as a percentage of the total number of cells, assessed by DAPI+ 
nuclei. The results were presented in Figure 4.2.2, B and C as proportions of negative 
and positive cells for E14 wild type cells and tauGFP ES cells. In the E14 
populations, 94.9% of cells were found to be Oct4 positive compared to 96.3% of the 
tauGFP cells. The comparison between the two types of cells is shown in Figure 
4.2.2, D indicating that an extremely high percentage of cells expressed Oct4, as 
expected from undifferentiated pluripotent cells. The two populations contained 
relatively the same proportion of positive cells, as shown by an unpaired student’s t-
test (p=0.4), as well as a low number of differentiated cells (E14 - 5.1%; tauGFP - 
3.7%). On the basis of these studies it was concluded that tauGFP ES cells were 
maintained undifferentiated as compared to their parent population and as normally 









A comparison between the levels of Oct4-


























Figure 4.2.4 - Characterisation Oct4 expression in tauGFP ESCs 
A – Micrographs showing the expression of Oct4 and tauGFP in tauGFP ESCs and 
the parent E14 stem cell line. Although background in the Oct4 channel is high, the 
images clearly demonstrated that Oct4 staining (nuclear) is distinguishable from the 
non-specific staining (whole cell). tauGFP cells expressed both Oct4 and tauGFP 
robustly under conditions of pluripotency; DAPI (dark blue), Oct4 (red), tauGFP 
(green). B – a pie chart showing the proportion of Oct4 positivity in control E14 
ESCs; C - a pie chart showing the proportion of Oct4 positivity in tauGFP ESCs; D 
– shows a comparison between the percentages of cell in E14 and tauGFP ES cell 





4.2.2.4 tauGFP mouse ESCs can differentiate to the three germ layers 
In addition to checking whether tauGFP cells expressed pluripotency markers, it was 
necessary to confirm that the genetically modified ES cell line had not lost its 
property to give rise to the three germ layers. In the design of this experiment it was 
taken into account that cells senesce with passages, which might limit their 
differentiation potential. Differentiation experiments were therefore performed at 
passage 50 - the latest passage that the cells were allowed to reach at any stage. 
 
The potential of tauGFP ESCs to differentiate to the three germ layers was assessed 
by screening mRNA transcripts by cDNA synthesis and PCR amplification of the 
cDNA fragments. The three genes selected to show the presence of endodermal, 
mesodermal and ectodermal lineages and the respective references are shown in 
Figure 2.4.5, A. The tissues that these markers are most commonly associated with 
are also given. 
 
For this set of experiments, embryoid bodies were formed from E14 and tauGFP 
embryonic stem cells and cultured for 14 days in a suspension culture. Embryoid 
bodies were harvested for RNA isolation and cDNA was synthesised for detection of 
gene-specific transcripts by PCR. For a positive control, RNA was isolated from 
whole E11.5 embryos. GAPDH was used as a loading control. The primer pairs used 
for these reactions are given in Table 2.5 of the Materials and Methods section of this 
thesis. The size of the bands resulting from cDNA synthesis and PCR amplification 
was assessed by running a DNA ladder and was compared to the expected values 
given in Table 2.5 to confirm that the reaction product was specific. 
 
The presence or absence of a specific product for the genes of interest was assessed 
by a comparison between E14 undifferentiated ES cells, tauGFP undifferentiated ES 
cells and E14 and tauGFP cells differentiated by the embryoid body method. The 
results show that there is no expression of differentiation genes in both types of ES 
cells, as expected. Cell differentiation led to the upregulation of all three markers in 




Gene Expressed in Reference 
endoderm 
alphafetoprotein 
(AFP) Hepatocytes Abelev, 1971 
mesoderm α smooth muscle 
actin (α SMA) smooth muscle 




Ruzicka et al., 1988; 
Sugi and Lough, 
1992 
skeletal muscle 








Figure 4.2.5 - Characterisation of the differentiation potential of tauGFP ES cells, 
as compared to control E14 ES cells 
A – a table illustrating a selection of markers associated with the three germ layers 
with the respective references; B – PCR results showing the presence of transcript 
of all three tested genes in both control E14 and tauGFP ES cells. These results 
are based on reverse transcription of total RNA extracts. Both types of ES cells 
show no expression of the three markers when cultured in pluripotency conditions 
and presence of all three markers after being cultured as embryoid bodies for 14 
days. –C (negative control) is water to detect unspecific products from 
contaminating DNA. +C (positive control) is based on cDNA prepared from a whole 




from the three germ layers and behaved similarly to wild type E14 embryonic stem 
cells. 
 
4.2.3 Undifferentiated mouse ES cells form chimeric structures with 
embryonic kidney cells 
After it was confirmed that the tauGFP cells robustly express GFP under different 
conditions, express Oct4 under pluripotency conditions, and are able to differentiate 
into the three germ layers, their ability to respond to the signals of the 
microenvironment and differentiate to kidney cells in reaggregated organotypic 
kidney rudiments could be tested. For this purpose, tauGFP ES cells were made into 
a single cell suspension and extruded through a 40µm cell strainer, before mixing 
15,000 ES cells with 100,000 embryonic E11.5 embryonic kidney cells for the 
formation of organotypic pellets. These experiments did not include a treatment with 
Y-27632 as reaggregates containing ESC are able to survive without ROCK 
inhibition. The ROCK inhibition step was omitted here to minimise the possible 
effects of the inhibitor on the differentiation potential of ESCs. The reaggregates 
containing ESCs were cultured for 7 days, and then fixed with 4% PFA and 
methanol. Epithelia were visualised by immunostaining for E-cadherin and tauGFP; 
ESC-derived cells - by their expression of GFP.  
 
Confocal sections showed that tauGFP positive structures formed physical contacts 
with wild-type renal epithelia (Figure 4.2.6, white dotted lines). It was observed that 
tauGFP+ and wild type cells do not form fine-grained chimeras, but rather segregate 
into separate regions of the structures formed. Some of the tauGFP positive 
structures did not have a particular cellular organisation, but others rarely formed a 
single-layered epithelium with a lumen, as characteristic of renal tubules (Figure 
4.2.6, G-I). Only from confocal micrographs, it was not clear whether these 
structures were formed just because they ended up next to each other by chance or 
whether a more complex process was involved. The former process would suggest 
that the number of contact points between tauGFP+ and tauGFP- epithelia on a  
confocal section would depend on the number of these structures. The more  
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Figure 4.2.6 - Undifferentiated tauGFP ESCs show formation of chimeric structures 
when mixed with E11.5 mouse embryonic kidney cells and cultured as organotypic 
rudiments for 7 days 
A, D and G show a double staining for E-cadherin (blue) and tauGFP (green); B, E 
and H show only the green channels of their respective panels A, D and G; C, F and I 
are a schematic version of the double stainings in A, D and G. Arrows indicate native 
kidney epithelia, which are E-cadherin+/tauGFP-. White dotted lines indicate the 
physical contacts between native kidney and tauGFP+ structures. The open arrows in 




structures, the more contact points. To test this, the number of both types of 
structures and the number of continuous contact points were quantified. The 
following criteria were used for quantification: 
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- structures had to be E-cadherin positive 
- more than 5 adhering E-cadherin+ cells were counted as an epithelial structure 
(examples of structures, as counted, could be seen in the diagram in figure 4.2.6, 
C, F and I) 
- the number of contact points between GFP- and GFP+ structures were counted 
(as shown by the dotted lines on Figure 4.2.6, C, F and I) 
 
For example, in Figure 4.2.6, C, there would be 1 wild-type structure (blue), 5 GFP+ 
structures (green) and 2 contact points. Figure 4.2.7, A and B, summarises the 
results from 4 organotypic cultures. The bars represent the average number of wild 
type structures, tauGFP+ structures or contact points per confocal section. Error bars 
are standard errors of the mean. The results are presented individually in A and as an 
average of all organotypic cultures in B. One-way ANOVA confirmed that the 
differences between the individual cultures were not significant in any of the three 
measured categories. To check whether the number of contact points between WT 
and tauGFP structures was dependent only on the number of structures of both types 
present on one confocal section, the following experimental analysis was designed. 
First, a coefficient was needed to provide information about the ratio of both types 
of structures co-existing on the same section. For this, the number (№) of tauGFP 
structures on one section was divided by the number of WT structures on the same 
section (№ TauGFP+/№ WT structures). This coefficient was then plotted against 
the number of contact points (Figure 7.2.7, C). The linear regression curve is also 
shown. Correlation analysis was performed by calculating the Pearson product - 
moment correlation coefficient (r). r shows the linear dependence between two sets 
of measurements and gives a value between -1 and 1. Values close to 0 show a very 
weak correlation, while values close to ± 1 indicate a strong correlation (Fowler et 
al., 1998). The r determined was 0.08 and suggested that there was only a very weak 
correlation between the number of contact points and the numbers of WT and 
tauGFP+ structures co-existing on a confocal section. This suggests that contact 
points are not formed by WT and tauGFP structures just ending up next to one 
another, but by another mechanism, possibly involving active recognition between 
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Figure 4.2.7 - Quantification of the fusion points between native and tauGFP-derived 
structures, as compared to the relative number of these structures 
A – quantification of the number of three different types events in 4 organotypic cultures. 
These are based on counting tauGFP+, tauGFP- structures and adhesion points between 
the two in 10 confocal sections per sample. A one-way ANOVA showed that the differences 
between organotypic cultures for all three categories of counts were not significant 
B - averages of all 4 experiments shown in A 
C - analysis of correlation between the number of contact points and the numbers of tauGFP 
and WT structures co-existing on the same section; linear regression shown; r - Pearson 
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structures. Although, this test was very conclusive it had one disadvantage - that it 
measures only linear dependence. Since it was not known whether the dependence 
examined was linear or non-linear, these results were re-evaluated by a second 
method, which measures dependence of monotonically related variables, even if they 
are not linear. For this test, Spearman’s rank correlation coefficient (ρ) was 
calculated and showed a value of 0.24 (for n=40, degrees of freedom=38) thereby 
confirming only a weak correlation between the variables. 
 
4.2.4 tauGFP ESC-derived cells found in reaggregated kidney 
rudiments expressed the renal marker Pax2 
To investigate whether the tauGFP ESC-derived cells found in chimeric structures 
of grafted and native kidney cells could be renal, organotypic pellets were stained 
for Pax2. As mentioned in Chapter 1, Pax2 is a marker of renal epithelia, but is also 
expressed in the nervous system (Dressler et al., 1990). Confocal micrographs 
revealed that some, but not all GFP-positive cells were positive for this marker 
(Figure 4.2.8). Co-localisation of green fluorescence and Pax2 staining could be 
clearly shown in some cells (as shown on Figure 4.2.8).  
 
4.2.5 The Pax2/tauGFP double positive cells found in mixed 
organotypic cultures do not associate with renal epithelia and 
exhibit processes similar to neurites 
To determine whether any of the observed Pax2 and GFP double positive cells 
localised into renal epithelia, cultured organotypic pellets were triply stained for E-
cadherin, Pax2 and GFP. This screen identified two categories of tauGFP cells, 
which expressed Pax2: 
- cells found in the interstitium, which were not associated with renal tubules 
- epithelial cells found in chimeric and non-chimeric epithelial structures 
 
Studies by confocal microscopy revealed that Pax2/tauGFP double positive cells of 
the first type, which localised in the interstitium did not express the epithelial marker 
E-cadherin, as would be expected from renal epithelia (Figure 4.2.9, A and C, 
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Figure 4.2.8 - Some tauGFP+ cells found in cultured organotypic pellets express the 
renal marker Pax2 
A, B, C and D show representative images of 10-day organotypic cultures containing 
tauGFP ES cells. Open arrows indicate ES cell-derived structures negative for Pax2. 
Block arrows indicate cells and cell aggregates positive for Pax2. Details of 








Figure 4.2.9 - Pax2+ cells derived from tauGFP ESCs do not co-express E-cadherin 
and show false positives 
A – L – Pax2 (red), E-cadherin (dark blue), tauGFP (green); A and C show 
tauGFP+/Pax2+ cells (arrows) clearly exhibiting neural processes (arrowheads). Only 
GFP is shown in B and D; E – shows a small cluster of WT cells, which appear as 
tauGFP+/Pax2+ double positive cells (arrow); F – shows a cells with unhealthy 
morphology and signs of stress, which appear E-cadherin+/Pax2+; G – shows more 
examples of cells appearing double positive for E-cadherin and Pax2 (arrows). 
Examination of all acquisition channels separately reveals that Pax2 expression is false 
due to its presence in all other channel, which detect only non-nuclear markers H, I and 
J, arrows); K – shows another example of cells appearing doubly positive for E-
cadherin and Pax2 (arrow); L – contains the same image as in K, but also includes 
three dimensional information showing that the Pax2+ nuclei are not surrounded by a 
layer of GFP+ cytoplasm indicating that these are intercalating WT cells (white arrows). 
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arrows). In addition, it was observed that in some cases these cells extended long 
processes very similar to neurites (Figure 4.2.9, A, B, C and D, arrowheads), 
detectable by the tauGFP reporter protein (Pratt et al., 2000).  
 
A close examination of the second type of ESC-derived cells, which expressed both 
Pax2 and E-cadherin, revealed two major problems. First, some of these cells 
exhibited a dotty Pax2 staining, abnormal morphology and signs of stress (Figure 
4.2.9, F and G). Examining individually the blue, red and green channels used to 
generate the overlay of a triply stained image, led to the observation that several 
events, which appeared to be Pax2 positive nuclei were present in all three channels. 
This, taking into account the different localisation of these markers (E-cadherin - on 
the plasma membrane; tauGFP - in the cytoplasm and Pax2 - in the nucleus) meant 
that this staining was artefactual. Together with the unusual morphology of the cells, 
this observation was very important in acknowledging the presence of false positive 
for Pax2 cells. The second problem with Pax2/tauGFP/E-cadherin triply positive 
cells was detected by extensive three dimensional studies of tauGFP structures 
containing Pax2 positive cells. Serial confocal sections of areas of interest, which 
contained putative triply positive cells, were made. The example shown in Figure 
4.2.9, K and L, demonstrated that when examining cultures in two dimensions only, 
cells appeared Pax2/tauGFP positive. Studying the third dimension of these cells 
demonstrated that the Pax2 positive nuclei were not enveloped by a layer of tauGFP 
cytoplasm, which was a clear indication that these cells were tauGFP negative and 
therefore not ESC-derived. 
 
In summary, on the basis of the information presented in this chapter up to this 
point, no ESC-derived cells could be identified as potentially being renal epithelia. 
Although detectable numbers of Pax2 positive cells were found in the interstitium, 
they did not have the ability to localise into renal epithelia and formed neurite-like 
extensions, which suggested that these could be Pax2 positive neural cells (Püschel 
et al., 1992; Cheng et al., 1998). The cells forming epithelial renal-like structures, 








Protein Present/absent Details 
Calbindin  -  not detected in any cells 
Laminin  + (+)  
expressed in the tauGFP part of chimeric 
structures and stand-alone epithelial structures; 
not expressed by single cells in the interstitium 
or other cell clusters 
Pax2  + (-) 
not expressed by cells in epithelial structures 
forming chimeras with renal tubules; expressed 
by stand-alone cells in the interstitium, frequently 
exhibiting neurites 
E-cadherin  + (+) 
expressed by cells forming chimeric structured 
with renal epithelia and some stand alone 
structures; not expressed by other single cells 
and cell clusters in the interstitium 
Wt1  -  not detected in any cells 
K 
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Figure 4.2.10 - Marker expression of tauGFP cells cultured in organotypic pellets 
A, C, E, G and I show individual markers; B, D, F, H and J show markers and 
tauGFP expression; A and B – Calbindin (blue) is expressed by WT structures, but 
not by tauGFP+ structures; C and D – Laminin (red) is expressed by both tauGFP+ 
and tauGFP- structures; E and F – Pax2 (red) is expressed by WT structures, but 
not by tauGFP+ epithelial structures; G and H - E-cadherin (blue) is expressed by 
both WT and tauGFP+ structures; I and J – Wt1 (blue) is not expressed by 
tauGFP+ structures, but expressed strongly (white open arrow) and weakly (blue 
open arrow) by WT cells. 
Open arrows indicate WT structures; white block arrows indicate tauGFP ESC-
derived structures 
K – is a summary of the overall marker expression of tauGFP ESC-derived cells 
found in organotypic cultures. A plus or a minus denotes whether any tauGFP+ 
cells express or do not express the respective marker. A plus or a minus in 
brackets gives information about whether this marker expression was consistent 
with markers of the respective renal compartment. More information about the 
expression patters is also provided 
L – shows a summary of all immunohistochemical data obtained from tauGFP 
ESCs grafted in organotypic cultures. Red boxes indicate combinations of markers, 
which if co-expressed by the same cells would be a strong indication for the 








  Calbindin Laminin Pax 2 E-cadherin Wt1 
Calbindin  -   -  n/a n/a n/a 
Laminin  -   +  n/a n/a n/a 
Pax 2 n/a n/a  +   -  n/a 
E-cadherin n/a n/a  -   +  n/a 
Wt1 n/a n/a n/a n/a  -  
L 
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all examined cases be classed as false positives or could be shown lacking tauGFP 
expression.  
 
4.2.6 Further marker expression studies confirmed that the ESC-
derived structures did not express the combination of markers 
normally present in developing renal structures 
The gene expression profile of the tauGFP ES cell-derived cells present in 
organotypic cultures was characterised for the following 5 markers individually and 
in combinations of two at a time. The markers examined were Calbindin, Laminin, 
Pax2, E-cadherin and Wt1. Representative images for all genes were shown in Figure 
4.2.10, A-J. The data was summarised in Figures 4.2.10, K and L. In the tables 
shown in Figure 4.2.10, K and L, a minus indicates that the marker examined was not 
detected by IHC in any tauGFP positive cells (i.e. the grafted ESC-derived cells) in 
any of the samples. A protein was marked as present (by a plus sign), when 
exogenous (tauGFP+) cells in the organotypic cultures were positive for this marker. 
Then, for all positive markers, the expression in the currect renal compartment was 
assessed. The result was indicated by a plus or a minus in backets on Figure 4.2.10, 
K. For example, “+ (-)” would indicate that tauGFP cells express this marker, but 
that positive cells did not localise into the correct compartments. These details were 
also provided in the last column of the table in Figure 4.2.10, K. The latter figure 
shows that only 3 out of the 5 genes tested were expressed by tauGFP+ cells and that 
only 2 of these were seen in the correct compartment. More importantly, a further 
assessment based on co-localisation studies (a summary is provided in Figure 4.2.10, 
L) confirmed that none of these cells fulfilled the requirement for co-expression of 
two or more kidney markers. In Figure 4.2.10, L, a red box indicates combinations of 
markers, which (if expressed by the same cell) would be a strong indication for this 
cell to be a kidney cell. Although, this summary shows that the tauGFP cells were 
positive for the genes of interest in some cases, they were never seen to express both 
markers of interest at the same time. No evidence was found that the cells forming 




Figure 4.2.11 - Oct4-GFP ESCs grafted in ogranotypic cultures show that expression of 
Oct4 is maintained even after 6 days of organ culture 
A – example of a Laminin-bound Oct4 positive structure (arrow); B – example of two 
Oct4-GFP expressing Laminin-bound structures, one of which in a close proximity to a 
renal tubule; C – example of an Oct4-GFP+ structure establishing a contact with a WT 
UB; D – Oct4+/Laminin+ structures have formed a chimeric structure with a renal tubule 
Laminin (red), Calbindin (blue), Oct4-GFP (green) 
 
4.2.7 Organotypic pellets contained undifferentiated cells after 6 
days of culture 
4.2.7.1 Mixtures of embryonic kidney cells with Oct4-GFP cells revealed the 
presence of undifferentiated cells in the organotypic culture 
Embryonic stem cells stably expressing GFP under the Oct4 promoter were a kind 
gift from Dr. Patricia Murray, University of Liverpool. 15,000 Oct4-GFP cells were  
mixed with 100,000 E11.5 embryonic kidney cells as previously described. 6-day 
organotypic pellets were fixed and stained for Calbindin and Laminin, as previously 





Figure 4.2.12 - Immunohistochemistry for Oct4 confirms the specificity of Oct4-GFP 
expression and the presence of Oct4+ structures in organotypic pellets containing 
ESCs 
A, B and C – examples of Laminin+ (blue) structures showing colocalisation of 
Oct4-GFP(green) and Oct4 antibody (red), arrows; D – Laminin expression of C 
(arrow); E – antibody detection of Oct4 of the sample shown in C (arrow); F - Oct4-
GFP detection of the sample shown in C; G – DAPI (cyan) showing nuclear 





microscopy revealed that GFP+ cells could be detected in the mixtures suggesting 
that undifferentiated cells could be still present even after 6 days of in vitro culture 
(Figure 4.2.11). Surprisingly, Oct4-GFP positive structures were observed to form 
chimeric structures with wild –type renal epithelia (Figure 4.2.11, D). This indicated 
that a differentiated state might not be required for the formation of chimeric 
structures, once again confirming that integration into renal epithelia does not 
provide sufficient evidence for renal differentiation and has to be used in conjunction 
with the co-expression of renal markers. 
 
4.2.7.2 Immunohistochemistry for Oct4 showed co-localisation with Oct4-GFP 
and confirmed that the grafted cells expressed this pluripotency marker 
As the Oct4-GFP transgenic line used in the experiments above had not been 
extensively characterised, the results obtained in the previous section had to be 
confirmed by immunohistochemistry for Oct4. For this reason, the organotypic 
cultures were co-stained for GFP, Oct4, Laminin and DAPI (Figure 4.2.12). Panels 
A, B and C of Figure 4.2.12 clearly showed that GFP fluorescence co-localised with 
nuclear Oct4, as detected by immunohistochemistry. The individual acquisition 
channels of the confocal section in panel C are shown in D, E and F. G shows DAPI 
staining for the same image and H – co-localisation between the nuclear stain and 
staining for the octamer-binding protein Oct4.  
 
4.2.7.3 Oct4 positive cells express E-cadherin but not Pax2 
In the previous section it has been shown that Oct4 positive cells can form chimeric 
structures with renal epithelia. To see whether these structures have similar 
expression profiles of relevant genes as the structures obtained with tauGFP ESCs, 
organotypic pellets containing Oct4-GFP ESC were stained for E-cadherin and 
Pax2. The Confocal micrographs produced from these cultures showed that Oct4-
GFP+ structures indeed expressed E-cadherin and did not express the renal marker 
Pax2 (Figure 4.2.13, A-H). Open arrows indicate GFP+, stem-cell derived structures  
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Figure 4.2.13 - ESCs grafted in reaggregated organotypic cultures co-express Oct4 
and E-cadherin, but not Pax2 
A and E – triple staining of organotypic cultures containing grafted cells showing 
that Oct4+ cells co-express E-cadherin and do not express Pax2; B and F – the 
same images in A and E, also showing nuclear staining for DAPI; C – E-cadherin 
staining of A; D – Pax2 staining of A; G – E-cadherin staining of E; H – Pax2 
staining of E 
arrow shows WT epithelia, open arrows show grafted cells 
 151
(E-cadherin+/Pax2-). White arrows indicate native renal epithelia, which co-express 
E-cadherin and Pax2. It should be noted that these images also show a chimeric 
structure between a GFP+/E-cadherin+/Pax2- structure and a native structure 
(Figure 4.2.13, A-D).  
 
4.2.8 How are chimeric structures assembled? 
The ability of kidney cells to form chimeric structures with exogenous cell types 
has previously not been reported. The results given in previous sections of this 
chapter provided evidence that the tauGFP positive cells forming chimeric 
structures with native renal epithelia did not possess renal characteristics. In such a 
case, it was interesting to investigate the mechanisms by which these structures 
were formed. Several possibilities for this process exist: 
-     cells directly assemble into chimeric structures at the single cell stage 
 -     cells first form either native or host structures, which based on proximity to 
each other simply adhere (as examined in section 4.2.3) 
- cells first form either native or host structures, which then fuse to each other as 
a result of recognition mechanisms (non-random, regulated) 
 
Studying multiple serial confocal sections of reaggregated kidneys acquired for all of 
the studies throughout this chapter located pairs of tauGFP positive and tauGFP 
negative structures in close proximity to each other. In some cases, thin Laminin-
positive extensions were seen connecting two individual structures (as in Figure 
4.2.11, C). This was in support of the data presented in section 4.2.3 suggesting that a 
form of recognition mechanism between the two types of cells might be involved. 
Figure 4.2.14 shows what looks like a more advanced stage of the same 
phenomenon. The serial confocal sections (Figure 4.2.14, A-C, E-G) show how a 
unilayered strip of cells invade a tauGFP+ structure. Although the mechanisms of 
this process could not be identified, it was also demonstrated that both structures 
were positive for the epithelial adhesion molecule E-cadherin (Figure 4.2.14, D).  
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Figure 4.2.14 -Three dimensional imaging of tauGFP+ and WT epithelia, in the 
process of forming a chimeric structure 
A, B and C – show serial confocal sections of the same epithelial structures, 
exhibiting a tauGFP ESC-derived component and a WT component. A string of WT 
cells can be seen intercalating between the cells of an entirely tauGFP ESC-
derived structure  
D – shows that both structures express E-cadherin; E, F and G – are magnified 
versions of A, B and C 
E-cadherin(blue), Pax2 (red), tauGFP (green) 
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Figure 4.2.15 - Generation of a human embryonic stem cell line constitutively 
expressing nuclear GFP under the CMV promoter 
A – diagram of the plasmid used for the generation of a transgenic hESC line; B – light 
micrograph showing a colony of undifferentiated RCM1 hESC; C – RCM1 hESC 
express nuclear GFP after transfection with pAcGFP1-Nuc plasmid; D – merge of B 
and C 
4.2.9 Pilot studies suggest that genetically labelled with GFP human 
embryonic stem cells behave similarly to mouse ES cells when placed 
in mixed organotypic cultures 
4.2.9.1 Generation of human ES cells constitutively expressing GFP under the 
CMV promoter 
As previously discussed, transient labelling methods show serious limitations for use 
in the organotypic pellet culture method. For this reason a stably expressing GFP 
hESC line had to be created for testing the renogenic potential of human ES cells. 
These experiments were done with the kind support and in the lab of Dr. Paul de 
Sousa, University of Edinburgh.  
 
RCM1 human embryonic stem cells at P78 were treated with 10µM ROCK inhibitor 
Y-27632 for 3h before detachment from the cell culture plates. Cells were counted  
and collected in aliquots of 10-7 cells. 1 aliquot was resuspended in 1mL chilled PBS
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 only (negative control) and 3 were each resuspended in 1mL chilled PBS containing 
50μg linearised with ApalI pAcGFP1-Nuc plasmid (Figure 4.2.15, A; Clonetech). 
The control and transfections were electroporated at 200μF, 340V (Biorad Gene 
Pulser) and plated on freshly coated with Matrigel 10cm cell culture dishes. 
Antibiotic selection with 200μg/mL G418 was started 2 days after plating. All plates 
were monitored for colony formation and growth over three weeks. In the control 
sample, colonies appeared and increased in size, but disappeared completely about 
two weeks of starting the antibiotic selection. In the transfected samples, colonies 
remained viable and showed a continuous growth. The transfected colonies were 
checked for GFP expression by fluorescence microscopy and 18 GFP colonies were 
picked in sets of 6 during weeks 3 and 4 after selection. Picking of colonies was 
carried out in sterile conditions, manually, by collagenisation and scraping with a 
200μL pipettor. All clones were cultured as described in section 2.4 for routine 
culture of hESC.  
 
4.2.9.2 GFP-tagged hESCs form chimeric structures with renal epithelia 
To select lines, which might be suitable for mixing in organotypic cultures, the 
selected clones were examined for chimerism (the presence of both GFP+ and GFP- 
cells in the same clonal line) and fluorescence intensity. The line showing least 
chimerism and brightest fluorescence was selected for use in cell mixing experiments 
(Figure 4.2.15, B, C and D). 
 
To avoid human cells disrupting the normal development of reaggregates (as they are 
considerable larger than mouse cells) 10,000 (rather than15,000 as in most 
reaggregates) of the selected clone RCM1 pAcGFP1-Nuc hESCs were mixed with 
100,000 embryonic kidney cells and cultured as previously described for 6 days. The 
pellets were fixed with 4% PFA and permeabilised by methanol, before staining 
them for DAPI, Calbindin and Laminin. 
 
Confocal micrographs revealed that the nuclear fluorescence of the genetically 
labelled hESCs could be detected in the organotypic pellets (Figure 4.2.16, A-F), 




Figure 4.2.16 - hESCs behave similarly to mESCs when mixed with embryonic kidney 
cells and cultured in organotypic pellets for 6 days 
A and B, C and D, and E and F – show that hESCs form Laminin-bound structures 
when grafted in reaggregated organotypic pellets (arrowheads); A and B – show a 
chimeric structure formed by a WT nephron and human cells; C and D – show a hESC-
derived and a WT UB enclosed by a continuous Laminin staining (arrow) 
G – compares the observations made for human and mouse ESCs after grafting in 




form Laminin - bound structures form Laminin - bound structures 
form chimeric structures with renal epithelia 
form chimeric structures with renal 
epithelia 
negative for Calbindin negative for Calbindin 
have small nuclei, which stain intensely 
with DAPI and show chromocentres 
have large faintly stained with DAPI 




nuclei considerably bigger than these of mouse embryonic kidney cells, which 
stained for DAPI more weakly and lacked chromocentres (Moser et al., 1975). 
Similarly to mouse ES cells they were also seen in Laminin-bound structures (Figure 
4.2.16, A-F), which in some cases formed chimeras with mouse renal epithelia  
(Figure 4.2.16, A-D). The major similarities and differences between mouse and 
human ES cells were summarised in Figure 4.2.16, G. As these were only pilot 
studies the hESC-derived cells were not characterised for marker expression and it 
was therefore unclear whether some cells remained pluripotent similarly to mESCs. 
Further studies would be necessary to investigate the behaviour of hESCs grafted in 
organotypic cultures. 
 
4.3 Summary and discussion 
In this chapter, I examined the potential of undifferentiated cells to differentiate to 
renal cells as a response to the signals from the kidney microenvironment, which in 
development is sufficient to support the growth kidney rudiments in vitro. The initial 
characterisation of constitutively expressing GFP mouse embryonic stem cells 
showed that these cells behaved indistinguishably from their parent ES cell line – 
E14. In conditions favouring pluripotency, the tauGFP ES cell line showed a normal 
expression of the pluripotency marker Oct4, combined with a robust expression of 
tauGFP in more than 95% of the cells in culture. No correlation was observed 
between Oct4 and tauGFP expression. The transgenic cells continued to express GFP 
on the long-term after withdrawal of Puromycin selection (EB experiments). tauGFP 
ES cells could also form embryoid bodies normally and were able to give rise to cells 
from the three germ layers. Since no abnormal changes could be detected in these 
cells, they could be used to study the differentiation potential of ES cells to renal 
cells after integration in reaggregated organotypic pellets. In the initial experiments, 
tauGFP ES cells showed promise for the generation of renal cells as they were 
observed to give rise to chimeric structures with renal epithelia. Further 
characterisation showed that these structures did not adequately fulfil the 
requirements for renal cells set out in the beginning of this chapter. First of all, 
although some ESC-derived structures showed the formation of a lumen, most of 
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them gave rise to tubular-like structures lacking a lumen, with a morphology and 
positional orientation very different from this of renal tubular epithelial cells. Only 
this information was insufficient to determine whether the cells could be renal or not, 
as they could have been in an immature stage still having to orient themselves 
properly and organise into continuous tubular structures. Examination of these 
structures for the expression of kidney markers and combination of kidney markers 
revealed that there was no evidence that these cells were renal. First, although ESC-
derived Pax2 positive cells were indeed present in the developing organotypic 
cultures, they were not found in kidney tubules and were not expressing the epithelial 
marker E-cadherin. At least some of them could be identified as neural derivatives, 
as in addition to their Pax2 positivity, they exhibited the extension of neurites. 
Furthermore, artefacts, which looked like Pax2 positive tauGFP cells integrating in 
renal epithelia were detected in regions exhibiting unhealthy morphology. It was 
likely that some differentiating ESC-derived cells were not able to survive in the 
microenvironment of a kidney rudiment and underwent cell death, which created 
structures resembling Pax2+ nuclei. These were identifiable by exhibiting 
fluorescence of nuclear appearance in other fluorescence channels. Additionally, 
native Pax+/E-cadherin+ renal cells intercalating in tauGFP+ structures, created false 
positives when examined only in two dimensions. The finding that tauGFP-derived 
cells were positive for Laminin was inconclusive, as many non-kidney types of cells 
also express this marker. The co-localisation studies revealed that no 
Laminin+/Calbindin+ or E-cadherin+/Pax2+ cells could be detected in any of the 
examined experiments, which strongly suggested that no kidney cells were produced 
in the pellets. It cannot be completely excluded that undetectably low numbers of 
ESC-derived kidney cells were present in the reaggregated organotypic pellets, but 
no evidence was found to support this possibility. Importantly, Oct4 staining of 
cultured for 6 days organotypic pellets led to the discovery, that even after 6 days of 
culture, Oct4+ cells were still present in the organotypic cultures. This was not 
surprising as ES cells can be detected in differentiation cultures lacking pluripotency 
- supporting factors even after 10-15 days of culture (Chapter 5). What was more 
surprising was that Oct4+ cells were also able to engage in cross-talk with native 
renal structures and exhibit chimerism with wild-type renal epithelia. More detailed 
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marker expression studies detected that Oct4+ cells were also positive for E-
cadherin, as normal for ES cells (Mummery et al., 1990).  
 
These results were not completely consistent with the study of Steenhard et al. 
(2005) who reported that a renal differentiation program took place in ESCs after 
they had been subjected to the signals of a kidney microenvironment for 5 days. 
Although, their study did not provide evidence that Oct4 expression had completely 
disappeared in the injected in kidney rudiments ROSA26 ES cells after 5 days of 
culture, the presence of a detectable number of Oct4 positive structures in the 
experiments described in this chapter suggested that 6 (and even less so - 5) days 
were not a sufficient period for a complete stem cell differentiation. The high number 
of tauGFP ESC-derived structures forming chimeric structures with native renal 
epithelia in reaggregated organotypic cultures is highly reminiscent of the “striking” 
number of ROSA26 ESC – derived structures identified as renal by Steenhard et al. 
(2005). The current chapter also presented evidence that Oct4 expressing cells can 
form Laminin-bound structures resembling renal vesicles, very similar to the ones 
observed by the authors. All this evidence suggests that a revision of the study of 
Steenhard et al. (2005) where samples of injected cells could also be stained for 
Oct4, might provide valuable additional information about the ESC-derived cells. 
But even if the existence of ESC-derived structures in the experiments described by 
Steenhard et al. (2005) could potentially be explained, at least to some extent, by the 
presence of isolated Oct4-positive structures, the marker expression that they have 
reported still does not fit this hypothesis. Here, it would be valuable to once again 
refer to the limitations of cell tracking and the danger of false positives in 
organotypic cultures. The authors have based most of their immunohistochemical 
analysis on sections stained for β-galactosidase, which is less sensitive than using 
GFP in cell mixing experiments, as no individual cells can be seen clearly. This 
chapter has also provided evidence for the necessity of an extremely robust detection 
method with a single-cell level resolution, which also allows for a three-dimensional 
characterisation, due to at least two different types of sources of false positive for 
renal markers staining of ESC-derived cells. Although the authors have presented an 
indeed careful examination of marker expression, importantly, additional data from 
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the Davies lab suggests that developing nephrons might have a way of taking up 
debris from dead neighbouring cells to generate a third type of false positive, in 
which long portions of nephrons appear positive for the cell label (unpublished data, 
Supplementary Figure 4).  
 
Of course, the limitation of using a single cell line for experiments should also be 
mentioned. It could not be excluded that although the tauGFP ESC line used in this 
thesis did not show any obvious differences from normally behaving mESCs by in 
vitro characterisation, it might have had a limited renogenic potential.  Although a 
second ESC line (the Oct4-GFP ESCs) was used in the experiments and showed 
consistent results, it does not allow the detection of cells which could have formed 
renal tubules, as Oct4 expression in these cells should have been switched off. 
 
 Furthermore, it is interesting to discuss that all structures localising into renal 
epithelia were also positive for E-cadherin. This observation suggested that E-
cadherin - associated cellular processes or E-cadherin itself could play an important 
role in the formation of chimeric structures. Very little is known about the process of 
how forming nephrons fuse to the ureteric bud (Georgas et al., 2009; reviewed by 
Gilbert, 2000). Working with treated in various ways or genetically modified 
embryonic stem cells might contribute to elucidating this process. As the data 
provided by the current study suggested a putative role for E-cadherin in the 
formation of chimeric structures, this could first be confirmed by knockout 
experiments and second – potentially transferred to studying whether E-cadherin has 
a role as a regulator of kidney development, especially in the fusion of renal vesicles 
to the UB. Cadherin-6 has already been implicated in this process (Mah et al., 2000). 
In Cadherin-6 mutants a significant number of renal vesicles fail to fuse with the UB 
and therefore fail to form functional nephrons. Similar experiments with abolishing 
only E-cadherin or both cadherins simultaneously could help clarify that further. It 
has already been reported that a stable transfection of Snail, which is a negative 
regulator of E-cadherin, is able to transform MDCK cells to a more mesenchymal 
phenotype (Cano et al., 2000).  
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Furthermore, studies combining the use of embryonic stem cells, which show an 
ability to produce fusions with renal epithelia, with studies in the in vitro 
disaggregation-reaggregation system could provide a valuable tool to dissect the 
timing and various steps of the process. Currently, evidence in the literature shows 
some disagreement about whether this process happens very early in renal vesicle 
formation (Bard et al., 2001) or later, at the late renal vesicle stage (Georgas et al., 
2009). In addition, both of the studies acknowledge the possible existence of a 
multistep process, which initiates this fusion – first, the formation of an intimate 
contact between the RV and the UB; second, the degradation of basal lamina 
between the two; and third – the formation of a continuous epithelium with a lumen. 
These problems could also be addressed by an ES cell - based in vitro system, which 
offers the advantages of easy genetic manipulation. 
 
Detailed confocal micrographs in the three dimensions presented in this chapter have 
captured the interactions between several pairs of tauGFP+ and native kidney 
structures. It would be therefore interesting to investigate, whether such fusion events 
could be following a mechanism similar to the one described by Samakovlis et al. 
(1996) for the tracheal development in Drosophila. The authors detail a process in 
which two tubes, which will fuse, establish a connection with each other on the basis 
of two single cells coming from the two different tubes, which extend protrusions to 
recognise each other. 
 
Finally, although based on pilot studies with human embryonic stem cells, the data 
presented in this chapter suggested that human embryonic stem cells might behave 
similarly to mouse cells after being placed in the microenvironment of a developing 
embryonic kidney. These initial studies were discontinued due to several reasons. 
First, the mixing properties between mouse and human cells have not been 
extensively characterised and the known differences between the two types of cells 
pose an additional challenge to the interpretation of results. Also, as the pilot 
experiments with human cells did not show any advantages over the use of mouse 
cells, the latter system would be more suitable for further investigations, due to the 





Inhibition of Notch signalling in mESC does not improve 
differentiation to kidney cells in the disaggregation-
reaggregation system
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5.1 Introduction  
 
In the previous chapter, I showed that in embryonic kidney disaggregation-
reaggregation experiments, undifferentiated mouse ES cells were able to associate 
with, and form chimeric structures with, renal epithelia, but failed to integrate into 
renal structures and to express normal kidney markers. On the basis of this finding, I 
hypothesised that pre-differentiation of ES cells might improve the renogenic 
abilities of these cells by first priming them to commit to a mesodermal lineage. 
Evidence in the literature suggested that Notch inhibition promotes the 
differentiation of ESCs to mesoderm at the expense of ectoderm (section 5.1.1). The 
studies described in this chapter evaluate whether Notch inhibition in differentiation 
cultures would be beneficial for generating ESC-derived renal cells. I will start this 
chapter by describing the motivation for the experiments herein in context of the 
published literature. Then, I will concisely review the mechanisms and players in the 
Notch signalling pathway and provide a few examples of how Notch signalling 
regulates developmental processes. I will then present pilot work suggesting that 
Notch inhibition does not positively affect renal differentiation. 
 
5.1.1 The role of Notch inhibition in the differentiation of mouse 
embryonic stem cells 
There are two possible ways for ESCs to obtain a renal identity. The first possibility 
is that they follow the normal processes that happen during development to become 
first mesoderm, then intermediate mesoderm and finally commit to the nephrogenic 
lineage (please refer to Figure 4.1.1 in the previous chapter and Chapter 1). The 
second way for obtaining kidney cells could be through developmental leaps, which 
would omit the intermediate stages and transit directly to a kidney fate via steps that 
are normally not present in development. The former possibility suggests that 
successful differentiation methods would have to take embryonic stem cells through 
the stages of normal development, in the process of which the desired lineage would 
have to be directed at each step at which cells normally make a “lineage choice”. In 
the case of trying to generate kidney cells, following the idea that cells have to 
follow the stepwise developmental pathway (epiblast, mesoderm, intermediate 
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mesoderm), would suggest that increasing the number of cells, which commit to a 
mesodermal lineage in a differentiation culture, could also increase the chances for 
obtaining kidney cells. For this reason, a method for the directed differentiation to 
mesoderm was sought. 
 
 A literature search identified a report that demonstrated Notch signalling in 
embryonic stem cells to be essential for some lineage fate choices. Lowell et al. 
(2006) discovered that the release of the Notch intracellular domain (NICD), 
activated genes favouring the differentiation of ESCs to a neural lineage. Conversely, 
inhibition of γ-secretase (which is necessary for Notch signalling activation) blocks 
most of the differentiation to neural cells and favours other lineages, especially 
mesoderm. This information was supported by other literature sources. Nemir et al. 
(2006) showed that inactivation of Notch1 enhanced the differentiation of ESC to 
cardiomyocytes, which are also of a mesodermal lineage. In addition, they concluded 
that Notch signalling influences the cell fate decision between mesodermal and 
neuroectodermal lineages, which is consistent with the previously presented data 
about the role of Notch signalling in development (see section 5.1.3).  Schroeder et al 
(2006) also report that activation of Notch signalling inhibits the generation of Flk1+ 
mesodermal cells from ESCs. Information about the effects of Notch inhibition on 
the differentiation of mouse ES cells to renal precursors was lacking, but based on 
evidence in the literature, this approach might be useful for discovering a method for 
directed differentiation to renal cells, based on the evidence that it favours mesoderm 
specification.  
 
5.1.2 The Notch pathway - discovery and mechanism 
Notch signalling is a way of communication between two or more neighbouring 
cells, based on receptor-ligand interactions. This is a conserved mechanism for 
modulating the cell’s response to developmental signals and controlling cell fate, 
which is based on amplification and consolidation of molecular differences between 
cells (Artavanis-Tsakonas et al., 1999; Fleming et al., 1998).  
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The first reference to Notch found in the literature was made by John Dexter in 1914, 
who described a mutant fly with notched wings. On the basis of Mendelian genetics, 
Dexter also determined that the mutation was caused by “a dominant sex-linked 
factor lethal when homozygous”. A later reference to Notch was made by Morgan 
and Bridges (1916), summarizing Dexter’s results and taking them further by 
Bridges’ mapping the position of this factor to 2.6 on the X chromosome (Morgan 
and Bridges, 1916; Bridges, 1917). Mohr (1919) also encountered this phenotype in 
his experiments. He extensively described a fly mutant phenotype called “notch”, 
characterised by a serration at the ends of the wings.  
 
The importance of Notch for developmental processes became clear later when 
experiments in developing fly larvae demonstrated that lethal loss-of-function 
mutations of Notch produce a “neurogenic” phenotype, in which endoderm and 
mesoderm are absent, or almost absent, and have been substituted for a proliferating 
ectoderm with the characteristics of an early nervous system (Poulson, 1937). These 
results also suggested that the mutated factor is necessary in gastrulation, for the 
normal specification of the three germ layers. 
 
NOTCH is a transmembrane receptor, which localises at the cell surface as a 
heterodimer resulting from an intracellular cleavage at site 1 (S1) of the protein in 
the trans-Golgi network (Blaumueller et al. 1997). Although flies have only one 
Notch receptor and C. elegans - two (which act redundantly) (Fitzgerald et al., 1993), 
mammals have four Notch paralogs (reviewed by Kopan and Ilagan, 2009) that could 
be either redundant or display unique functions (Krebs et al., 2003; Cheng et al., 
2007). Notch proteins (Notch1, Notch2, Notch3, and Notch4) contain epidermal 
growth factor (EGF)-like repeats (Wharton et al., 1985; Kidd et al., 1986), which are 
followed by negative regulatory regions (NRR), consisting of three cysteine-rich Lin 
12-Notch repeats (LNR). The intracellular region of Notch contains multiple 
functional domains - an RBPjκ-association module (RAM), seven ankyrin repeats 
(ANK domain), NLS (nuclear localisation sequences) and a PEST (proline, 
glutamate, serine and threonine-rich) domain, which regulates the stability of Notch 
intracellular domain (reviewed by Kopan and Ilagan, 2009). 
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Notch signalling is initiated by an interaction between Notch receptors and their 
ligands (Figure 5.1.1), which in mammals are the transmembrane proteins Jagged1, 
Jagged2, Delta1, Delta3 and Delta4 (Lindsell et al., 1995; Shawber et al., 1996; 
Bettenhausen et al.,1995; Dunwoodie et al., 1997; Shutter et al., 2000). On binding, 
the Notch receptor is activated by a series of proteolytic cleavages, which is initiated 
by ADAM (A disintegrin and metalloproteinase) (Qi et al, 1999). The enzyme 
cleaves Notch at site 2 (S2), which is deeply buried in the NRR (Figure 5.1.1). The 
initial release of the Notch ectodomain, creates a membrane-tethered intermediate - 
NeXT (Notch extracellular truncation), which acts as a substrate for γ-secretase (a 
multicomponent intramembrane-cleaving protease, I-CLiP) (de Strooper et al., 1999; 
Ray et al., 1999; reviewed by Wolfe and Kopan, 2004). This final cleavage at site 3 
(S3) fully releases NICD for translocation to the nucleus, where it interacts with the 
sequence-specific DNA-binding protein CSL (also known as CBF1or RBPjκ and a 
homologue of the Drosophila suppressor of hairless Su(H)) (reviewed by Lai, 2004) 
via its RAM domain.  Fortini and Artavanis-Tsakonas (1994) have observed a direct 
protein-protein interaction between NCID and the transcription factor CSL. After 
translocation to the nucleus the CSL-containing co-repressor complex is displaced by 
a CSL and NICD-containing co-activator complex, which mediates the activation of 
Notch target genes. In the absence of NICD, the co-repressor complex actively 
represses Notch target genes (reviewed by Lai, 2004). Components of the Notch 
signalling pathway or events resulting from Notch-mediated gene activation interact 
and cross-talk with other pathways, which then exert a cooperative effect on cell fate. 
For example, activated Notch signalling has been associated with an effect on histone 
acetyltransferases (HATs), SMADs, NFκB, HIF1α, Hes and many others (reviewed 
by Kopan and Ilagan, 2009; Jarriault et al., 1998). As the focus of this section is to 
give information about the general principles of Notch signalling, rather than provide 
a complete review about the complex regulatory networks involved in transcriptional  
activation and repression. As a summary, a snapshot of some important players is 




Figure 5.1.1 - General principle of Notch signalling activation (from Kopan and Ilagan, 
2009) 
After polypeptide synthesis, the Notch receptor undergoes post-translational 
modifications in the ER and is cleaved in the Golgi to form a heterodimeric protein 
trafficked to the cell surface. When the Notch extracellular domain establishes a contact 
with its ligand a cleavage by ADAM at S2 is initiated followed by a cleavage of the 
resulting intermediate (NEXT) at S3, which finally releases NICD. NICD is then 
translocated to the nucleus where it associates with other co-activators and CSL, thereby 




Figure 5.1.2 - Core components of the Notch signalling pathways (from Kopan and Ilagan, 
2009) 
This table gives information about the different components of the Notch signalling pathway in 
different species. 
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Figure 5.1.3 - Notch signalling in lateral inhibition and lateral induction 
Modified after Lai, 2004 
5.1.3 The role of the Notch pathway in development and self-renewal 
Notch signalling is a mechanism of controlling cell fate decisions on the basis of 
local cell interactions. The mechanisms, which drive cell fate decisions are lateral 
specification (lateral inhibition) or lateral induction (Greenwald, 2005). One example 
of a lateral specification event involves a cell fate decision between an anchor cell 
(AC) and a ventral uterine precursor cell (VU) in early gonadogenesis in C. elegans 
hermaphrodites (Seydoux and Greenwald, 1989). This process starts with two 
equivalent cells, which can both become either an AC or a VU. Initially, both cells 
express LIN12 (Notch) and LAG2 (Delta). An initial stochastic event in expression 
levels results in one cell (the presumptive, but uncommitted AC) producing enough 
ligand to activate lin12 in the receiving cell. From this point onwards, lin12 
expression becomes restricted to the presumptive VU and lag2 expression becomes 
restricted to the presumptive AC (Wilkinson et al., 1994). Importantly, the authors 
have identified that the essential step in this process is an auto-regulatory feedback, 
which amplifies and stabilises the initial stochastic event. lin-12 activity promotes 
expression of lin12 and represses lag2 (Wilkinson et al., 1994).  This has explained 
how a small balance shift of gene expression could lead to a profound effect on cell 
determination. These experiments have also demonstrated that cells committed to a 
certain fate inhibit their neighbours from adopting the same fate (hence “lateral 
inhibition”). Another example of a lateral specification event is the epidermis of 
Drosophila, where cells take the lineage decision between neural precursors or 
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epidermal cells (Heitzler and Simpson, 1991). The authors have reported that cells 
produce neural precursors when neighbouring cells have a higher level of Notch 
activity and epidermal precursors if they have a lower Notch activity. They have 
concluded that cell fate choice is taken on the basis of competition between cells.  
 
In contrast, it has been shown that Notch can positively regulate Jagged1 via “lateral 
induction” (Daudet and Lewis, 2005; Hartman et al., 2010). Daudet and Lewis 
(2005) have investigated this in inner ear morphogenesis. In mammalian inner ear 
morphogenesis, the prosensory specification defines regions of the otic epithelium, 
which will give rise to the six separate inner ear organs essential for hearing and 
balance. Electroporation of NICD-IRES-GFP resulted in the formation of ectopic 
sensory patches. Daudet and Lewis (2005) have shown that activation of Notch 
within hair sensory patches represses hair cell differentiation, but at the same time 
positively regulates Serrate1. In a positive feedback loop Serrate1 induces and 
perpetuates Serrate1 in neighbouring cells leading to a mechanism of lateral 
induction.   
 
Artavanis-Tsakonas et al. (1999) have classified the Notch-Delta - mediated 
interactions between cells into three different types. The first one involves 
communication between equivalent cells. This type of interaction was discussed in 
the example of VU/AC cell specification in C. elegans. The second and third types, 
involve interactions between non-equivalent cells. In these, one of the cells is 
subjected to an internal or external bias, which is then stabilised by Notch-Delta 
signalling to result in a specific cell fate choice. The differentiation of the sensory 
organ precursors (SOP) of the peripheral nervous system in Drosophila is an 
example of an interaction involving a factor intrinsic to one of the cells. The SOPs 
divide ones to produce two cells (IIa and IIb), which divide a second time to give rise 
to the 4 cells of the socket, hair, neuron and sheath (Frise et al., 1996). During the 
first division, the membrane-associated Numb protein (antagonist of Notch activity) 
is asymmetrically segregated. Thus, only one cell receives Numb. In this cell, Notch 
signal transduction will be prevented and it will be specified as IIb, while the cell 
with active Notch signalling will be specified as IIa (Frise et al., 1996). An example, 
 171
of non-equivalent cells regulated by extrinsic signals is found in the development of 
the Drosophila compound eye where the cell fate of the R3 and R4 photoreceptor 
precursors are specified on the basis of a concentration gradient of Wingless 
emanating from the poles of the eye disc, which is then stabilised by Notch-Delta 
interactions (Fanto and Mlodzik, 1999; Yang et al., 2002) 
 
In short, Notch signalling is necessary for cell fate choice at multiple steps of normal 
and postnatal development. The broad range of processes that Notch signalling 
regulates includes inhibition or induction of differentiation, binary cell fate decisions 
and, border formation, proliferation, apoptosis, and tumorigenesis (reviewed by 
Wilson and Radtke, 2006). In addition to its important role for cell specification and 
morphogenesis in development, it has also been implicated in in vitro systems. Since 
it has been shown that inhibition of Notch activity favours the formation of 
mesoderm in ES cell differentiation cultures, the pilot work described in the 




5.2.1 Inhibition of Notch signalling in embryoid bodies does not 
improve renal differentiation 
To test whether Notch inhibition in differentiating embryoid bodies will improve the 
differentiation of ESCs to renal cells on the basis of increasing the proportion of 
ESC-derived mesodermal cells, the ability of Notch-inhibitor treated EB-derived 
cells to integrate into developing renal epithelia in the disaggregation-reaggregation 
system was examined.  
 
Embryoid bodies were formed from tauGFP ESCs over 2 days by plating the single 
cell suspension in non-adherent bacterial Petri dishes. 6x106 cells were used per 
10cm dish. The cells were cultured in DMEM supplemented with 10% FBS, 
100U/mL Penicillin and 100µg/mL Streptomycin, 2mM L-Glutamine, 1mM Sodium 
Pyruvate, 1x non-essential amino acids and 5µM 2-mercaptoethanol. For 
differentiation, EBs were cultured in 35µM γ-secretase inhibitor DAPT. The control 
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pool of EBs was supplemented with an equivalent volume of DMSO (vehicle for 
DAPT). After 12 days of culture in suspension (11 days in DAPT or vehicle), the 
embryoid bodies were harvested and disaggregated into single cells by enzymatic 
treatment. As embryoid bodies proved very difficult to disaggregate, the cell 
suspension was passed through a 40µm cell strainer to make sure that no clumps of 
cells were present in the mixture. 15,000 control and DAPT-treated EB cells were 
mixed with 100,000 embryonic kidney cells, pelleted and cultured for 24h in ROCK 
inhibitor, as previously described for the formation of organotypic cultures. 
Experiments were cultured in CKCM for further 6 days after the removal of ROCK 
inhibitor. They were then fixed with PFA and post-fixed with ice cold methanol. The 
resulting pellets were stained and prepared for confocal microscopy. 
 
In two independent experiments, microscopic images of immunostained pellets 
showed no integration of ESC-derived cells into renal structures in either the control 
sample or the DAPT-treated sample (Figure 5.2.1, A and B). On rare occasions cells 
were seen associated with renal epithelia, but formed structures distinct from 
nephrons or UBs. Observations showed that overall there were less tauGFP+ cells in 
the pellets at the end of the experiment than what was observed for undifferentiated 
ESCs in Chapter 4. This was not examined quantitatively.  
 
The measurement of RNA with the Agilent Bioanalyzer is based on traditional 
electrophoretic assays, which have been transferred to a chip format. Charged 
molecules, like RNA, are electrophoretically mobilised by a voltage gradient, which 
separates them by size, aided by a sieving polymer matrix (Agilent 2100 
Bioanalyzer, user manual, available at: 
http://www.chem.agilent.com/Library/usermanuals/Public/G2946-
90004_Vespucci_UG_eBook_(SecPack).pdf ). The advantage of this method is the 
presence of a number of internal controls, which help assess concentrations 
accurately, and provide detailed information about the integrity of the RNA based on 
an analysis of the ribosomal units and on the entire electrophoretic trace of the whole 
sample. Figure 5.2.2 shows the comparison between the three methods for RNA 
quantification. Samples are numbered as follows: 
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Figure 5.2.1 - Cells from EBs differentiated with or without the addition of DAPT do not 
integrate into the structure of renal epithelia 
A - vehicle (DMSO)-treated EB cells mixed with kidney cells do not localise into the structure 
of renal epithelia. Pax2 (red) stains the nuclei of renal epithelia; B - DAPT-treated EBs found 
in proximity, but not integrated into renal epithelia. E-cadherin (blue) expression is stronger in 
UBs and weaker in nephrons; EB-derived cells are in green 
 
1 - ESC RNA 
2 - EB RNA at day 4 of culture (control) 
3 - EB RNA at day 4 of culture (EBs supplemented with DAPT) 
4 - EB RNA at day 6 of culture (control) 
5 - EB RNA at day 6 of culture (EBs supplemented with DAPT) 
6 - EB RNA at day 8 of culture (control) 
7 - EB RNA at day 8 of culture (EBs supplemented with DAPT) 
8 - EB RNA at day 15 of culture (control) 
9 - EB RNA at day 15 of culture (EBs supplemented with DAPT) 
 
Samples 5 and 6 were not measured with a conventional spectrophotometer for 
technical reasons. The general observation from all three types of measurements was 
that the readouts were comparable. It was observed that the NanoDrop and the 
Spectrophotometer almost always gave readouts higher than the Agilent Bioanalyzer. 
Although, the measurements made with the spectrophotometer were very similar to 
the rest, it had one major disadvantage - the large volume needed for 
spectrophotometric analysis caused a huge loss of valuable RNA, needed for cDNA 
synthesis. For this reason, this method was not considered any further. On the basis 
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Figure 5.2.2 - A comparison of three methods for RNA quantification. 
Overall, the three methods showed comparable measurements. The Nanodrop and 
spectrophotometer seemed to overestimate the concentration of nucleic acid in comparison to 
the measurements obtained with the Agilent Bioanalyzer. Samples 6 and 7 could not be 
measured with a spectrophotometer. Sample are labelled, as follows: 1 - ESC RNA, 2 - EB 
RNA at day 4 of culture (control), 3 - EB RNA at day 4 of culture (EBs supplemented with 
DAPT), 4 - EB RNA at day 6 of culture (control), 5 - EB RNA at day 6 of culture (EBs 
supplemented with DAPT), 6 - EB RNA at day 8 of culture (control), 7 - EB RNA at day 8 of 
culture (EBs supplemented with DAPT), 8 - EB RNA at day 15 of culture (control), 9 - EB RNA 
at day 15 of culture (EBs supplemented with DAPT) 
of the results presented in this section, it was concluded that the NanoDrop was as 
efficient as the Agilent for RNA quantification. For reasons of convenience and cost, 
the Nanodrop was selected for all future measurements. 
 
For the semi-quantitative gene expression studies, 200ng of RNA from all samples 
were used for first-strand synthesis. PCR was performed as described in the 
Materials and Methods chapter. The product was run on gel electrophoresis. Images 
of gels were collected as printouts and digitalised by scanning. GAPDH data was 
used for correcting experimental errors of DNA quantification and loading. 
Measurements were performed with the NIH software ImageJ. The band with lowest 
intensity for GAPDH product (sample 8) was given a value of 1.00 and all other 
bands were assigned a value according to their intensity as compared to the basal 
band. The area of all bands for each gene was counted as 100% and the percentage of 
a single band, representing one sample, was determined. The percentage value for 
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each band was then divided by its corresponding coefficient obtained from the 
GAPDH quantification. These values were then plotted as graphs to illustrate the 
change of gene expression over time (Figure 5.2.3, A, B, C, D and E). The original 
data is shown in Figure 5.2.3, F. 
 
5.2.2 Expression of the intermediate mesodermal marker Osr1 is not 
enhanced by DAPT treatment of embryoid bodies 
As no EB-derived cells, both treated and untreated, were detected in renal epithelia, 
gene expression studies were performed to monitor whether embryoid bodies had a 
normal gene expression profile and whether there was a detectable difference of gene 
expression between the control and the sample incubated with Notch inhibitor. For 
this purpose, in an experiment performed as described in the previous section, EBs 
were cultured with either DMSO or DAPT and harvested at different time points for 
RNA isolation. The RNA was extracted immediately after sampling the EB 
suspensions by using a column-based RNA isolation kit (Promega), as described in 
the Materials and Methods section. RNA was stored at -80°C for the synthesis of 
cDNA. Before cDNA could be synthesised, the concentration of isolated RNAs had 
to be accurately determined to make sure that the same amount of RNA would be 
used for cDNA synthesis for comparing relative levels of gene expression.  
To validate RNA quantification measurements, several methods for RNA 
quantification were compared. These included using a NanoDrop, a conventional 
spectrophotometer, and the novel-technology of Agilent Bioanalyzer 2100.  
With the progression of differentiation, we expect a downregulation of pluripotency 
genes, such as Oct4 and Nanog (Scholer et al., 1990; Chambers et al., 2003). As can 
be seen on Figure 5.2.3, A and B, the data were consistent with these expectations. 
Expression of Oct4 decreased first and is brought to almost 0 at day 15 of 
differentiation. Brachyury (T), which has been detected in the mesoderm of 
developing embryos, peaked at day 6. That is 2 days later than what has been found 
in some reports (Pearson et al., 2008; Bruce et al., 2007), but consistent with others 
(for example, Nemir et al., 2006). In normal development, the mesoderm expresses 
Brachyury only transiently and after a peak its expression decreases with the 
progression of development (Wilkinson et al., 1990). Consistently, in in vitro 
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Figure 5.2.3 Gene expression analysis of control and DAPT-treated differentiating 
embryoid bodies 
A and B - relative Oct4 and Nanog expression after correction for GAPDH levels. Oct4 
and Nanog levels decrease from day 0 to day 15. The levels of pluripotency genes 
seem to decrease slightly faster in treated samples, as compared to the controls; C and 
D - comparison of the relative expression of T (Brachyury) and Osr1 in control and 
DAPT-treated samples; E - the original data from gel electrophoresis of the PCR 
product, which detects the relative levels of mRNA for the tested genes. The positive 
control for Oct4, Nanog and T is contained within the experiment and a separate such 
was not performed. The positive control for detection of Osr1 was done on the basis of 
RNA extracted from whole E11.5 embryos. 
In A, B, C and D, each line shows data from a single experiment, which is why there 
are no error bars seen in the diagrams. 
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differentiation systems Brachyury should start to decrease with the maturation of 
cells (as seen on Figure 5.2.3, C). The earlier decline of Brachyury expression 
suggested that the DAPT-treated EBs might differentiate faster than the control ones. 
On the other hand, the fact that Brachyury gene expression did not at all decline in 
the control sample by day 15, was unusual. Osr1, the marker for intermediate 
mesoderm, which is expressed by multipotent kidney progenitors (Mugford et al., 
2008), started to be expressed at day4 and was highly upregulated after day 6. Its 
presence indicated that differentiation was taking place in the EBs. The levels of 
Osr1 in the control and DAPT were similar. From the gene expression analysis data, 
it was clear that EBs performed as expected by downregulating pluripotency genes 
and upregulating markers for different stages of differentiation in the normal 
sequence. The gene expression levels between the control and DAPT-treated sample 
were very similar, but the latter progressed through the sequence of losing Oct4 and 
Nanog expression, going through a peak of Brachyury expression and gaining Osr1 
expression slightly faster. The only noticeable difference between control and sample 
was in the detected mRNA levels of Brachyury, which remained higher in the control 
sample indicating attenuated differentiation (Figure 5.2.3, panel C). 
 
5.2.3 DAPT treatment shows an efficient inhibition of the Notch 
signalling pathway 
As DAPT treatment produced an inconclusive result for Brachyury (mesoderm) and 
showed neither an upregulation of Osr1 nor an increase of renal integration, 
compared to controls, it was necessary to verify that the γ-secretase inhibitor was 
functioning as expected and that it efficiently blocked Notch signalling. On the basis 
of information found in the literature, a functional assay to test the effect of DAPT 
was designed. Cheng and Kopan (2005) reported that Notch signalling is essential for 
developing embryonic kidneys. They demonstrated that a lack of Notch activity leads 
to severe abnormalities in maturing renal compartments. They reported that Notch 
signalling is essential for proximal tubule and podocyte formation at the stage where 
S-shaped bodies are formed. To verify that the DAPT inhibitor was active, kidney 
rudiments were isolated from E11.5 mice and pooled. Half of them were cultured in 
medium containing 5µM DAPT, the other half - in medium containing vehicle 
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Figure 5.2.4 - Treatment of E11.5 embryonic kidneys with DAPT resulted in a loss of the 
proximal tubular segment and presumptive podocytes 
A and B - (treated with DAPT samples) kidneys isolated from E11.5 kidney rudiments, 
cultured in 5µM DAPT for 5 days did not  show presence of the proximal tubular marker 
LTL (in green). The high levels of expression of Wt1 (red) in characteristic crescents 
normally present in the presumptive podocytes, was also lacking. C and D - (untreated 
samples) control images of kidneys treated with an equal volume of DMSO (vehicle for 
DAPT) show normal LTL (green, arrowheads) and Wt1 (red, arrows) expression; inset in D 
is a magnification of a fragment of D showing luminal LTL and nuclear Wt1. Bar in inset - 
50µm; DAPI is in blue 





   
   
   
   
   
   
   
   
   







 (DMSO). After 5 days in culture, the kidney rudiments were fixed and stained with 
Lotus tetragonolobus lectin (LTL), which is a marker of the proximal tubule 
(Laitinen et al., 1987), and for the podocyte marker WT1 (Mundlos et al., 1993; 
Grubb et al, 1994). The results undoubtedly confirmed the absence of the proximal 
tubular segment of the nephron, as shown on Figure 5.2.4. LTL staining was 
absolutely absent in the DAPT sample (Figure 5.2.4, A and B) and present, as 
expected, in the control (Figure 5.2.4, C and D). The success of this experiment was 
remarkable as the development of the proximal tubule was blocked in 100% of the 
treated samples (10 out of 10 cultured kidneys). These results were also confirmed 
by the staining for Wt1 with the same efficiency. As described in the introduction 
chapter, Wt1 is expressed at low levels in the induced MM and at high levels in the 
glomerular podocytes (Grubb et al, 1994; Cheng et al., 2003; Schedl and Hastie, 
2000). Wt1 staining of the DAPT-treated embryonic kidneys showed a lack of 
Wt1high cells forming characteristic crescents of glomerular podocytes, though these 
were present in the vehicle control, Figure 5.2.4, C and D. This result was completely 
consistent with the data published by Cheng et al. (2003), who demonstrated that 
developing embryonic kidneys lacking γ-secretase activity for more than three days 
irreversibly lose their potential to form podocytes. These experiments therefore 
confirmed that the batch of DAPT used in ESC differentiation experiments was 
working normally. 
 
5.2.4 Monolayer differentiation of ES cell cultures supplemented 
with DAPT does not improve the generation of cells integrating in 
renal structures 
The differentiation strategy described in previous chapters was devised on the basis 
of published data reporting that inhibition of Notch signalling favours the generation 
of mesoderm from ESCs. This data was generated by EB-based differentiation of ES 
cells. Lowell et al. (2006) have reported successful mesoderm derivation in a 
monolayer cell differentiation system. This alternative approach was also tested 
based on the experimental conditions described in this paper. 
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For monolayer differentiation tauGFP ESCs were enzymatically disaggregated to 
produce a single cell suspension. 1x104 cells per cm2 were seeded in differentiation 
medium (DMEM with 2mM L-Glutamine, 1mM sodium Pyruvate, 1x non-essential 
amino acids and 5µM 2-mercaptoethanol with 10% FBS) supplemented with 4µM 
DAPT or the respective amount of vehicle (DMSO). Cells were incubated in these 
conditions for 4 days, then disaggregated enzymatically, passed though a 40µm cell 
strainer, counted and mixed with embryonic kidney cells. 15,000 ESC-derived cells 
were mixed with 100,000 kidney cells. The formed pellets were then cultured for 24h 
in medium supplemented with ROCK inhibitor and a further 3 days in CKCM. A 
staining of the pellets for Calbindin and Laminin showed that the localisation of 
treated cells into renal epithelia had not improved. On very rare occasions, patches of 
GFP positive cells could be seen either in a close proximity to renal tubules possibly 
initiating contact with renal tubules, or in already formed chimeric structures (Figure 
5.2.5, A, C, D). These structures were negative for the UB marker Calbindin and 
could not be identified as UBs. Although the structures were Laminin-bound, they 
did not display the cellular organisation and size typical of nephron cells.  The same 
observations were made in the DAPT-treated cells and the vehicle control, which 
confirmed that the inhibitor treatment did not improve differentiation. The adhering 
structures were very similar to the ones observed when undifferentiated ES cells 
were mixed with kidney cells, suggesting that undifferentiated cells might  
be remaining in the organotypic cultures. The PCR data presented on Figure 5.2.5 
strongly supports this hypothesis as efficient Oct4 downregulation was achieved at 
about day 15 after LIF withdrawal, which is almost double the time used for 
monolayer differentiation combined with pellet culture. No cells in any of the 4 
pellets examined seemed to integrate appropriately in the structure of developing 
renal epithelia. In comparison to EB differentiation, monolayer differentiation did 
not improve the generation of cells having properties to mix with renal epithelia and 
even seemed to favour the survival and presence of undifferentiated cells. 
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Figure 5.2.5 - Monolayer differentiation of DAPT-treated and control tauGFP+ cells 
1x104 tauGFP cells per cm 2 were plated in differentiation medium supplemented with 
4µM DAPT or an equivalent volume of vehicle. The cells were predifferentiated in these 
conditions for 4 days, then detached from the cell culture dishes. 15,000 ESC-derived 
cells were mixed with 100,000 embryonic kidney cells for the generation of organotypic 
reaggregates. Pellets were cultured for further 4 days, fixed and stained for Laminin (red) 
and Calbindin (blue). TauGFP cells were detected by their expression of GFP (green). 
A and B - control cells formed Laminin-bound structures, which on rare occasions 
associated with renal epithelia, but did not integrate in their structure. 
C and D - DAPT-treated cells were also seen in Laminin-bound structures, comparable 
to the ones seen in the control samples, did not show a normal renal morphology and 
also did not integrate into the structure of renal epithelia. 
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 5.3 Summary and discussion 
 
In Chapter 4, the ability of undifferentiated mESC to give rise to kidney cells after 
mixing in reaggregated organotypic cultures was assessed. As this strategy did not 
result in the generation of kidney cells, a pre-treatment of the cells was evaluated in 
the current chapter. The differentiation strategy used in this chapter was based on 
blocking Notch signalling to increase the formation of mesoderm. Screening results 
showed that two different methods for ES cell differentiation, embryoid bodies and 
monolayers, did not successfully generate cells that can integrate into renal tubules. 
At the same time, it could be concluded that this effect was not due to a lack of 
activity, or presence of a decreased activity of DAPT, as kidney culture experiments 
confirmed that the inhibitor blocked Notch signalling efficiently. This also indicated 
that the unsuccessful differentiation of ESCs to renal cells cannot be attributed to a 
lack of Notch inhibition, but rather to the inefficiency of this method in generating 
ESC-derived renal cells. On the basis of this result, it could be concluded that in the 
conditions used, blocking Notch does not lead to improving the differentiation of ES 
cells to kidney cells. 
 
Before considering the semi-quantitative reverse-transcription PCR data, it is 
important to mention that as the results presented here are based on only one 
experiment, they cannot be treated as completely conclusive, but rather - as 
guidelines. Reverse transcription analysis showed that the transcript levels of Oct4, 
Nanog and Osr1 were very similar in the control and DAPT-treated samples. 
Although, the DAPT-treated EBs seemed to downregulate Oct4 and Nanog and 
upregulate Osr1 slightly faster than control EBs, it could not be determined whether 
this small difference was statistically significant. The only obvious difference in the 
tested gene expression profiles of treated and untreated samples was in the 
expression of Brachyury at day 8 and day 15 of EB culture. After similar expression 
levels until day 6, control EBs continued upregulating Brachyury until day 15, while 
expression levels started decreasing in the DAPT-treated sample. In mouse 
embryonic development Brachyury expression peaks at E8.5-E9.5 and starts to be 
downregulated thereafter (Wilkinson et al., 1990). A similar expression pattern has 
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Figure 5.3.1 - Brachyury expression in early embryo development 
Pink indicates Brachyury expression; blue indicates a lack of Brachyury expression; white - not 
reported; PS - primitive streak 
been observed in in vitro differentiation systems (Nemir et al., 2006; Pearson et al., 
2008). The DAPT-treated sample behaved consistently with these reports, unlike the 
control samples. To explain this, the expression patterns of Brachyury in 
development had to be more closely examined. Importantly, Brachyury is very often 
incorrectly referred to as a mesodermal marker. First, Brachyury transcripts have 
been detected before the onset of primitive-streak formation when the mesoderm has 
not yet formed (Thomas and Beddington, 1996). In addition, in early gastrulation, 
transcripts are found in the primitive ectoderm next to the primitive streak, which 
consists of cells destined to delaminate and form both mesoderm and definitive 
endoderm (Wilkinson et al., 1990). Expression has been shown in hindgut endoderm 
and neurectoderm (Inman et al., 2006). Furthermore, Brachyury is not only expressed 
by the notochord, but its expression there persists until very late developmental 
stages. Transcripts have been detected in mouse embryos even at E17.5, restricted to 
repeated clusters of cells along the spinal cord (Wilkinson et al., 1990). Interpreting 
the data from reverse-transcription PCR in the context of this information was very 
difficult. On one hand, the continuous increase in Brachyury transcript in the control 
sample could be an attenuated peak of mesendoderm formation. In this case, the 
earlier peak in the DAPT-treated sample could indicate a better (quicker) 
differentiation to mesendoderm. In combination with the observation that the relative 
levels of Osr1 in both samples were similar, that could mean that although 
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mesendoderm was enhanced, intermediate mesoderm was not. This interpretation fits 
well with the report of Nemir et al (2006) who showed that deactivation of Notch 
signalling leads to an increased efficiency in generating ESC-derived cardiomyocytes 
(which are of mesodermal origin). In another interpretation, the Brachyury 
expression graph at D15 could be seen not as an attenuation of expression, but as a 
higher level of expression as compared to DAPT-treatment. At the same time, it has 
been reported that Notch inhibition favours mesoderm at the expense of ectoderm 
(Nemir er al., 2005; Lowell et al., 2006). Since, Brachyury is also expressed by some 
neurectodermal cells (Inman et al., 2006) this could mean that Notch inhibition 
functions to deplete the Brachyury+ neurectodermal cells in DAPT-treated, but not in 
control samples. Overall, the most relevant observation that Osr1 expression did not 
change after DAPT-treatment remains. Together with the data from reaggregated 
pellets, this suggested that Notch inhibition did not show any evidence for enhancing 











In the previous two chapters, two strategies for the differentiation of ESCs to renal 
cells were tested. First, ESCs were exposed to the microenvironment of a developing 
embryonic kidney to see whether undifferentiated ES cells have the potential to 
respond to the signals from the environment and differentiate to renal cells. Second, a 
strategy of Notch signalling inhibition was employed with the purpose of improving 
the results obtained with undifferentiated ES cells. These experiments were based on 
reports showing that inhibition of Notch in ES cells leads to increase in the 
proportion of cells characteristic of a mesodermal lineage after differentiation. 
Neither strategy showed satisfactory results in producing kidney cells, as defined by 
the criteria described in Chapter 4 for obtaining cells with the potential to integrate in 
renal epithelia indistinguishably from kidney cells and express kidney markers. From 
these experiments it became clear that the methods tested were not useful for 
producing ESC-derived renal cells in vitro. It was then logical to address the question 
of how far, in developmental states, is an ES cell separated from the first type of cell 
that meets the criteria for renocompetence defined in Chapter 4.  
 
One of the central gaps in knowledge that was observed while performing the studies 
described in this thesis was the lack of experimental evidence about the earliest cell 
lineage or cell type in mouse embryo development, which was able to give rise to 
kidney cells either on its own or when exposed to renogenic signals in vitro. Some 
reports have investigated similar problems in amphibian gastrulae (Holtfreter, 1944; 
Toivonen and Saxen, 1955), but it would be inappropriate to translate this 
information directly to mammalian systems, due to the extensive cell plasticity that 
amphibians possess. Unlike mouse work, transplantation studies with early 
amphibian gastrulae have shown that almost any part of them would be able to 
generate nephric tubules when grafted to the appropriate region of another embryo 
(Holtfreter, 1933; reviewed by Saxen, 1987). Attention has also been given to 
determination and cell commitment rather than acquisition of competence. For 
example, Sariola et al. (2003) summarised that after determination the MM “is 
committed to nephrogenesis and is thus genetically programmed to respond to 
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Figure 6.1.1 – Diagram illustrating the concepts of plasticity, competence, commitment 
and specification in the context of renal development 
This diagram illustrates that development starts with cells possessing the highest 
plasticity or the ability to give rise to cells with different fates. At a certain moment in 
development, the potential for generating kidney cells in given conditions (without the 
complete set of signals and events present in development) is acquired. Such 
competent cells might have both the potential to give rise to kidney cells, but when 
placed in different conditions might show a potential to generate other cell types, as 
well. With development, all, or a subset of the competent cells get specified to a renal 
fate and lose their ability to produce other lineages. 
Dotted lines indicate that some cells in early embryonic development might be specified 
or that a fraction of cells retain some plasticity even in advanced developmental stages 
and/or after their completion (stem cells) 
inductive cues from the ureteric bud and so ready to give rise to the range of cell 
types that characterise the kidney”. Although, it seems like most people support the 
hypothesis that once formed the MM is already committed, the possibility of cells 
being competent to give rise to kidney cells outside the embryo without them being 
terminally committed and the timing of the acquisition of this competence, are not 
well understood. 
 
Commitment defines the stage at which certain cells significantly decrease their 
plasticity to form other lineages and can essentially produce only more specified 
cells of the same lineage and in some cases retain multipotency to persist as organ-
resident stem cells. The purpose of this chapter is not to address commitment (which 
has also already been temporally defined for the metanephros), but to address 
acquisition of competence or investigate when in development cells acquire the 
ability to give rise to renal cells independently of embryo development (Figure 
6.1.1). First, this information will help pinpoint the size of the leap that embryonic 
stem cells would have to make in order to acquire the ability (competence) to 
respond to external signals promoting a renal fate (such as the ones found in the 
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Figure 6.1.2 – A diagrammatic representation of methods for determining renocompetence 
used in this study 
1 – the respective tissues from tauGFP+ embryos are isolated, disaggregated into single 
cells and mixed with disaggregated into single cells E11.5 embryonic kidney rudiments. 
Organotypic reaggregates are then re-formed by pelleting and cultured at the air-liquid 
interface on a polycarbonate filter 
2 – conventional organ culture, in which structure formation is monitored after pieces of 
tissue are cultured at the air-liquid interface on a polycarbonate filer for several days 
3 – the same as in 1, with the difference that wild type tissues stained with CellTracker are 
used instead of genetically labelled cells (data shown only on Supplementary Figure 7) 
microenvironment of the embryonic kidney). Second, it will provide valuable 
information that will improve our understanding of kidney development and renal 
lineage specification. Third, combined with other studies, it could contribute to 
unravelling the principles of cell specification, in general. 
 
To address the acquisition of renocompetence in mouse embryos, a strategy was 
devised to follow the ability of cells isolated from different embryonic stages to give 
rise to renal or renal-like cells and structures. Two assays were used for testing the 
renocompetence of cells (Figure 6.1.2). First, the kidney rudiment disaggregation-
reaggregation approach was used as the main method for analysing the abilities of 
embryo-derived cells. The criteria for considering a test cell to be a renal cell in the 
disaggregation-reaggregation system have already been described in section 4.1.2 of 
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Chapter 4, for assessing ESC differentiation to renal cells. The same criteria are used 
here for testing the renocompetence of early embryo cells. The disaggregation-
reaggregation assay was used as a primary method as it has the advantage of 
allowing the tested cells to be analysed at multiple levels. The ability of cells to 
integrate into renal tubules and orient themselves correctly with respect to 
neighbouring native kidney cells provides a functional test. At the same time, a 
combination of molecular markers can be studied to characterise these cells at the 
molecular level. Furthermore, this assay can also provide quantitative information (as 
demonstrated by Chapter 3). The second assay for studying the renogenic properties 
of early embryo tissues was traditional organ culture where tissue fragments are 
grown on a polycarbonate filter placed on a Trowell metal screen (Grobstein, 1953, 
Saxen et al., 1962). For the scientific questions to be addressed in this chapter, the 
tissue culture assay has two disadvantages. First, it does not provide as much 
information as the disaggregation-reaggregation system. Second, since it does not 
allow for a simultaneous assessment of cell integration, marker expression and 
morphology, when used only by itself, it would not provide conclusive results. One 
example of the latter is the lack of a possibility to mix labelled and unlabelled 
populations of cells, which means that the exact region of interest cannot be 
accurately mapped. Another example is that due to the lack of the appropriate 
external signals, complete UB development and nephrogenesis are not likely to take 
place, so only very rudimentary structures might be observed. At the same time, in 
spite of its disadvantages, tissue culture would be useful for providing an 
independent confirmation of the results obtained with the primary method. The 
robustness of the disaggregation-reaggregation system, supported by an independent 
check by a second very different method offers a very good tool for addressing the 
acquisition of renocompetence in early embryos. Disaggregation-reaggregation 
experiments with CellTracker-labelled tissue-derived embryonic cells (instead of 
tauGFP-labelled cells) have also been performed (Supplementary Figure 7). These 
results have not been presented here, as in other chapters and supplementary 
information (Chapter 4, Chapter 7, Supplementary Figure 4) it has been 
demonstrated that CellTracker is not a robust marker.  
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Figure 6.1.3 - A “backward” approach of addressing the acquisition of renocompetence 
in mouse embryo development 
The backward approach works by an incremental decrease of the embryonic age of 
tested mouse embryos, First, metanephrogenic tissues from E11.5 are used. Embryo 
age is decreased by 1 embryonic day for every successful experiment until no 
successful integration/marker expression in the disaggregation-reaggregation system 
can be obtained. The yellow, pink, green and peach colour blocks help correlate the 
embryonic ages tested to the timing of mesoderm, intermediate mesoderm, MM, etc, 
formation. The blue strips address commitment and competence. Although it is known 
that the MM is competent to produce nephrons, it is not known whether the 
intermediate mesoderm (IM) or the mesoderm do so, as well. 
 
All experiments presented up to this point of this thesis follow the normal course of 
embryonic development. For example, the differentiation of ESCs to mesoderm, 
intermediate mesoderm and kidney cells was followed. This chapter differs 
significantly from previous ones, as it adopts a “backward” approach to studying 
renogenic potential. In ESC experiments, a “forward” approach would be testing the 
cells at various time points of their differentiation, while they get more “mature”. If 
in vitro differentiated to mesoderm cells had shown the potential to integrate into 
reaggregated kidney rudiments and expressed kidney markers it would have been 
concluded that the mesoderm present in embryo development before any 
intermediate mesoderm is formed already possessed renocompetence. In contrast, the 
experiments in this chapter work “backwards” by isolation of tissues from 
progressively younger embryos and testing them in the reaggregation system (Figure 
6.1.3). The experiments start by using GFP+ E11.5 kidney rudiments as test cells. 
This serves as a positive control, as E11.5 rudiments are renocompetent and can 
contribute to the structure of other E11.5 kidney rudiments (shown in Chapter 3). 
The age of the test tissue is then incrementally decreased by 1 embryonic day (E10.5, 
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E9.5, E8.5, etc) at a time for every successful experiment (Figure 6.1.3). In this 
backward sequence, the first embryonic stage at which cells can no longer integrate 
into developing renal epithelia as previously described, will indicate that no 
renogenic competence is present at that stage. For example, if no integration is seen 
in E9.5 embryos, this would mean that E9.5 embryo cells are not yet competent to 
make kidney cells. The earliest renocompetent stage would then be one experimental 
step back, or in this example - E10.5. Unlike normal development, where the 
renogenic competence increases with increasing age (cells become more competent, 
while the embryo develops), in this approach, the renogenic competence will 
decrease with decreasing age (cells become less competent with each stepwise 
decrease of the embryonic age of the sample). The advantage of this “backward” 
approach is that it allows only one failed attempt of integration (the stage at which 
the cells would be too immature to give rise to kidney cells). The interval between 
the last successful integration (the youngest embryo stage, which contains 
renocompetent cells) and the first unsuccessful integration (the oldest embryo stage, 
which no longer contains renocompetent cells) will define the period in embryonic 
development when renocompetence is acquired. This is in contrast with “forward” 
approaches like ESC differentiation experiments, which can have many failed 
attempts of pinpointing the stage of acquisition of renogenic potential as many 
different treatments might not be useful for generating mesoderm, intermediate 
mesoderm, etc or as good markers for defining these populations are not available. 
 
In order to evaluate the results from the “backwards” experiments, it was necessary 
to consider two factors – one, the exact location of tissue that was mechanically 
dissected for use in organ culture or cell mixing experiments; and two – the 
properties that these tissues have been reported to have in the literature (in 
correlation with the embryonic stage they have been isolated from). The staging of 
the embryos and the areas isolated have been described in the Materials and Methods 
Chapter of this thesis. To correlate the stage of kidney development with the 
embryonic age of mouse embryos, a literature search was performed. The results 
were given in Figure 6.1.4, A. As a whole, the key resources agreed in defining the 




Developmental event Embryonic day Reference 
   
One-stage egg E0.0-E1.0 Kaufman, 2001 
Two-cell stage E1.0 Kaufman, 2001 
4/16-cell stage (morula) E2.0 Kaufman, 2001 
Morula-blastocyst E3.0 Kaufman, 2001 
Blastocyst E4.0 Kaufman, 2001 
Blastocyst attachment E4.5 Kaufman, 2001 
Embryo implantation E5.0 Kaufman, 2001 
Mesoderm E7.0 Downs and Davies, 1993 
E7.0 Kaufman, 2001 
Presomite stage E7.5 Kaufman, 2001 
Intermediate mesoderm E8.5 So and Danielian, 1999 
E9.0 Kaufman, 2001 
Nephric duct E8.0 Gilbert, 2000 
E8.5 Vetter and Gibley, 1966 
E9.0 Kaufman, 2001; Theiler, 
1989 
Pronephric anlage E8.5 Vetter and Gibley, 1966 
Pronephros E8.0 Hoar, 1976 
E8.83 Vetter and Gibley, 1966 
Mesonephric anlage E9.5 Smith and MacKay, 1991 
Mesonephros E9.0 Vetter and Gibley, 1966 
E9.5 Hoar, 1976 
E10.0-E10.5 Kaufman, 2001 
Metanephric anlage E10.0 Vetter and Gibley, 1966 
E11.0-E11.5 Kaufman, 2001 
Ureteric bud E11.0 Hoar, 1976 
E11.0 Vetter and Gibley, 1966 
E11.0-E11.5 Kaufman, 2001 
Metanephros E11.0 Saxen, 1987 
E11.0 Vetter and Gibley, 1966 
E11.0-E11.5 Kaufman, 2001 
Condensates E12.5 Hoar, 1976 
E12.5 Vetter and Gibley, 1966 
E12.5-E13.0 Kaufman, 2001 
A 
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Figure 6.1.4 – A summary of developmental events relevant to kidney development 
A – a table summarising information available from studies, which have examined the 
timing of structure/tissue/organ formation in mouse development. The data emphasises on 
the differences in reported timing, especially in the periods of most relevance to early 
kidney development (intermediate mesoderm, pronephros, mesonephros formation) 
B – a schematic of important developmental events, plotted on a time line with the time of 
embryonic development shown as a ruler. For events, which were subject to disagreement 
in the examined reports the approximate median of the embryonic ages suggested was 
plotted 
 
developmental events occurring in the organogenesis of the kidney and is preceded 
by the generation of the pronephros and mesonephros. It is important to note that the 
information available from the literature for the descriptions of the temporal 
occurrence of the metanephric anlage and all earlier stages, mesonephros, 
pronephros, nephrogenic cord and intermediate mesoderm, we more discordant 
(Figure 6.1.4, A). Although many of the mechanisms and genes involved in kidney 
development have now been identified, it seems like there has been less interest in 
describing the exact timing of these processes in the mouse. One of the few studies 
that correlates some stages of kidney development with the timing of embryo 
development was published by Vetter and Gibley (1966) and describes 
B 
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morphogenetic processes in mesonephros and metanephros development. In his 
“Atlas of mouse development”, Kaufman (2001) also provides information about the 
timing of structures appearing in the mouse. Hoar (1976) reviews the main events in 
the development of the gastrointestinal and urogenital systems with regard to time. 
These, together with other resources were used for the construction of a “map” and a 
table to match developmental events with the respective day of mouse embryo 
development, which will be referred to in further sections of this chapter. Figure 
6.1.4, A and B do not describe certain major developmental events, as they have 
been made with relevance to kidney development only. Early stages of embryonic 
development have not been represented in detail on the diagram as they will not be 
relevant to the studies described in this chapter. For constructing the diagrammatic 
representation in Figure 6.1.4, B, the approximate medians of the developmental 
stages given in Figure 6.1.4, A were used.  
 
In summary, two different tools will be used in this chapter to define the 
developmental stage at which renocompetence is acquired. The disaggregation-
reaggregation assay will be used to test the cells at multiple levels, which can be 
summarised into three main categories - the ability of the cells to integrate into renal 
epithelia; the morphological properties of integrating cells; and the ability of 
integrating cells to express renal markers. These results will be presented together 
with the second assay, organ culture, which will provide an independent check for 
reaggregation experiments. First, only qualitative data will be presented. These 
experiments will demonstrate that cells from early embryos are able to integrate into 
developing nephrons and ureteric buds, and that tissue explants from the same 
embryo stages can form UB-like and nephron-like structures in culture. Next, 
quantitative data is going to be presented to follow how the numbers of cells able to 
integrate change with changing embryo age. In these quantitative experiments, 
labelled E11.5 kidney cells will be mixed with unlabelled E11.5 kidney cells as a 
control and the change of integration at different embryo stages will be followed by 
incrementally decreasing the age of the embryos used (E11.5, E10.5, E9.5, E8.5). 
Finally, the properties of these cells are going to be studied at the molecular level by 
immunohistochemistry for various markers.  
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Figure 6.2.1 – Diagram of different embryonic stages and tissues used in this study 
This diagram provides information about the embryo stages that were used in this 
study, as well as the tissues that have been isolated from each stage for the 
generation of single-cell suspensions for use in cell mixing experiments; images 
showing embryos at E11.5 and E10.5 were modified from the online atlas of mouse 




6.2.1 Early embryo cells integrate into renal epithelia in the kidney 
disaggregation-reaggregation assay 
The screening for integration of cells in organotypic cultures was performed by using 
genetically labelled cells explanted from TgTP6.3 mice. Cells or tissues from these 
transgenic mice will be referred to as tauGFP+ for conciseness. Embryos harvested 
from mouse uteri were individually examined for GFP+ fluorescence and only GFP+ 
embryos were selected for further dissections. Tissues from E11.5, E10.5, E9.5 and 
E8.5 embryos were isolated as described in the Materials and Methods chapter. A 
summary of the tissues used is provided in Figure 6.2.1.  
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For cell mixing experiments the test tissues were disaggregated to single cells as 
previously described and mixed with disaggregated embryonic kidney cells from 
E11.5 rudiments. 15,000 labelled “test” cells were mixed with 100,000 E11.5 
embryonic kidney cells. The reaggregated by centrifugation pellets were placed in 
organ culture and maintained for 6 days, before fixation with PFA and ice-cold 
methanol. The experiments were stained for Calbindin and Laminin. The grafted 
cells were detected by tauGFP fluorescence and all nuclei - by a staining for DAPI. 
For intact organ culture experiments (see Figure 6.1.2), tissues were isolated as 
above and cultured on a polycarbonate filter at the air-liquid interface. The samples 
were fixed with ice-cold methanol after 5 days of culture and stained for Calbindin 
and Laminin to detect possible kidney-like structures. The results obtained by both 
assays were presented according to the embryonic age of the tissue and the 
experimental method used starting with control E11.5 mixing experiments (Figure 
6.2.2). 
 
Image 6.2.2, A shows tauGFP+ cells from E11.5 kidney rudiments integrating in 
both nephrons (open arrow) and UB structures (block arrow). The labelled cells 
observed in renal epithelia were not distinguishable in their shape and orientation 
from native kidney cells (Figure 6.2.2, A). Most cells integrating in the UB were 
positive for the marker Calbindin (Figure 6.2.2, A, block arrow). The control studies 
of mixing labelled and unlabelled populations of E11.5 metanephric cells were 
confirmed by control organ culture (Figure 6.2.2, B). As expected, E11.5 embryonic 
kidney rudiments developed branched UBs (block arrow) and nephrons (open arrow) 
after 4 days in culture (Figure 6.2.2, B).  
 
Similar results were obtained for the tissues isolated from the metanephrogenic 
regions of E10.5 embryos, which contained uninduced MM and the adjoining piece 
of WD (Figure 6.2.2, C and D). As demonstrated by Figure 6.2.2, C, tauGFP - 
labelled E10.5 cells were found integrating into both reformed UB structures (block 
arrows) and nephrons (open arrows). Tissue culture experiments indicated that when 
cultured with or without spinal cord, these metanephric anlagen formed UBs, which 
were able to branch, and nephrons (Figure 6.2.2, D, respectively open arrow and 
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Figure 6.2.2 – The ability of cells and tissues from different embryonic stages to 
contribute to integrate into renal epithelia and generate renal-like structures in organ 
culture 
The respective embryonic stage is shown on the left; the isolated region was shown by a 
red dotted line if necessary; block arrows indicate cells integrating in UBs or forming 
Calbindin+ UB-like structures in the last column of images; open arrows indicate cells 
integrating in nephrons or the formation of nephron-like structures in the last column of 
images 
A, C, E and G show that tauGFP+ cells from E11.5 metanephroi were able to integrate 
into both nephrons and UBs, where at least some of the integrating UB cells were 
Calbindin+; organ culture experiments in B, D, F and H show that the tissues isolated 
from different embryonic stages (as indicated in the diagrammatic panels on the left) for 
both UB-like and nephron-like structures; the ability of Calbindin + structures to branch 
disappeared in F and H. 
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block arrow). Although structures were formed, this observation suggested that at 
this stage, external signals for the complete development of branching UBs and 
nephrons might already be lacking. 
 
No metanephros formation is seen in E9.5 embryos and even metanephric anlagen 
are not yet formed at this stage of embryonic development. Interestingly, cells 
isolated from the prospective metanephrogenic regions of these embryos were still 
able to integrate into either UBs (Figure 6.2.2, E, block arrow) or nephrons (Figure 
6.2.2, E, inset, open arrow). Furthermore, a large proportion of the cells integrating 
in UBs were also positive for the marker Calbindin (Figure 6.2.2, E). Tissues 
cultured with the inducer spinal cord exhibited non-branched UB-like Calbindin+ 
structures, surrounded by tubular-like Laminin-bound structures (Figure 6.2.2, F, 
respectively block arrow and open arrows).  
 
Cells with the ability to integrate into either UBs or nephrons were still present in 
tissues isolated from E8.5 experiments, as indicated by Figure 6.2.2, G, although 
these events were extremely rare. Some of the cells seen in UBs were positive for 
Calbindin (Figure 6.2.2, G, inset, block arrow). The cells found in nephrons were not 
distinguishable morphologically from normal nephron cells and seemed to have a 
consistent orientation with their neighbours to form a renal tubule with a lumen 
(Figure 6.2.2, G, open arrow). Culture of tissues isolated from the whole posterior 
part of embryos still showed the presence of Calbindin+ structures surrounded by 
Laminin-positive tubules (Figure 6.2.2, H, block arrow and open arrow respectively).  
 
6.2.2 Cells from E7.5 embryos interfere with the normal 
development of reaggregated organotypic cultures 
Reaggregated pellets were also prepared with cells isolated from an earlier 
embryonic stage. Since no metanephros, mesonephros, pronephros or their primordia 
are yet present in E7.5 embryos and the isolation of only mesoderm poses a serious 
limitation to the number of cells that could be used for experiments, whole embryos 
were disaggregated for mixing in the organotypic cultures. The renogenic capacity of 
tauGFP+ embryo-derived cells in the reaggregates was difficult to analyse, as the 
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reaggregated cultures grew abnormally in comparison to all previous cell mixing 
experiments (Figure 6.2.3 A-F). Pellets containing E7.5 cells, grown as previously 
described were unusually small and underdeveloped after 6 days in culture (Figure 
6.2.3, C and D). To investigate whether this was due to an experimental error (such 
as expiry of any of the reagents used) or whether it was a real experimental result, the 
following test was performed. E11.5 kidney rudiments (which were used as “host” 
cells) were dissected, disaggregated into single cells and separated in two equivalent 
batches. One of the test tubes of cells was used for the generation of reaggregated 
organotypic cultures, which contained 115,000 embryonic kidney cells and no E7.5 
embryo cells. The second test tube was used for the generation of organotypic 
cultures containing 115,000 cells, 100,000 of which were E11.5 embryonic kidney 
cells and 15,000 – tauGFP cells isolated from E7.5 embryos. These pellets were 
cultured for 6 days as described for reaggregated cultures in previous experiments. 
After 6 days, the difference between pellets lacking and containing E7.5 cells was 
discernible even by bright-field microscopy (Figure 6.2.3, A, B, C and D). Control 
pellets, which did not contain any E7.5 cells behaved as generally observed in cell 
mixing experiments – a large number of structures was present after 6 days of 
culture, the morphology of the pellets was healthy and the samples had greatly 
increased in size (Figure 6.3.2, A and B). On the other hand, pellets containing E7.5 
cells were small, contained very few structures and showed signs of cell death, as can 
be seen on Figure 6.2.3, C and D. Although variation was observed in the survival 
rate of cells and the number of structures present, three independent experiments 
confirmed the general pattern trend of these results. The low number of structures 
was also confirmed when the pellets were stained for the markers Calbindin and 
Laminin (Figure 6.2.3, E and F). These results indicated that the unusual behaviour 
of pellets was not due to an adverse effect from any of the reagents or an error in 
preparation of the materials and that it was most probably due to the presence of E7.5 
cells in the organotypic reaggregates. 
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Figure 6.2.3 – Cells from E7.5 embryos interfere with the normal growth of reaggregated 
organotypic cultures 
A and B – reaggregated pellets cultured for 6 days, exhibiting the formation of numerous 
structures (light, often round areas) 
C and D – experiments performed with the same pool of reaggregated cells, but 
containing E7.5 tauGFP cells showed abnormal growth and degeneration after 6 days in 
culture; the difference between C and D also demonstrates the variation in the number 
of structures formed in these experiments (a few in C, but none in D) 
E and F – reaggregates containing tauGFP+ E7.5 cells, stained for Calbindin (blue) and 
Laminin (red) also demonstrated that an abnormal number if structures was formed 
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6.2.3 Cells from E7.5 embryos might also be competent to integrate 
in developing renal epithelia 
Although the results from E7.5 experiments could not be treated as conclusive due to 
the abnormal growth of the pellets, the samples, which contained some structures 
were fixed and stained for Calbindin and Laminin for examination. In many cases, 
the disaggregated E11.5 kidney cells had not developed normally (this will be 
discussed later in the text). Figures 6.2.4, A and C were a good representation of why 
these experiments were difficult to analyse. First, this confocal micrograph revealed 
that tauGFP+ cells can form chimeric structures with renal epithelia (arrows). At the 
same time, the borders between the Laminin-bound and Calbindin-positive part (UB) 
and the Laminin-bound and Calbindin-negative part (nephron) were not clear, as 
observed in normal reaggregates (for comparison see Figure 6.2.2). The Calbindin 
staining itself showed a strong mosaicism, which was not characteristic of normal 
ureteric buds. The dotted red and blue lines in Figure 6.2.4, A and B indicate 
unusually alternating Calbindin+ and Calbindin- areas. This did not allow 
determining which part of the renal epithelium was a nephron, UB, or possibly 
another unknown type of epithelium. Therefore, it was impossible to assess the 
ability of the mixed tauGFP+ E7.5 cells to contribute to kidney structures. In the few 
samples that could be examined, no tauGFP+ Calbindin+ cells were seen. 
  
6.2.4 E7.5 tissues generate rudimentary tubular structures 
Consistently with cell mixing experiments from later embryonic developmental 
stages, tissue culture experiments were also performed with E7.5 embryos. The 
tissues were isolated as previously described and co-cultured with spinal cord on a 
polycarbonate filter at the air-liquid interface for 5 days. The methanol-fixed tissues 
were stained for Calbindin and Laminin to look for the formation of rudimentary 
renal structures. Fluorescence micrographs showed that in some samples, there were  
Calbindin+ tubules connected to Laminin-bound and Calbindin-negative epithelia 
(Figure 6.2.5, A-D). 
 
To illustrate the presence or absence of structures in cultured E7.5 embryos and 
characterise them for expression of Calbindin and Laminin, the observations of all 
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Figure 6.2.4 – Cells from E7.5 embryos 
localise into renal epithelia 
A, C and E – show tauGFP+ E7.5 cells 
localising within the Laminin boundary of 
renal epithelia; cells were localised into both 
Calbindin- (block arrows) and Calbindin+ 
(open arrows) areas; it was difficult to 
determine whether these were indeed UB 
structures and nephrons, as unusual areas of 
alternating Calbindin +  (blue dotted lines) 
and Calbindin-  (red dotted lines) staining 
could be seen, as shown in A and B 
B and D show that the integrating tauGFP 
cells were negative for Calbindin 
E – gives a better representation of all 














no SC SC 
Side 1 Side 2 Side 1 Side 2 
C+ L+ C- L+ C+ L+ C- L+ C+ L+ C- L+ C+ L+ C- L+
1 - - - - - - - - 
2 - - - - - - - - 
3 - - - - + + - - 
4 + + + - - - - - 
5 + - + - - - - - 
6 + - + + n/a n/a n/a n/a 
7 - - - - n/a n/a n/a n/a 







Figure 6.2.5 – Cultures E7.5 embryos exhibit the ability to produce rudimentary kidney-
like structures 
A, B and C were stained for Calbindin (green) and Laminin (red) 
D was stained for Calbindin (green), Laminin (red) and DAPI (cyan) 
A and B are micrographs of two different embryos, showing Laminin+ Calbindin+ 
structures (block arrows) with associated Laminin+ Calbindin- tubules (open arrows) 
C and D show a magnification of B 
E – is a summary of the results of several tissue culture experiments, in which embryos 
were cultured either alone or together with spinal cord; SC denotes spinal cord; “side 1” 
was to the left of the midline with respect to the viewer, while “side 2” was to the right; 
“left” and “right” might not correspond to the real sides of the embryos, as their 
orientation after culture was  not known; C and L denote Calbindin and Laminin; + or – 




Figure 6.2.6 – Summary of the ability of cells or tissues from different embryo stages to 
integrate in renal tubules or form structures when cultured in vitro 
A Calbindin+ Laminin+ structure was marked as a UB. A Calbindin- Laminin+ structure was 
marked as a nephron.  
 
 Integration tauGFP 
Structure formation (culture of 
tissue fragments) 
Age UB Nephron UB Nephron 
E11.5 yes yes yes yes 
E10.5 yes yes yes yes 
E9.5 yes yes yes yes 
E8.5 yes yes yes yes 
E7.5 inconclusive inconclusive yes inconclusive 
samples were presented in Figure 6.2.5, E. Since kidneys are paired organs, both 
sides of the embryo were examined for the presence of structures. “Side 1” and “Side 
2” were used to describe whether the structures were seen on the left side or right 
side with respect to the viewer. This was done as it was important to document 
whether the two types of structures were both present at the same side of the embryo. 
Describing the sides with “left” and “right” was not possible for two reasons: 1 - it 
was not known whether the embryos were placed in culture on their dorsal or ventral 
side; and 2 – some embryos were misshapen after 5D in culture and rostral and 
caudal sides were also difficult to distinguish. “C” and “L” stand for Calbindin and 
Laminin. A plus or minus indicates presence or absence of the marker in a structure. 
SC stands for spinal cord, which was used as an inducer in some experiments (as 
indicated). The summary of data indicates that more structures were observed in the 
samples, which were not co-cultured with spinal cord. This might suggest that very 
high concentrations of signals emanating from spinal cord might be interfering with, 
rather than supporting renogenesis. This observation also provides support for the 
speculation that signals from E7.5 embryos could have interfered with normal 
reaggregation and development of the E11.5 kidney cells. 
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6.2.5 Quantitative characterisation of the ability of embryonic cells 
to integrate into renal structures 
A summary of the renogenic capacity of cells derived from different stages of mouse 
embryonic development was given in Figure 6.2.6. Although, the experiments 
described in the previous sections of this chapter provided valuable information 
about the presence or absence of renogenic capacity in the different cell populations, 
they did not describe how this capacity decreases with the stepwise decrease in the 
age of embryos used for experiments. To characterise this, reaggregated organotypic 
pellets were set up and cultured as previously described. The numbers of cells 
integrating in nephrons and UBs were counted as detailed in Chapter 3 (Method 2). 
Calbindin and Laminin were used for distinguishing between the two renal 
compartments. The quantified data was expressed as integrating cells per megapixel 
of the screened confocal micrographs ± standard error of the mean. Significance was 
calculated by an unpaired student’s t-test. The criteria for integration were applied, as 
described in Chapter 4. In short, cells were considered to integrate in UBs when they 
were seen in the structure of this renal compartment, expressed Calbindin and were 
morphologically indistinguishable from the surrounding cells. Cells were considered 
integrating in nephrons, if they fulfilled the criteria above, but were not Calbindin 
positive. The results were shown graphically in Figure 6.2.7, A - D, and numerically 
in Figure 6.2.7, E. Panels A and C present the data on a linear scale, while B and D – 
on a logarithmic scale.  
 
From Figure 6.2.7, it becomes obvious that there was no significant difference in the 
ability of the isolated E11.5 and E10.5 cells to integrate into nephrons, but the 
difference for UBs was significant. The tauGFP+ cells integrating in UB decreased 
from 220 ± 33 to 140 ± 11 cells per megapixel between E11.5 and E10.6, while cells 
integrating in nephrons decreased from 130 ± 17 to 120 ± 10. One embryonic day 
earlier, the cells integrating into both compartments decreased significantly to 9.6 ± 
4.0 (UB) and 5.3 ± 1.5 (nephrons) cells per megapixel. At E 8.5, cells integrating in 
both compartments could still be observed. The decrease from E9.5 for tauGFP+  
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Figure 6.2.7 – Quantitative characterisation of the ability of early embryo cells to 
integrate into renal structures 
All data is presented as the number of green cells integrating in nephrons or UBs per 
megapixel (1000000pixel = 1megapixel); 
A and B present the integration of cells in UBs;  
C and D present the integration in nephrons; 
B and D display the data on the x-axis on a logarithmic scale as the presence of bars 
in the E8.5 samples is not well visible in A and C; 
A and C present the same data as B and D, on a linear scale; 
1000x1000 pixel = 230x230 µm 
* p<0.05, ** p<0.01, *** p<1x10-23 
E - provides the numerical data used for the generation of the graphs in A-D. The 
values have been rounded to two significant figures. 
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cells found in UBs was significant, while that for cells found in nephrons was not. 
The cells quantified at this stage were 0.14 ± 0.11 and 0.81 ± 0.81 cells per 
megapixel respectively. Quantification of experiments with E7.5 embryos was not 
possible due to the morphological changes of the two “host” renal compartments. 
 
6.2.6 Cells from E11.5 mesonephroi were able to integrate into renal 
epithelia 
As mentioned in Chapter 1 of this thesis and in the introduction section of this 
chapter, the metanephros is not the only renal structure found in embryonic 
development. The development of the pronephros and mesonephros precedes the 
appearance of metanephrogenic primordia. Therefore, it could not be excluded that 
the cells of these organs could also be able to contribute to the structure of 
metanephric renal epithelia. This could mean that, potentially, in the qualitative and 
quantitative experiments described in previous sections, mesonephric cells could 
have integrated into metanephric renal epithelia. To test whether mesonephric cells 
had the capability to localise into metanephric structures, mesonephroi were isolated 
from tauGFP+ E11.5 embryos, disaggregated into single cells and mixed in the 
reaggregation system. The experiments were cultured for 6 days for consistency with 
all other experiments in this chapter, fixed, and stained for Calbindin and Laminin. 
Analysis by confocal microscopy revealed that mesonephric cells localised into both 
metanephric nephrons and metanephric UB structures (Figure 6.2.8). The 
morphology of the detected cells was also indistinguishable from metanephric renal 
epithelia at that level of microscopic analysis. Some, but not all of the cells 
integrating in ureteric buds were Calbindin-positive (Figure 6.2.8). 
 
6.2.7 Early embryo cells mixed in reaggregated kidney rudiments do 
not express Oct4 
Since experiments with embryonic stem cells have shown that a detectable number 
of cells remain Oct4 positive even after being cultured for 6 days in the 
disaggregation-reaggregation system. Although Oct4 is expressed by inner cell mass 
cells (and ESCs), it persists in certain types of cells in early embryogenesis. Oct4  
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Figure 6.2.8 – Cells from E11.5 mesonephroi can integrate into developing renal 
epithelia 
A-F – show that mesonephric cells integrating into both nephrons (open arrows) and 
UBs (block arrows); many cells integrating in UBs were positive for Calbindin 
Calbindin (blue), Laminin (red), tauGFP (green), DAPI (cyan) 
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transcript has been detected at high levels in the neural ectoderm at E8.0 (Scholer et 
al., 1990). It was therefore interesting to check whether early embryo-derived Oct4+ 
cells could be found in the reaggregates and whether these integrated in renal 
epithelia. Since the earliest tissues used in organ disaggregation-reaggregation 
experiments (E7.5) caused abnormal development of reformed organotypic kidney 
rudiments, tissue from E8.5 caudal parts was used for performing these experiments. 
Single-cell suspensions were prepared as previously described and the resulting 
pellets were placed in a conventional organ culture system and cultured for 6 days. 
The fixed pellets were stained for Oct4. Laminin and DAPI were used to visualise 
the nuclei and the borders of renal epithelia.  
 
Analysis by confocal microscopy did not identify any GFP+ Oct4+ in the 
reaggregates in both tauGFP+ cells found in renal tubules or the interstitium (Figure 
6.2.9, A-F). In Figure 6.2.9, block arrows show that tauGFP+ structures were 
negative for GFP. Open arrows indicate artefacts, which looked similar to nuclear 
staining. These exhibited fluorescence in both the red and the red (blue) fluorescence 
channels, did not show colocalisation with DAPI or were much smaller than a 
normal nucleus, as indicated by the staining of neighbouring cells.  
 
6.2.8 Marker expression analysis of tauGFP+ cells in the 
organotypic culture system 
Next, it was necessary to determine whether tauGFP+ cells derived from early 
embryos expressed other renal markers in addition to Calbindin and Laminin, (which 
are quite wide-spread in epithelia) after integration in the disaggregation – 
reaggregation system. For screening for renal markers, it would be ideal to use 
tissues from the earliest stage that has shown a renogenic potential. This was 
identified as E8.5. Quantification experiments in section 6.2.5 of this chapter, 
however, suggested that too few cells with the potential to integrate were present at 
this stage and covering the scope of many different markers would not be possible 
due to the low prevalence of integrating cells. For that reason, E9.5 cells were used 
to characterise the properties of early embryo - derived tauGFP-tagged cells instead. 
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The disadvantage of studying renal markers in E9.5 embryos is that the information 
is not directly transferable to integrating E8.5 cells, as non-kidney cells have also 
shown the ability to localise into renal tubules.  An example was presented in 
Chapter 4 of this thesis where ESC-derived cells were seen to form chimeric 
structures with renal epithelia, but failed to express renal markers.  Integration is 
therefore not a sufficient condition for renal differentiation. Still, it should be noted 
that ESC-derived cells localising into renal tubules (which didn’t express renal 
markers) were morphologically distinct from the neighbouring E11.5 embryonic 
kidney cells. This suggests that the criterion “morphology” can still be applied to 
E8.5 cells to obtain more information about what these cells are. Studying marker 
expression in E9.5 embryos is key in understanding whether cells isolated from an 
embryo stage, at which the intermediate mesoderm has not yet formed a metanephric 
blastema, are able to integrate, and also differentiate to the different kidney subtypes 
in the reaggregation system. 
 
To address these questions, organotypic cultures were prepared as previously 
described for E9.5 tissues and cultured for 8 days (longer time was allowed for 
induction of marker expression in the tested cells). The experiments were stained for 
the following combinations of markers: 
- Pax2 and WT1 
- Megalin and E-cadherin. 
- Six2 and E-cadherin 
 
The expression patterns of these genes have been discussed in more detail in Chapter 
1. In short, in the metanephros, Pax2 is expressed in the UB, the condensing 
mesenchyme, renal aggregates and nascent nephrons (Dressler et al., 1990); WT1 is 
expressed at low levels in the condensing mesenchyme and renal vesicle, and persists 
at high levels in the glomerular podocytes (Self et al., 2006; Pritchard-Jones et al., 
1990); Megalin is a member of the low density lipoprotein receptors and transcript 
has been detected within the brush-border membrane of proximal tubular cells 
(Lundgren et al., 1997); E-cadherin expression is abundant in the distal tubule, but 
decreases significantly in the proximal tubule (Prozialek et al., 2004); Six2 is  
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Figure 6.2.9 – Early embryo cells do not express Oct4 after 6 days in culture 
A-F – images of organotypic cultures containing cells from the caudal parts of E8.5 
emrbyos 
A-D – tauGFP embryo cells localising into Laminin-bound structures do not express 
detectable levels of Oct4 (block arrows) 
E and F – tauGFP cells, which did not localise into renal epithelia did not express 
detectable levels of Oct4 (block arrows); open arrows point at artefacts, which 




expressed by the MM cells surrounding the UB tips (Self et al., 2006). It is also 
important to note that all of these genes are also expressed in other non-kidney 
tissues (discussed in Chapter 1).The Pax2 and WT1 staining allowed screening for 
tauGFP+ cells localising in the condensing mesenchyme and glomeruli, in addition 
to cells integrating into renal tubules. The wild-type kidney cells showed a normal 
expression of these markers – WT1 was highly expressed in glomerular podocytes 
and detected at a weaker level in the metanephric mesenchyme (Figure 6.2.10, A, B, 
C and D). Pax2 was expressed by the cap mesenchyme and in already formed renal 
tubules (Figure 6.2.10, A, B, C and D). Many wild-type cells were doubly positive 
for Pax2 and WT1 (Figure 6.2.10, C and D). These were largely found in the 
induced/condensing mesenchyme. Interestingly, some Pax2+ WT1+ cells were also 
observed in what appeared to be already formed tubules (Figure 6.2.10, E, F, G and 
H). 
 
In tauGFP+ cells, the following four types of marker profiles were observed: 
– tauGFP+ Pax2- WT1-  
– tauGFP+ Pax2+ WT1- 
– tauGFP+ Pax2- WT1+  
– tauGFP+ Pax2+ WT+ 
 
The four types of cells above were also listed in an order of decreasing abundance. 
Most frequently seen were tauGFP+ Pax2- WT1- cells (Figure 6.2.10, A-D, block 
arrows). There was a detectable number of tauGFP+ Pax2+ WT1- (Figure 6.2.10, I 
and J, block arrows). These could be clearly seen integrating into already formed 
renal tubules and in the condensing mesenchyme (Figure 6.2.10, I and J, arrows). 
tauGFP+ Pax2- WT1+ cells were also present in the metanephric mesenchyme, but 
these were seen extremely rarely, sometimes in clusters of several cells (Figure 
6.2.10, K-R, arrows). Only one occasion of tauGFP+ Pax2- WT1+ cells was 
detected in a glomerulus (n=3; Figure 6.2.10, W and X, arrows). tauGFP+ Pax2+ 
WT+ were extremely hard to detect and only a few occasions of these triply positive 
cells were seen in the experiments (n=3, Figure 6.2.10, S, T, U and V, arrows). 
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Megalin and E-cadherin staining identified E-cadherin+ tauGFP+ cells in renal 
tubules (Figure 6.2.11, A-D, arrows). A few tubules containing tauGFP+ cells were 
also positive for Megalin (Figure 6.2.11, A-D, block arrows). Micrographs also 
suggested that Megalin was specifically expressed by some tauGFP+ E-cadherin+ 
cells, as well as native proximal tubular cells, as in some cases the areas of positivity 
appeared to be on the luminal side of integrating tauGFP cells. 
. 
The Six2 and E-cadherin marker expression screening was more difficult to analyse 
as staining for Six2 was not as bright as the immunohistochemistry for other 
proteins. The properties of some tauGFP+ cells also contributed to the limitations as 
they seemed to be able to wrap around other cells thereby creating potential false 
positives. This could be more clearly demonstrated by the WT1 and Pax2 staining as 
the quality of these confocal images was superior. Figure 6.2.12, A and B, C and D 
show two serial confocal sections of an organotypic pellet containing E9.5 cells, 
stained for WT1 and Pax2. An arrow points at a cell, which shows an apparent 
expression of tauGFP, WT1 and Pax2. Looking at the neighbouring section showed 
the same WT1+ Pax2+ nucleus, which was not enveloped by a layer of tauGFP 
cytoplasm. Still, Six2+ cells could be observed in the reaggregates (Figure 6.2.12, E 
and F, arrows), although these events could be detected extremely rarely. Six2+ cells 
were negative for E-cadherin suggesting that these cells hadn’t undergone MET 





Figure 6.2.10 – Pax2 and WT1 expression of tauGFP E9.5 cells after an 8-day culture 
in the organotypic pellets 
A, B, C and D – most tauGFP+ cells found in the organotypic pellets were Pax2- WT1- 
(arrows) 
C and D – some tauGFP+ cells forming chimeric structures with renal epithelia were 
Pax2- and exhibited an uncharacteristic for renal tubules morphology (arrows) 
E, F, G and H - demonstrate that rarely WT cells, which have already formed tubules, 
co-express Pax2 and WT1 (arrows) 
I and J – show that some tauGFP+ cells integrating in renal epithelia express Pax2+; 
these were negative for WT1 (arrows) 
K , L, M, N, O, P, Q, R – show tauGFP cells expressing low levels of WT1, as 
characteristic of the condensing mesenchyme (arrows); the tauGFP+ WT1+cells on the 
lower side of the panels K, L, M and N show a more loose distribution than wild type 
cells 
S, T, U and V – the arrow points to a tauGFP+ cell, which is also co-expressing Pax2 
and WT1, thereby appearing purple in the merged images S and V; U shows that the 
cells is tauGFP+ 
W and X – show tauGFP+ cells located in a glomerulus and expressing a high level of 
GFP+ 
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Figure 6.2.11 – Megalin and E-cadherin expression of tauGFP E9.5 cells after an 
8-day culture in organotypic reaggregates 
A – shows tauGFP+ cells localised into a renal tubules, which express both E-
Cadherin and Megalin (arrows); the tubule with three arrows pointing at it 
expresses high levels of E-cadherin and seems to express low levels of Megalin; 
the tubule with one arrow pointing at it expresses high levels of Megalin and a very 
low level of E-cadherin 
B and C – show the tauGFP and Megalin channels separately 
D – is a merge, of all channels and also shows DAPI nuclear staining 
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Figure 6.2.12 – Six2 expression of E9.5 tauGFP cells after a 6-day culture in 
reaggregated organotypic rudiments 
A, B, C and D show two consecutive confocal sections of reaggregated pellets containing 
E9.5 cells, which have been stained for Pax2 (red) WT1(blue) and DAPI (in B and D, 
cyan); in A (and B), a white block arrow points at a cell, which seems to be tauGFP+ 
Pax2+ and WT1+; in C, the arrow points at the same cell at a distance of 2μm on the z-
axis, which is now clearly negative for GFP; 
E and F – show tauGFP+ Six+ positive cells in the condensing mesenchyme 
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6.3 Summary and Discussion 
 
The aim of this chapter was to examine the ability of cells from early embryos to 
generate renal cells and structures in vitro and, by working backwards in 
development, identify when this ability stops with the decrease of the age of samples. 
This was done first to understand to what stage embryonic stem cells should be 
taken, in order for them to become competent to generate renal cells; and second, to 
contribute to the understanding of how and when the acquisition of renocompetence 
happens in development. To accomplish this, two independent experimental methods 
were used. The first method consisted of the disaggregation and reaggregation of 
E11.5 mouse kidney rudiments to provide a convenient way of mixing test cells into 
a reassembled growing rudiment capable of UB extension and branching, and 
nephron production. The populations of cells tested in that case were traced by 
genetic labelling with GFP (as previously described in this thesis). This approach 
tested cells’ ability to integrate into the structure of UBs and nephrons and their 
ability to produce kidney cells, according to the criteria described in Chapter 4. The 
second independent method was ordinary organ culture. It examined the ability of 
whole pieces of tissue isolated from various embryo stages, to give rise to structures 
resembling the structures normally produced by an early stage of a developing 
kidney rudiment – nephrons and UB structures. Although with this method we could 
expect some structure formation, the resulting structures would not be expected to 
have the intricate morphology of renal epithelia found in vivo or produced in the 
organ culture system, due to the possible lack of many molecules necessary for their 
development. 
 
Experiments with labelled cells showed that cells isolated from the caudal parts of 
E8.5 embryos were already able to give rise to renal tubular cells, although their 
number relative to control E11.5 experiments was extremely low. E8.5 was the 
earliest stage tested, which gave a conclusive result. The same result was obtained by 
organ culture experiments, which showed the formation of a very rudimentary 
Calbindin+ and Laminin-bound tubule, connected to another Laminin-bound tubule. 
It should be noted that although the presence of a tubular structure with a basement 
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membrane, expressing Calbindin strongly suggested that the structure observed was a 
UB or its precursor, the nephric duct, the same was not true for Laminin-bound 
Calbindin-negative structures with regard to being a nephron. With respect to the 
formation of UB-like structures, although the nephric duct cannot be considered 
equivalent to the UB due to its different temporal developmental origin and lack of 
branches, it has been shown competent to produce ureteric buds in vitro in the right 
conditions (Sainio et al., 1997). Therefore, for the purposes of this chapter, no 
attempt was made to examine whether these structures were Calbindin+ Laminin+ 
ureteric bud fragments or nephric duct fragments. On the other hand, unlike UB-like 
structures, nephrons were identified by the expression of one rather than two markers 
(Laminin), general morphology and morphology with respect to neighbouring 
Calbindin+ structures. Although in the kidney that provides sufficient evidence for 
recognising a nephron, the same is not true in the developing embryo, where other 
Laminin-bound ducts exist. Although of a number of molecular markers available 
Calbindin was the best marker for UB cells, as it is the only one present only in this 
renal compartment, it has also shown some limitations for distinguishing between 
UB structures and nephrons. Observations made in Chapter 1 identified that some 
UB cells downregulate Calbindin expression after CellTracker treatment due to an 
unknown reason. Also, experiments with disaggregated mesonephroi showed that 
Calbindin expression in some nephric duct fragments can be downregulated after 
reaggregation, while other markers were expressed as appropriate (Supplementary 
Figure 5). Therefore, it could not be excluded that the Calbindin- Laminin+ 
structures detected in ordinary cultures might not be nephrons, but possibly UB 
fragments, which have downregulated Calbindin. Another factor that could have an 
impact on the interpretation of reaggregates with labelled E8.5 cells is the potential 
presence of fusion events. Experiments with transplanted bone marrow-derived cells 
have shown that fusion of host and grafted cells is possible and could occur in 
various experimental conditions (reviewed by Alison et al., 2004). For example, 
grafted bone marrow cells were seen fused with host hepatocytes (Vassilopoulos et 
al., 2003; Wang et al., 2003), cardiomyocytes (Alvarez-Dolado et al., 2003) and 
Purkinje neurons (Weimann et al., 2003; Alvarez-Dolado et al., 2003). Although, cell 
fusion could potentially be present in any of the cell mixing experiments, it should be 
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noted that the possibility of such events occurring in organotypic cultures containing 
E8.5 cell mixes could have a more significant impact on results due to the low 
numbers of integrating cells. For example, if some cell fusion occurred in the 
reaggregates, such events would comprise a low percentage of integrating E11.5 or 
E10.5 cells (as almost all of these integrate), but could be responsible for a 
significant proportion (up to a 100%) of integrating E8.5 cells. Although no evidence 
for cell fusion and formation of heterokaryons was seen on the basis of fluorescence 
microscopy, no experiments were particularly performed to examine this possibility 
in detail in the reaggregation system. Furthermore, the integration of test cells in 
renal epithelia was carefully examined by confocal microscopy in three dimensions 
and the morphology of integrated cells was taken into account. Such an approach 
makes it less likely to leave fused cells unnoticed.  
 
Tissues from E7.5 embryos were also mixed in the reaggregation system. 
Unfortunately, the analysis of these could not be completed, due to an abnormal 
development of the nephrons and UB structures. The reason for these abnormalities 
was most probably signals released from the early embryo cells. This comes from the 
fact that in early embryo development, a lot of signalling pathways are active to steer 
embryogenesis and that it is very likely that some of these could interfere with 
nephron and UB structure formation. For example, Wnts, FGF and retinoic acid and 
their production in the correct regions are essential for the correct patterning of the 
early embryo (Villanueva et al., 2002). Although tissue culture experiments 
suggested that renal primordia can be formed even at that very early developmental 
stage, due to the reasons described in the previous paragraph, with the screening 
tools available both independent methods used were inconclusive for this embryonic 
stage.  
 
On the basis of this data, E8.5 of mouse embryonic development was concluded to 
be the earliest stage that contained renocompetent cells. At the same time, in the light 
of the experiments performed with E7.5 embryos, it could not be excluded that even 
earlier cells could also posses this ability. A conclusive assessment of this and earlier 
stages will require the development of a different assay for analysis, due to the 
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adverse influence of very early embryo cells on reaggregated embryonic kidney 
cultures and the limitations for analysis of ordinary tissue culture.  
 
It has previously been mentioned that there is a lot of disagreement in the literature 
about the timing of intermediate mesoderm specification (Figures 6.1.3). This made 
it difficult to identify whether at E8.5 the intermediate mesoderm is already specified 
or whether the prospective intermediate mesodermal cells have not progressed to that 
stage, yet. This would mean that at E8.5, the earliest lineage that will give rise to the 
kidney has reached the stage of being mesoderm or intermediate mesoderm. 
According to Kaufman (2001) the intermediate mesoderm gets specified around E9.0 
of mouse embryonic development. This would suggest that at E8.5, mesodermal cells 
have not yet become allocated to being intermediate mesoderm. On the other hand, 
So and Daniellian (1999) have seen Osr1 transcripts at E8.5 (and possibly earlier) 
suggesting that the intermediate mesoderm might have already been specified. The 
information in the literature therefore does not allow making a conclusive statement 
about what developmental stage the cells that will give rise to kidney have reached at 
E8.5. Experiments will have to be performed to characterise the timing of 
intermediate mesoderm formation before this can be resolved. In such studies 
embryos ranging from having 5 to 25 somite pairs could be studied for the formation 
of intermediate mesoderm. This could be first examined by bright-field microscopy 
to detect when a distinct region of cells is specified between the lateral and paraxial 
mesoderm. Furthermore, the onset of expression of a number of genes in the 
prospective intermediate mesoderm could be studied and linked to the number of 
somites present at the respective stages. Genes helpful to clarify this process could be 
Osr1, Lim1, Pax2, Pax8, all of which have been found important for the specification 
of the nephrogenic field (Chapter 1). Also, it should be taken into account that the 
timing of intermediate mesoderm specification most likely differs between the 
anterior and posterior parts of the embryo. Using this information to construct a 
temporal map of intermediate mesoderm specification along the antero-posterior axis 
would greatly help for future studies of the renogenic potential of early embryo cells. 
With regard to defining the stage at which cells acquire renocompetence in early 
embryo development in particular, it was safer to accept that the intermediate 
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mesoderm is already specified at E8.5. The results presented in this chapter therefore 
suggest that the cells of the intermediate mesoderm already possess the competence 
to give rise to renal cells in the conditions tested. Furthermore, this is also supported 
by studies with cells from the presumptive metanephrogenic regions of E9.5 
embryos, which were also able to integrate into renal epithelia. At this stage no 
metanephric blastema is yet formed. For E9.5 cells, marker expression studies have 
revealed that integrating cells are also able to express the markers normally seen 
during normal kidney development. Markers were expressed as appropriate for all 
renal compartments. Calbindin and E-cadherin - expressing cells were found in 
ureteric buds, Megalin and E-cadherin (low) - positive cells were found in nephrons, 
WT1 (high) cells were seen in glomeruli, and Pax2 or WT1 (low)-positive cells were 
seen in the condensing mesenchyme. These results strongly suggest that the full 
nephrogenic capacity of cells is acquired earlier in embryo development than 
previously thought. Although no metanephric blastema is seen at E9.5, it seems like 
the cells in the intermediate mesoderm at this stage, which are directly adjacent to the 
WD at the nephrogenic ridge are already capable of producing the kidney lineages 
detectable in the corresponding stages of normal kidney development. Still, it should 
be taken into account that the age of acquisition of full renogenic capacity might be 
underestimated in these studies, due to the variation in the development of the 
embryos used in the study. 
 
Further experiments described in this chapter have already reported that mesonephric 
cells were also able to integrate into the renal structures produced in reaggregated 
metanephric organotypic cultures. These experiments were performed to understand 
whether it was possible for integrating cells to come from the transient kidneys 
present in development and this possibility was confirmed. This being said, I would 
also like to discuss this possibility with respect to the tissues that have been isolated 
for mixing in the reaggregation system (summarised in Figure 6.2.1). As implied by 
the schematic, for the stages E11.5 and E10.5, only metanephrogenic tissues were 
mixed – either E11.5 metanephric kidney rudiments or E10.5 metanephric anlagen 
with the neighbouring WD). E9.5 is more unclear, although, as indicated the tissues 
explanted for disaggregation and reaggregation were situated much more posteriorly 
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than the presumptive zone of mesonephric formation (this can be compared to 
images of Pax2 and Pax8 staining in the mesonephros of 19-somite stage embryos 
equivalent to E9.0 (Supplementary Figure 6, from Bouchard et al., 2002). The E9.5 
explants were also likely to contain parts of the paraxial mesoderm and surface 
ectoderm. The literature suggests that the pro- and mesonephrogenic anlagen at E8.5 
were also rostral to the isolated tissue and should not have been included in the 
organotypic reaggregates (Bouchard et al., 2002). Although, more precise methods 
might be needed to study the development of the three embryonic kidneys with 
respect to particular markers, the current information hereby presented implies that a 
contribution from the pro/mesonephros in reaggregates containing E9.5 tissues is 
unlikely. This could be resolved experimentally by checking whether integrating 
cells are positive for markers expressed only in the mesonephros, but not in the 
metanephros, or whether they are negative for markers, which are present only in the 
metanephros, but not in the mesonephros. Suitable genes could be the Hox11 
paralogs, for example, which have been reported to be present only in the 
metanephros, but not mesonephros (Mugford et al., 2008). 
 
Also, the quantification of the ability of cells from different embryonic stages to 
integrate in UBs and nephrons also provided interesting observations. First of all, it 
should be noted that this method of quantification does not correct for the different 
proportions of UB versus nephrogenic cells that might be present at various stages of 
development. For example, the number of cells capable of producing nephrons and 
UBs could be equal at E11.5, but twice as many MM cells could be present at E10.5 
when the UB is just starting to form. The change of the proportions of integrating 
cells with the stepwise decrease in age of embryonic tissues used has been shown in 
Figure 6.2.7.We can observe that the stepwise decrease of the age of embryonic 
tissues is accompanied by a steady and significant for all stages decrease in 
integrating UB cells (as compared to the previous stage). Interestingly, the onset of 
the capacity of embryonic cells to produce UB structures determined by these 
experiments (E8.5) coincided with the reported stage of formation of the Wolffian 
duct (Figure 6.1.3). These observations differed from the ones made for nephrons. 
The drop in the relative number of cells integrating in nephrons per unit area between 
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E11.5 and E10.5 was not significant indicating that metanephric mesenchymal cells 
had the same renogenic capacity at both stages. This is consistent with previous 
reports that once formed at around E10.5 the metanephric blastema possesses a full 
nephrogenic capacity (Sariola et al., 2003). On the contrary, a significant drop in 
renogenic capacity was observed from E10.5 to E9.5, which is consistent with the 
previously reported times of induction of MM cells (Figure 6.2.3). Still, the 
experiments described in this chapter have presented evidence that early embryo 
cells still possess renogenic capacity, which diminishes with the stepwise decrease of 
the age of embryos used for the studies. As discussed in detail in the introduction 
section of the chapter, presented this way, the data reflects the chronology of 
experiments, which is a backward to normal development. This means that when 
regarded forward to reflect normal development, the renogenic potential of early 
embryo cells starts with the intermediate mesoderm and increases with the 
progression of embryo development. However, when examining quantitative data, it 
should be taken into account that there is one limitation to using them to evaluate the 
proportion of cells in the isolated tissues, which are able to contribute to renal 
epithelia. As previously demonstrated, quantification works accurately when it is 
known that near a 100% of the cells used in the experiment have the ability to 
contribute to renal epithelia. This is the case when E11.5 embryonic kidney 
rudiments are used. The situation is similar for tissues isolated from E10.5 embryos 
are used. Let’s say that these experiments measure the probability of one cell to 
become a kidney cell. When all cells are committed, the probability of them 
becoming kidney cells is 1. At earlier stages, however, due to the limitations of the 
dissections, there are cells present in the tissue isolate, which are not capable of 
producing kidney cells, for example, as they are endodermal or ectodermal 
derivatives (Figure 6.3.1). In these cases, quantification studies are not directly 
comparable to E11.5 and E10.5 as the measurement also includes the bias of these 
cells that do not have the ability to become renal (Figure 6.3.1, B). For example, if 
three cells are isolated from an E9.5 embryo, let’s say that 1 of the cell has a 
renogenic ability, and 2 cells belong to endoderm and ectoderm and have other fates.  
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The ideal measurement would be to check whether the 1 cell can form kidney cells 
without any further instruction when placed in the reaggregation system and exclude 
from the measurement the two cells that cannot (Figure 6.3.1, C). As currently 
designed, the quantification measures the ability of all three cells to produce kidney 
cells, which introduces a bias, as the two cells are not fated to produce renal cells (as 
illustrated by Figure 6.3.1, B). This bias could be corrected for by experiments, 
which would determine the frequency of cells used for each experiment that are of 
the correct lineage. For example, a correcting coefficient could be obtained by 
isolating the regions used for mixing experiments, staining them for an intermediate 
mesodermal marker, such as Osr1, and quantifying what percentage of cells from the 
whole population are Osr1-positive. A similar approach would be to use a transgenic 
mouse, which has a reporter gene inserted under the regulation of the Osr1 promoter 
and sorting the cells dissected from regions of interest at each step, which would 
them allow their direct mixing in the disaggregation-reaggregation system. 
 
On a more general level, it would be interesting to explore whether cells of the 
posterior intermediate mesoderm present at E9.5 are already committed to generating 
only kidney cells or whether they have the ability to produce other cell lineages, as 
well. This would be a second step, which would help us understand the timing and 
the segregation of different tissue types, and help identify the molecules, which 
might be involved in the lineage choice of a renal fate.  
 
It is also important to discuss the impact of the results presented in this chapter with 
regard to ES cell biology as the second aspect of this study was to investigate the 
acquisition of renogenic capacity of differentiating embryonic stem cells. I have 
determined that in development, cells resident in the intermediate mesoderm of E9.5 
embryos are capable of independently giving rise to kidney cells when placed in the 
reaggregation system. As currently presented, these data suggest that it should be 
sufficient to induce ESCs to intermediate mesodermal cells to make them capable of 
producing renal cells (Figure 6.3.2). A way of testing this would be to generate ESC 
reporter cell lines for intermediate mesodermal markers. These cells can then be 
differentiated by various methods, sorted for the intermediate mesodermal marker  
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Figure 6.3.2 - Differentiation of ESC to intermediate mesoderm should be sufficient for 
induction of a renal program in the reaggregation system 
Experiments with early embryos have suggested that cells from the intermediate mesoderm 
are able to produce kidney cells when integrated in the kidney rudiment disaggregation-
reaggregation system. This suggests that the differentiation of ESC to the correct type of 
intermediate mesoderm is sufficient for their acquisition of renocompetence in the 
environment of a developing kidney rudiment. 
Figure 6.3.1 -The presence of cells allocated to non-kidney lineages creates a bias in 
quantitative assessment 
Tissues isolated from embryos are a mixture of cells, which (1) are destined for non-kidney 
fates in the embryo and (2) will become kidney cells with the progression of embryonic 
development (A, B). To determine whether cells from the correct lineage (e.g, intermediate 
mesoderm) can generate kidney cells independently in vitro, the ideal measurement would 
exclude cells, which have other fates (e.g. ectoderm), as shown in C. In the experiments 
performed, however, the limitation of the dissection creates a bias by including a mixed 
population of cells, as shown in B. 
p - probability of generating a kidney cell 
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and mixed in the disaggregation-reaggregation system to check whether they 
integrate in renal tubules and express kidney markers after integration. Although, this 
seems as a straightforward experimental plan, many issues would have to be resolved 
before such experiments can be undertaken. First, this strategy does not resolve the 
lack of an efficient method for cell differentiation to intermediate mesoderm. Second, 
the selection of marker for generation of the transgenic ESC line would be a key step 
of the experimental planning. Similarly to the lack of a single marker for renal cells, 
there is no single marker for intermediate mesodermal cells. Foxc1 and Foxc2, for 
example are expressed in the prospective intermediate mesoderm, but also in the 
prospective paraxial mesoderm, which gives rise to the somites (Wilm et al., 2004; 
Sasaki and Hogan, 1993). If cells are sorted for Foxc1/Foxc2 expression in ESC 
differentiation experiments, this would not necessarily mean that intermediate 
mesodermal cells are obtained. If only paraxial, rather than intermediate mesodermal 
Foxc1+ or Foxc2+ cells are obtained, no integration will be observed in the 
reaggregation system. However, this will not be due to an inability of IM cells to 
generate renal cells, but to the absence of renogenic cells in the isolate in the first 
place. Other markers expressed in the mesoderm, pose similar problems. Other 
candidates that could be considered are Osr1, Lim1, Lhx1, Pax2 and Pax8 (James et 
al., 2006; Fujii et al., 1994; Cirio et al., 2011; Bouchard et al., 2002). To solve this, a 
combination of two markers could be used and cells sorted two times. This, however, 
poses another challenge for further marker expression studies, as the number of 
channels that can be imaged simultaneously is limited, so this will also have to be 
taken into account.  Furthermore, the IM might contain different cell populations, all 
of which express the selected markers, but segregate on the basis of the expression of 
other, also possibly unknown markers. This could potentially also create a bias in the 
results.  
 
Cell mixing experiments performed in this chapter identified that cells from the 
intermediate mesoderm have already acquired competence and are able to produce 
the main types of kidney cells, as shown by marker expression studies. This finding 
also suggests that ESCs would have to become intermediate mesoderm first, in order 
to become renocompetent. In addition to experiments with intermediate mesoderm, 
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in future studies, obtaining results for the renogenic capacity of E7.5 would be 
important in assessing whether the mesoderm shortly after gastrulation would also be 











In previous chapters, the acquisition of renocompetence was addressed from several 
different angles. First, a quantitative system for assessing the renogenic potential of 
cells on the basis of a combination of marker expression and the functional ability of 
cells to integrate into renal tubules was devised. Second, it was determined that the 
microenvironment of a developing kidney rudiment is not sufficient for priming 
ESCs to become kidney cells. Third, it was determined that although inhibition of 
Notch signalling seems to increase the proportion of mesodermal at the expense of 
ectodermal cells in ESC differentiation culture, it was not a good approach for 
generating ESC-derived renal cells in vitro in the conditions tested. Finally, 
experiments with early embryo cells provided evidence that cells found in the 
intermediate mesoderm (and possibly even in the mesoderm before intermediate 
mesoderm formation) are already able to give rise to kidney cells in vitro, when 
explanted from the developing embryo. These results have been summarised and 
discussed in chapter discussions. The purpose of this last chapter is therefore not to 
repeat previous material, but rather to build on these results and comments to assess 
their impact on future directions for embryonic stem cell differentiation to renal cells, 
kidney development and regenerative medicine and also to assess the limitations of 
this thesis. The chapter will be concluded by a final short summary of the results 
obtained during this work. 
 
7.1 Derivation of renal cells from ES cells in vitro 
7.1.1 Kidney cells and artefacts 
This thesis made use of two very different approaches to studying the acquisition of 
renocompetence. The first approach was to use embryonic stem cells and 
differentiate them to a renal lineage in vitro. When done successfully, this would 
allow further studies of what processes and changes take place in cells to instruct 
pluripotent cells to become renal in the cell culture dish. It would also allow for an 
extremely convenient tool to model disease or to modify particular properties of 
these cells and investigate the outcomes of these modifications. For these purposes 
two approaches have been tested for their ability to produce renal cells entirely in 
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vitro - undifferentiated ESCs or ESCs treated with a Notch inhibitor have been 
placed in the environment of a developing kidney to test whether they will give rise 
to kidney cells in these conditions. Steenhard et al. (2005) had already suggested that 
exposing ESCs to the environment of a developing kidney was sufficient to produce 
renal cells outside the embryo. It was then surprising to find that although 
undifferentiated cells placed in disaggregated and then reaggregated E11.5 
embryonic kidney cells formed chimeric structures with renal epithelia, they did not 
express markers normally present in renal epithelia.  Interestingly, the formation of 
embryoid bodies and treatment with Notch inhibitor, which has been reported to 
favour the formation of mesoderm from ESCs (Nemir er al., 2005; Lowell et al., 
2006) did not improve the outcome. As a matter of fact far fewer “test” cells seemed 
to persist in the reaggregates after culture and almost no cells even forming contacts 
with renal epithelia were seen. This was also surprising as other sources in the 
literature suggested that EB formation, even without treatment, induces a 
spontaneous program of ESC differentiation to renal cells. At the same time, several 
very important observations were made, which suggested that unusual artefacts 
might be observed when labelled cells are placed in the environment of a developing 
kidney rudiment. First, marker expression studies presented in Chapter 4 showed that 
cells appearing positive for certain renal markers are actually intercalating host 
kidney cells, which appear to be positive for the tracer, but are not when looked at in 
three dimensions. A number of staining artefacts, which generate staining in the 
wrong cellular compartment or generate staining in all fluorescence channels have 
also been detected. Second, experiments with CellTracker - stained amniotic fluid 
stem cells (AFSCs) have suggested that labelling reagents might be transferred 
between cells and being accumulated in nephrons (Supplementary Figure 4). These 
experiments were based on mixing human CellTracker Green - stained AFSCs with 
E11.5 embryonic kidney cells. This resulted in green nephrons being detected by 
confocal microscopy suggesting that AFSCs were able to generate nephrons in the 
reaggregation system. As an independent confirmation of these results, an old 
method was used, which allowed to distinguish between mouse and human cells on 
the basis of nuclear morphology (Moser et al., 1975). Moser et al. (1975) have shown 
that when stained with DNA-binding compounds mouse nuclei are small, bright and 
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have chromocentres (dots of high fluorescence intensity), while human ones are 
large, faint and lack chromocentres. These results have been experimentally 
confirmed by mixing human ESCs with mouse E11.5 kidney cells (Supplementary 
Figure 4). Comparisons of images of CellTracker - labelled AFSCs and GFP-labelled 
hESCs suggested that the green cells seen in AFSC experiments might not be human. 
But also, we should ask how it is possible for considerable levels of a label to 
artefactually accumulate in a nephron, in the first place. We could imagine that cells 
taken away from the environment their favour (for example the cell culture dish) and 
placed in an adverse for them environment (potentially an embryonic kidney) might 
die. This will release labelled cell fragments or the soluble, activated (cleaved by 
intracellular enzymes) CellTracker label in the interstitium. But at the same time, we 
know that even early nephrons possess some filtrational capabilities as illustrated by 
their expression of the endocytotic receptor megalin, for example (reviewed by 
Fisher and Howie, 2006). It is then possible that they filter the low concentrations of 
released by dead cells dye and progressively accumulate it into their cells. If these 
results are independently confirmed by other methods, this would suggest that 
introducing labelled cells into developing kidney rudiments might pose a problem 
more serious than previously thought.  
 
7.1.2 ESCs – loss of differentiation potential? 
But also, the limitations of the experiments presented in this thesis should also be 
noted. First, for the detailed marker expression studies of undifferentiated ESCs 
mixed in the reaggregation system only one ESC line was used due to the 
unavailability of an independent genetically labelled cell line.  Performing 
characterisation of possible karyotypic abnormalities could have revealed genetic 
changes, which could have interfered with the ability of these cells to generate renal 
cells. There is a phenomenon, in which pluripotent cells lose their ability to 
differentiate, but retain their ability to self-renew indefinitely. A very radical 
example of cells, which have lost their ability to differentiate is the nullipotent 
embryonal carcinoma cell line 2102Ep (Duran et al., 2001)  
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7.1.3 Do alternative differentiation programs exist? 
It will also be interesting to re-examine the results obtained from mixing 
undifferentiated ESCs in the reaggregation system from a different perspective. 
Confocal microscopy has revealed that ESC-derived structures express E-cadherin, 
but not Pax2, Wt1 and Calbindin. At the same time, the cells formed tubular-like 
structures, some of which appeared to have a lumen. It would therefore be interesting 
to ask whether these tubules could be functional renal epithelia even though they 
didn’t express markers normally present in kidney development. Analysis of the 
expression of proteins, which are markers of later stages of nephron formation might 
be a suitable way for addressing this. No markers of more mature renal tubules, such 
as Aquaporin2, KSP-Cadherin and Tamm-Horsfall protein (Takata et al., 2008; Shao 
et al., 2002; Sikri et al., 1981) have been addressed in this thesis, as their expression 
hasn’t yet been characterised in particularly reaggregated kidney rudiments. I would 
suggest that this latter option is not likely, as the tubular-like structures produced by 
ESCs in reaggregates had a rather disorganised appearance and looked 
phenotypically different in size and shape from host embryonic kidney cells. A more 
likely option, however, is that ESCs might need more time in the organotypic 
culture. If ESCs are considered as developmentally equivalent to ICM cells, then the 
gap between the ICM and the metanephric mesenchyme is more than 5 days of 
development. To address this problem, reaggregated from embryonic kidney cells 
pellets containing undifferentiated ESCs could be transplanted under the kidney 
capsule of adult mice to allow for a long-term culture and re-evaluation of the results 
with this improved approach. This is not possible in vitro culture, as observations 
have shown that rudiments start to degenerate after 10 days in culture. Also, 
undifferentiated cells could have been prevented from differentiating in reaggregated 
pellets by signals secreted by embryonic kidney cells. Evidence was presented in 
Chapter 4 that expression of Oct4 in at least some ES or ESC-derived cells persists 
for at least 6 days of culture. Barasch et al. (1999) have reported that LIF is a key 
regulator of MET in the developing rat kidney. Although the mechanism seems to be 
different in the mouse (reviewed by Sariola, 2002) the possibility that embryonic 
kidney cells produce LIF could explain why tauGFP ESCs persisted after mixing 
with embryonic kidney cells in the reaggregation system. This comes from the fact 
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that LIF/LIFR/gp130 are major players in embryonic stem cell self-renewal (Niwa et 
al., 1998). 
 
7.1.4 Cell differentiation is not a stochastic process 
ES cell differentiation experiments performed in this thesis allowed making 
observations about the mechanisms by which these cells generate derivatives of one 
of the germ layers. It could be hypothesised that there were an equal probability for a 
cell to become mesoderm, endoderm or ectoderm (p= 1/3). Let’s say that once 
committed to mesoderm, cells can become chordamesoderm, paraxial mesoderm, 
lateral plate mesoderm or intermediate mesoderm, which has a probability of 1/4, 
whilst the intermediate mesoderm can give rise to kidneys and gonads (p=1/2). In 
that case, the overall probability of an ES cell becoming a kidney cell would be: 
 
1/3 x 1/4 x 1/2 = 1/24. 
 
Therefore, if differentiation happened stochastically, 1/24th of all ESCs used in 
experiments should have generated kidney cells. Both of the ESC differentiation 
strategies tested, mixing untreated ESCs with embryonic kidney cells in reaggregates 
and pre-treatment of ESCs with γ-secretase inhibitor, did not generate any cells that 
could be identified as renal. This suggests that the production of kidney cells from 
ES cells is not a stochastic event. Rather, this implies that an active process (a series 
of controlled inductive events) is required for the generation of renal tissue. This also 
raises interesting questions about which tissues or types of cells can be a result of 
spontaneous differentiation and what are the barriers for all types of cells occurring 
spontaneously in ESC differentiation. 
 
7.1.5 A very complex differentiation strategy might be necessary for the in vitro 
generation of renal cells 
However, the simple explanation for the unsuccessful differentiation of ESCs both 
when mixed with kidney cells undifferentiated or after being cultured as embryoid 
bodies and treated with Notch inhibitor, is that they did not receive the signals to 
induce them acquire renocompetence in vitro. Although, no benefit was seen by the 
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Figure 7.1 - A schematic of an efficient multi-step differentiation strategy for generating 
dorsal neurons from embryonic stem cells; Murashov et al. (2005) 
treatment of differentiating cells with the γ-secretase inhibitor DAPT in the condition 
tested, modifications of this differentiation strategy could yield a significantly better 
result. Directed differentiation often requires much more complex multi-step 
protocols. There are a lot of factors, which can contribute to the differentiation of 
stem cells - the basal growth medium, the presence or absence of serum, the levels of 
oxygen, the combination of external signals provided in the medium, the 
concentration of these signals, the possibility for adhesion to a substrate, the type of 
substrate and the chronology of applying all these different manipulations. To 
illustrate the complexity of a successful ES cell differentiation processes, a schematic 
for the generation of dorsal interneurons has been shown in Figure 7.1 (from 
Murashov et al., 2005). Murashov et al. (2005) tested 6 different conditions each of 
which included the consecutive application of at least 4 different types of media. At 
the same time, this strategy was combined with formation of EBs, plating the formed 
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EBs, their disaggregation and replating on polyornithine – coated glass slides, all in a 
defined temporal sequence. For the differentiation of ES cells to kidney cells, 
protocols with a similar complexity may be required to either recapitulate the 
molecular signals present in in vivo embryonic development, or to find alternative 
combinations of molecules and treatments, which generate kidney cells efficiently. 
 
It seems like the generation of renal cells is much more difficult than generating 
other cells types. One of the reasons for this might be the fact that from a 
developmental point of view, the kidney is a very late organ. In other words, kidney 
cells get specified much later in embryo development than other cell types. For 
example, the metanephros starts to form at about E10.5, when a metanephric 
blastema is visible and the ureteric bud is recognisable only as an enlargement of the 
Wolffian duct. At that point in embryonic development, most organs and systems 
have already formed or have started forming. For example, the following structures 
can be seen - forebrain, midbrain, hindbrain, spinal cord, notochord, lens vesicle, 
olfactory pits, primitive gut, maxillary and mandibular components of the first 
branchial arch, fore- and hindlimb buds, elongated tail, a primitive heart showing 
processes of septation, thyroid primordium with evidence of canalisation, lung buds 
and primitive liver (Kaufman, 2001). It is well known that embryonic stem cells 
easily generate certain cell types even by spontaneous differentiation - for example, 
cells of the nervous system and beating cardiomyocytes (Brüstle et al., 1997 and van 
Laake et al, 2007). This is also consistent with their developmental counterparts, the 
brain and heart, arising much earlier than the metanephros. Late organs such as the 
metanephros might need an intricate sequence of signals, which due to its complexity 
might be extremely difficult to identify and reproduce in vitro. Although not all 
processes taking part in the in vivo induction of intermediate mesoderm have been 
elucidated, evidence from the literature provides information indicative of such a 
complexity. For example, it has been reported that signals from the surface ectoderm 
are essential for nephric duct formation in the chick (Obara-Ishihara, 1999). The 
authors hypothesised that the surface ectoderm might secrete factors that directly 
support nephric duct progenitor differentiation or that it could be responsible for the 
regulation of factors expressed in the lateral or paraxial mesoderm, thus acting 
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indirectly in the induction process. Furthermore, Obara-Ishihara (1999) have 
identified that the surface ectoderm regulates Bmp4 mRNA expression levels in 
lateral mesoderm and reported that the delivery of BMP4 in the culture medium 
rescues the initiation of the nephric duct. As this was determined by monitoring Pax2 
levels, it rather proves the importance of BMP4 for Pax2 induction, but does not 
exclude the possibility that other factors from the paraxial mesoderm might also be 
needed for the normal progression of early or later nephrogenesis. Similarly, Mauch 
et al. (2000) presented evidence that signals from the paraxial mesoderm are required 
for pronephros formation in the chick. All this evidence collectively demonstrated 
that neighbouring tissues exert a considerable influence on intermediate mesoderm 
for kidney specification. In addition, above, only the specification of intermediate 
mesoderm to renal components was discussed. It is very important to note that the 
specification of intermediate mesoderm itself is likely to require another set of 
signals. Not only is the expression of the right molecules needed, but it is needed at 
the right levels as embryo development is frequently patterned as a response to 
chemical gradients. James and Schultheiss (2005) conducted a very extensive study 
about the role of Bmp proteins on the specification of mesoderm after gastrulation in 
the chick. They discovered that when administered at early stages of development, 
Bmp2 was able to induce expression of intermediate mesodermal genes in regions, 
which normally get restricted to paraxial mesoderm. In in vitro experiments, they 
demonstrated that, surprisingly, low levels of Bmp were much more efficient in 
generating mesoderm than high levels, which emphasised on the importance of the 
concentration of signalling molecules. Also apart from positive regulation, inhibitory 
regulation is also necessary for specification of the intermediate mesoderm (Figure 
7.2) and therefore likely to be needed for ESC differentiation. Foxc1 and Foxc2 have 
been reported to balance paraxial and intermediate mesodermal fate (Wilm et al, 
2004). Mouse embryos lacking these genes exhibited expansion of the intermediate 
mesoderm into the paraxial domain. Similar results were obtained in chick embryos, 
where gain of function negatively regulated intermediate mesoderm formation, while 
Foxc1 and Foxc2 misexpression in the prospective intermediate mesoderm seemed to 
drive it to a more paraxial fate (Wilm et al, 2004). 
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Figure 7.2 - Model of the regulation of mesodermal gene expression by Bmp signalling 
(from Wilm et al., 2004) 
There is a low expression of Bmp signalling in the somites. Foxc1/2 and other paraxial 
transcription factors activate somite gene expression and and repress IM gene expression. 
Low levels of Bmp in the IM lead to a repression of somite genes, which “unlocks” the 
expression of IM genes. 
 
These examples describe the complexity of the processes governing intermediate 
mesoderm specification, some of which are still poorly understood. On the basis of 
the data presented in this thesis and the information about intermediate mesoderm 
and renal tissue specification, two important factors for designing an efficient 
strategy for differentiation of ES cells to renal cells have been identified. First, the 
mechanisms that govern development (and intermediate mesoderm development, in 
particular) have to be very well understood - the interplay between gene networks 
clarified, the regulatory functions of more genes uncovered and the role and levels of 
signals for correct patterning established. In this number, gene expression profiling 
patterns for the different germ layers and their subdivisions would be extremely 
useful, as this would allow the monitoring of cell differentiation and specification at 
smaller, more accurate increments (rather than the stages that are currently accepted 
as preceding the renal lineage - mesoderm and intermediate mesoderm). The second 
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step in the successful design of a protocol for directed differentiation to renal cells 
would be an efficient approach to monitor the changes of gene expression and 
functional abilities of the produced cells at different stages of the differentiation 
process, where the incremental changes from the developmental studies suggested 
above could be recognised. Also, the processes happening in differentiating EBs or 
monolayers in general have to be mapped with respect to all germ layers and their 
derivatives in various strictly defined conditions, as this would give more 
information about the pathways that are active at different time points in 
differentiation and allow hypothesising about the regulatory interplay that takes place 
between them. 
 
7.2 Contribution to embryo and kidney development 
7.2.1 Defining kidney progenitor cells in early embryos 
The “backwards” experiments performed as a part of this thesis have offered new 
insight on when renocompetence is acquired during embryo development. Similarly 
to ESCs, which produce kidney cells when injected into blastocysts but have more 
difficulty doing so in vitro, the fact that early embryo cells will eventually produce 
kidney cells in the embryo does not necessarily mean that they will be able to do so 
autonomously when explanted from the embryo. Studies in this thesis have shown 
that cells at the stage when the intermediate mesoderm is already specified are 
already able to become a part of renal tubules and express renal markers. The 
discovery that renocompetent cells are present in the intermediate mesoderm before 
the formation of a metanephric blastema raises many further interesting questions, 
the answers of which would lead to a much better understanding of how 
renocompetence is acquired. For example, a logical continuation of these 
experiments would be to use transgenic mice carrying reporters under the promoters 
of genes important for mesoderm and intermediate mesoderm formation. Such genes 
would be Brachyury, Eomes, Goosecoid, Osr1, Lim1, Lhx1 Pax2 and Pax8 
(Wilkinson et al., 1990; Ciruna and Rossant, 1999; Blum et al., 1992; James et al., 
2006; Fujii et al., 1994; Cirio et al., 2011; Bouchard et al., 2002). Nephrogenic 
regions could be dissected from E8.5 and E9.5 embryos, made into single-cell 
suspensions and sorted for marker expression. The sorted cells could then be mixed 
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in the reaggregation system to identify which populations of cells are renogenic. This 
approach has a significant advantage over using genetically modified ES cells for the 
same purposes. This is the fact that the definition of regions in embryo development 
helps explant only relevant regions and circumvent the problem of expression of 
these markers in other tissues. One example is Pax2, which is expressed in both the 
kidney and the brain (Dressler et al., 1990). Dissecting only the relevant region 
would allow examining only potentially renogenic, but not neurogenic Pax2+ cells.  
 
Cell sorting for different markers would also allow using the reaggregation system 
quantitatively to compare the integration efficiencies of embryo-derived cell 
populations. Such experiments might help identify which the early progenitor cells in 
early embryos are and what combinations of markers they express. Furthermore, 
double reporter mice can help identify these progenitors even more accurately.  
 
7.2.2 Are cells present in the mesoderm prior to intermediate mesoderm 
formation renocompetent? 
Some aspects of studying kidney development include understanding how kidney 
primordia form. Experiments with E8.5 embryos in which the mesoderm is specified 
but no intermediate mesoderm is yet present have also raised interesting questions 
about embryo development. Although, experiments with these embryos were 
inconclusive they also did not reject the possibility that E8.5 cells may also be 
competent to give rise to kidney cells in the reaggregation system. If future 
experiments manage to resolve this, a lot of insight could be gained about the 
allocation of prospective renal cells in gastrulating embryos. Different regions of 
mesoderm could be dissected from gastrulas or sorted cells used to test different 
populations in the reaggregation system. This would allow mapping the location of 
the renogenic progenitors normally present in embryo development. It would also 
allow examining embryos at different stages of gastrulation to investigate whether 
renogenic cells might arise with the formation of posterior mesoderm only, or 
whether anterior mesoderm can also generate kidney cells. The possibility for cells 
from the mesoderm to give rise to metanephric cells would provide interesting 
insight about the acquisition of renocompetence in early embryo development. The 
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metanephros comes from the posterior mesoderm and intermediate mesoderm. If 
anterior mesodermal cells had the ability to give rise to metanephric cells, this could 
suggest that many mesodermal cells might have a renogenic ability at different points 
in time. This would raise the question of whether all or most mesodermal cells could 
be renogenic when provided with the right signals. For example, renogenic 
competence could be acquired and then lost in a wave from the anterior to the 
posterior until the correct signals become available to “stabilise” the persistence of 
these cells. The segmentation clock responsible for somite formation, for example, 
acts in an anterior-to-posterior manner, where anterior somites are formed first, 
followed by the formation of posterior somites with the progression of development 
(reviewed by Pourquie, 2003). Renocompetent cells could be specified in a similar 
antero-posterior fashion. Anterior cells might be competent to respond to the signals 
that would lead them to a renal fate, but might not receive the right nephrogenic 
signals, which could cause them to lose this renogenic potential. At the same time 
more caudal cells could acquire such a competence with the progression of 
development. Only more caudal signals (in the right combination and concentration) 
could then be able to induce the formation of the metanephros. Since the 
metanephros is formed on the same caudal plane as the hind limb buds, it might be 
interesting to investigate whether the signals responsible for hind limb bud 
development also instruct the formation of the metanephros. For example, FGF10 
specifies the area of limb formation and at the same time has a role in the early stages 
of kidney development (Ohuchi et al., 1997; Michos et al., 2010). Also, if the 
anterior intermediate mesoderm indeed contains renocompetent cells, it would be 
interesting to investigate whether these cells are related to the formation of the 
pronephros and mesonephros. This hypothesis could be tested by checking whether 
anterior renocompetent cells, destined to give rise to the pro- or mesonephros would 
be able to generate metanephric cells when transplanted to the metanephrogenic 
signals of embryos. The reverse experiment of transplanting early metanephric 
primordia to regions, which normally give rise to the pro- or mesonephros could 
provide still more insight on whether potential anterior and posterior renogenic cells 
actually have the same properties.  
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Figure 7.3 - Renal injury and prevention of progressive damage by structural support 
A - morphologic changes of proximal tubules after ischemia/reperfusion; loss of brush 
order, loss of polarity and redistribution of integrins and Na+/K+-ATPase; from Thadhani et 
al. (1996) 
B – tubular damage leads to a loss of tubular cells; exogenous cells (green) might provide 
structural support to renal epithelia preventing further damage; progressive degeneration 





7.3 Potential applications in regenerative medicine  
As covered more extensively in section 1.7 of Chapter 1, ESC-derived renal cells 
could be useful for many translational applications. A few examples are: using in 
vitro generated kidney cells to assess drug efficacy and renotoxicity; seeding ESC-
derived cells in medical devices to recapitulate the physiological function of kidneys 
more closely; or directly transplanting in vitro generated renal cells into patients to 
replace damaged or lost cells. Even though the experiments presented in this thesis 
could not show any usefulness of ES cells for any of these, they were important for 
identifying a novel approach to cell replacement therapies. The potential use of ESC-
derived cells directly in regenerative medicine could be to inject them in damaged 
kidneys to replace the cells that have been lost. This addresses the problem that when 
tubular cells are damaged they can no longer contribute to filtration until replaced by 
new cells to carry out this function. At the same time, there is another factor that 
leads to renal failure. Once tubular cells are damaged and start to be shed off, they 
leave gaps in the renal tubules, which if serious enough lead to the collapse of the 
whole nephron (Figure 7.3, Thadhani et al., 1996). The use of non-kidney cells could 
be, to fill in the gaps in damaged nephrons to offer structural support and protect 
renal tubules from further damage. So rather then restorative effect, this approach 
would offer renoprotection. In Chapter 4, I have demonstrated that Oct4+ cells and 
other non-kidney cells are able to form chimeric structures with renal epithelia. This 
provides the first proof-of principle that non-kidney cells could potentially be used as 
a “glue” to “patch up” damaged nephronal areas. Of course, a lot of experimental 
work is outstanding to accumulate further proof that this approach might be useful. 
First of all, in the experiments presented in this thesis, ES cells have been used to 
show that non-renal cells can form chimeric structures with renal epithelia. This still 
does not resolve the issue of safety of ESCs for regenerative therapies, as 
undifferentiated cells in cell transplants could lead to tumour formation. As 
previously discussed adhesion molecules are likely to be responsible for the 
formation of structures. Work with ES cells could be done to determine whether this 
is the case and identify, which are the molecules mediating chimeric structure 
formation and find other physiologically occurring, stem cell-derived or 
transgenically-generated cells with the respective properties. Experiments in this 
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thesis have shown that in chimeric structures both renal cells and ESC-derived cells 
express E-cadherin. Experiments with the disaggregation-reaggregation system could 
be used to check whether loss of E-cadherin in ES cells would prevent the formation 
of chimeric structures. This could be done by treating ESCs with siRNAs for E-
cadherin before mixing them with embryonic kidney cells. This could also be done 
by generating genetically modified ESCs containing floxed E-cadherin. 
Recombination can be induced by the application of cell-permeable Cre-recombinase 
(Jo et al., 2001; Patsch et al., 2011) before mixing with embryonic kidney cells and 
reaggregation. After the molecule(s) mediating the formation of chimeric structures 
has (have) been identified, experiments could be performed to identify cell types 
expressing this (these) molecule(s). Then the cells could be tested in the 
reaggregation system to confirm their ability to make kidney structures. Then these 
cells could be injected into the kidneys of mice with experimentally-induced kidney 
injury (for example by cisplatin administration or glycerol injection) to test the 
behaviour of the cells after transplantation. Although many challenges lie ahead of 
this approach, many of these challenges also apply to the use of ESC-derived cells. 
For example, issues about the delivery of the cells to the kidney are still an important 
problem for related cell replacement therapies. But if this method proves efficacious 
for blocking the progressiveness of renal injury, it might show even more advantages 
than ESC-derived cells. For example, an embryonic or even adult cell line with the 
derived properties could be established. This does not raise the ethical and safety 
concerns of using embryonic stem cells. Virtually, unlimited numbers of cells could 
be obtained and no expensive growth factors would be necessary (such as the ones 
that would have to be used for ESC differentiation). Also, the use of a cell line rather 
than generating new batches of cells de novo every time, would allow for the 
standardised use of the same cells every time. These initial, but important steps could 
be taken to investigate whether grafting cells for renoprotection of degenerating renal 




7.4 Limitations of this thesis 
Before the global impact of this thesis could be finally summarised the limitations of 
the studies in this work should also be acknowledged. Most of these have been 
addressed in chapter discussions and in the current chapter, as they had to be taken 
into account for the interpretation of the results. This section provides a summary of 
the issues that were not resolved by this thesis, but might have an impact on the 
conclusions made. 
 
Embryonic stem cell differentiation: 
- the use of only one cell line for ESC differentiation experiments (this cell line 
could have lost in particular some of its ability to generate kidney cells) 
- no karyotypic analysis was performed to confirm that the used ES cells were 
genetically stable 
- although the ability of ES cells to generate embryoid bodies and to give rise to 
derivatives of the three germ layers is routinely used to confirm the pluripotency 
of cells, this is not the most accurate method as cell lined might still be biased to 
forming particular lineages. A better method could be provided for by 
performing ES cell injections into blastocysts to generate chimeric mice, which 
could then be analysed for ES cell contribution in different organs. 
 
Developmental studies: 
- the difficulty of cell identification on the basis of marker expression profiles still 
remains 
- the presence of fusion events of host and test cells has not been addressed by 
specifically designed experiments 
- ideally, for an accurate quantification, in quantitative studies measuring the 
proportions of renogenic cells at different embryo stages the numbers of cells of 
the correct lineage present in tissue isolates would have to be determined 
- although tissue culture experiments provide a good independent check for 
reaggregation studies, there are serious limitations to using Calbindin and 
Laminin for structure identification 
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- although, all developmental studies suggested that some cells resident in the 
intermediate mesoderm present before the formation of a nephric duct or 
metanephric blastema are renocompetent, mesoderm before the formation of 
intermediate mesoderm could not be evaluated; a new approach would have to 
be designed to study this particular stage 
- although the time frame of acquisition of renocompetence in embryo 
development was defined, the time interval obtained is still very wide; 
experiments should be performed to narrow it down by correlating stages to the 
number of somites present rather than days of embryonic development  
- ways would have to be devised to isolate renocompetent renal progenitors to 
maintain and propagate them in in vitro cultures; this would allow studying their 
properties more closely 
 
7.5 Summary of the impact of this work 
In the beginning of this thesis, discussions on the potential impact of this work have 
identified that there are three interconnected areas, which will benefit from the work 
performed herein - kidney development, embryonic stem cell differentiation and 
traditional or regenerative medicine (Figure 1.6). After considering the results from 
this work, it is important to summarise the conclusions obtained in the context of 
each of these three different areas. 
 
With respect to stem cell biology, the experiments in this work have identified that: 
- undifferentiated embryonic stem cells are not capable of producing kidney cells 
when placed in the reaggregation-disaggregation system 
- inhibition of Notch signalling in the conditions tested does not improve the 
differentiation of ES cells to renal cells 
- ES cells might first have to be differentiated to intermediate mesodermal cells to 
be primed to acquire renocompetence before they can produce kidney cells 
autonomously, in in vitro systems 
 
With respect to developmental biology, experiments have suggested that: 
- renocompetence is acquired early in embryo development 
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- the intermediate mesoderm already contains renocompetent cells 
- the first renocompetent cells appear in the intermediate mesoderm at E8.5 of 
mouse development or earlier 
- intermediate mesodermal cells from the prospective metanephrogenic regions of 




 - both ESC and developmental studies have shown that non-kidney cells are able to 
become a part of renal tubules; this might open a whole new approach for 
regenerative medicine, where non-kidney cells could be integrated into damaged 
renal tubules for providing structural rather than functional support and therefore 
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Abstract
Here, we present a novel method for culturing kidneys in low volumes of medium that offers more organotypic
development compared to conventional methods. Organ culture is a powerful technique for studying renal development. It
recapitulates many aspects of early development very well, but the established techniques have some disadvantages: in
particular, they require relatively large volumes (1–3 mls) of culture medium, which can make high-throughput screens
expensive, they require porous (filter) substrates which are difficult to modify chemically, and the organs produced do not
achieve good cortico-medullary zonation. Here, we present a technique of growing kidney rudiments in very low volumes of
medium–around 85 microliters–using silicone chambers. In this system, kidneys grow directly on glass, grow larger than in
conventional culture and develop a clear anatomical cortico-medullary zonation with extended loops of Henle.
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Introduction
This paper describes a method for organ culture of developing
kidneys that improves on conventional methods in terms of both
economy and organotypic realism.
Organ culture of embryonic kidney rudiments has been
established for almost ninety years. The earliest methods
suspended renal rudiments in Carrell flasks in semi-solid media,
such as clotted owl plasma [1–6]. The clot system, which yielded
good though variable development, was replaced in the 1960s by a
simpler system in which kidney rudiments are grown on filters
supported on a metal grid at a gas-medium interface [7–9]. This is
the system generally used to this day, with the occasional variation
of using filter inserts designed for multiwell plates, still at a gas-
medium interface, in place of pieces of filter supported on steel
grids. The filter supports are used because culture in simple liquid
hanging drops, which works well for other organs such as salivary
glands, does not work well for kidneys and their development in
such systems is very poor.
Organ culture of kidney rudiments has been, and continues to
be, very valuable in the study of renal development [3;10–13]. The
system has been used to study the dynamics of normal
development by time-lapse photography, initially by brightfield
microscopy and more recently with fluorescent reporter proteins
[8;14]. It has been used to study the developmental functions of
specific molecules by experimental addition of exogenous growth
factors [15], function-blocking antibodies [16], vitamins [17],
oligosaccharides [18], drugs [19], antisense oligonucleotides [20]
and short interfering RNAs [21;22]. It has also been used to test
the cell autonomy of mutations by production of chimaeric
recombinant kidneys [23].
Useful as it is, the established culture system suffers from a
number of limitations. It requires volumes of media of the order of
millilitres, which limits its use in high-throughput screens that
require high concentrations of expensive reagents such as siRNAs,
and it requires supporting filters that are significantly harder to
modify with custom substrates than is glass. Also, while cultured
kidneys show good development of the branched collecting duct
system and of nephrons to the S-shaped stage and beyond,
including differentiation of specific regions such as proximal
tubule, distal tubule etc, they do not show development of a
distinct renal medulla into which Loops of Henle extend. In
conventional culture, the loops of Henle do not form [24] while in
culture systems that optimize the maturation of nephrons, such as
those using hyaluronic acid, loops of Henle form but are arranged
haphazardly rather than extending into the medulla [25].
In this paper, we describe a simple culture system that allows
kidney rudiments to be cultured directly on glass coverslips in just
85 ml of medium. The development of these kidneys is superior to
traditional methods when compared by any of the usual metrics
(overall size, nephron number and the extent of ureteric bud
branching) and they show correct cortico-medullary zonation. This
new technique therefore offers considerable advantages, of economy
and realism of development, over the established method.
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Materials and Methods
Organ culture
Organ rudiments were microdissected from E11.5 NMRI or
CD1 mouse embryos; they were pooled and assigned randomly to
control or experimental groups. For conventional culture, the
rudiments were placed on 5 mm pore-size polycarbonate filters at
the bottom of a well insert in a six well plate (Corning, Costar), or
on top of a stainless steel Trowell grid in a 3.5 cm culture dish in
kidney culture medium (KCM: Eagle’s minimal essential medium
with Earle’s salts and non-essential amino acids (GIBCO), 10%
foetal bovine serum (Biochrom/Biosera) and 1% penicillin/
streptomycin (Sigma)). For some experiments, 1 nM TGF-b
(Sigma T7039) or 100 ng/ml GDNF (Sigma G1777) were added.
Low-volume cultures used sterilized silicone rings (flexiPERM
Cone shape A, Greiner BioOne), on 22622 mm coverslips
(Menzel Gläser, Germany), cleaned in 5:1:1 H2O:H2O2:NH4OH
(10 min, 70uC), in tissue culture dishes (35610 mm, Sarstedt/
Greiner). Kidney rudiments were placed close to the middle of the
circle; medium carried over in this pipetting operation was
removed and replaced by the final KCM culture medium (70–
200 ml), the complete enclosed area of the coverslip being wetted.
The dish surrounding the silicone ring was filled with PBS
containing 1% penicillin/streptomycin). All cultures were
incubated at 5% CO2 at 37uC, medium being changed every 2
days.
For time lapse movies, cultures were placed in the incubation
chamber of a Zeiss Axiovert 200 microscope and images were
taken every 10 or 15 min. NIH ImageJ 1.37v. was used to create
time lapse movies. Phase contrast images of living cultures were
taken every 12 h using an Olympus IX50 microscope.
Fixation and immuno/lectin fluorescence
Kidney rudiments were fixed in methanol at 220uC, washed in
PBS 10 min, then incubated in primary antibody in PBS,
overnight at 4uC. Primary antibodies were anti-laminin (1:100
Sigma L9393), anti-calbindin D28k (1:100 Sigma C9848),), anti-
megalin (1:150, obtained from Thomas Wilnow), anti-human-
Wilms’ Tumour 1 (1:50, Dako M3561), anti-Pax-2 (1:100,
Covance PRB-276P) and anti-E-cadherin (1:100, BD Transduc-
tion Laboratories 610181). Samples were washed for at least
30 min in PBS then incubated with appropriate secondary
antibodies overnight at 4uC. The secondary antibodies used were:
anti-rabbit IgG - TRITC (1:100, Sigma T6778), anti-mouse IgG–
TRITC (1:100, Sigma T5393) and anti-mouse IgG - FITC (1:100,
Sigma F6257). For antibody/lectin co-stainings, all solutions
contained 1% milk powder in PBS and 10 ng/ml lectin from
Dolichos biflorus-FITC (Sigma L9142) was included with the
secondary antibody. Finally the samples were washed in PBS
and mounted on slides.
Cell proliferation and apoptosis detection assay
BrdU (5-bromo-2-deoxy-uridine) was added to the medium of
kidney rudiments in culture 4 hours before fixation to a final
concentration of 100 mM. Detection was performed as described
by [26] except that cell death detection master mix (In Situ Cell
Figure 1. Methods for embryonic kidney culture. (A) The low-volume culture method described in this paper, drawn from the side and
photographed from above. (B) Conventional, high volume culture either on a membrane on a Trowell grid (above) or on the membrane at the
bottom of a well insert (below). The blue in (A) depicts PBS, the red in all diagrams depicts culture medium, yellow in (A) symbolizes the silicone ring
and dark grey the embryonic kidney rudiments. The numbered divisions on the ruler are centimetres.
doi:10.1371/journal.pone.0010550.g001
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Death Detection Kit, TMR red, Roche 12156792910) was added
along with primary antibodies. Samples were washed for 30 min
in PBS and incubated in secondary antibodies overnight at 4uC.
After a PBS wash, 1 mg/ml DAPI (Sigma) in PBS was added for
20 min. Finally the samples were washed in PBS and mounted on
slides.
Morphometric quantification
Immunostained samples were examined on a confocal laser
scanning microscope (TCS SP5, Leica Microsystems, Wetzlar,
Germany). Serial 5-mm optical sections of each kidney were
acquired. FITC, TRITC and DAPI emissions were acquired
sequentially. Ureteric bud tips and nephrons were counted
manually. Area was defined manually and measured using NIH
ImageJ 1.37v (http://rsb.info.nih.gov/nih-image/).
Measurement of cytokines
Right and left kidneys of the same embryo were dissected and
allocated randomly to either conventional culture or the new
method. Supernatants conditioned from 0–2 d 2–4 d were
collected and diluted in fresh medium to a standard total of
3 ml. Expression of 40 cytokines was assessed using R&D systems’
mouse cytokine array panel according to the manufacturer’s
directions. Experiments were performed in triplicate.
Figure 2. Development of mouse kidney rudiments in conventional culture and on glass inside silicone rings. (A–C) show phase
contrast views of kidney rudiments grown for 4 days in silicone rings on glass in 85 ml, 120 ml and 200 ml respectively, while (D) shows a kidney grown
in the conventional system (on a filter on a Trowell grid: the ‘noise’ in the background is the filter). On glass, the lowest volume, 85 ml, shows the best
development, resulting in a larger kidney than the conventional system. (A9–D9) show kidneys grown in the same conditions as (A–D) but stained for
basement membrane marker laminin (red) and the ureteric bud marker calbindin-D28k (green). (E) shows a quantitative analysis of area, nephron and
bud tip numbers for each of these culture conditions. Error bars depict standard errors of the mean and are derived from at least 49 kidneys in total,
from six different runs of the experiment, each run using between 6 and 18 kidneys. Scale bars = 500 mm.
doi:10.1371/journal.pone.0010550.g002
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Surface tension measurements
DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine; Sigma P6354)
was added to and dispersed at 1 mg/ml in KCM by 30 min. of
sonication on ice. Surface tension was determined using the pendant
drop-method based on the Young-Laplace equation [27]. After
calibrating the system (Contact Angle System OCA 30, DataPhysics
Instruments, Germany) with degassed water, the surface tensions of
KCM and KCM with DOPC were measured.
Animals
The animals from which tissue samples were obtained, bred
and kept according to relevant UK Home Office guidance (http://
scienceandresearch.homeoffice.gov.uk/animal-research/legislation/
index.html) and the Animals (Scientific Procedures) Act, 1986,
available from the same website: they were killed by trained technical
staff according to a method listed in Schedule 1 of that Act. Ethical
approval for keeping the animals and obtaining these tissue samples
was approved by the University of Edinburgh’s local ethics approvals
process.
Results
Kidney rudiments develop well on glass if cultured in low
volumes of medium
We began this work with the aim of growing embryonic kidney
rudiments on glass coverslips that could be coated easily with
defined matrix components. To define a small culture area on the
glass, we used FlexiPERM silicone rings, each with the
approximate shape of a decapitated cone, the smallest end of
which defined a 1 cm2 (i.e. 5.6 mm radius) circle (Fig 1A). It was at
once clear that kidney rudiments did not grow well when supplied
with large volumes of media in this system. Smaller volumes, of 85,
90, 120 or 200 ml were therefore tried (volumes of 70 ml and less
were found to be insufficient to wet the whole circle permanently).
Development of the organ rudiments after four days in each
condition was quantified by measuring rudiment area, number of
ureteric bud tips (2 at the time of isolation) and number of
nephrons (0 at the time of isolation).
Control kidneys, cultured by the conventional Trowell method
(Fig 1B) developed normally, showing a calbindin-positive ureteric
bud that was well-branched (mean 23.4, s= 16, n = 49) and many
developing nephrons (mean 20.2, s= 16, n = 49), identifiable by
their shapes and by their laminin-rich basement membranes and
absence of calbindin staining (Fig 2D, D9). In 200 ml medium,
many times deeper than the height of the kidney, kidneys
remained rounded and developed poorly (Fig 2C, C9), showing
less than half the ureteric bud branches and nephrons of control
kidneys grown on conventional Trowell filters. This was expected
from previous reports (see Introduction). With lower volumes of
medium, however (Fig 2A, A9, B, B9), the extent of development
improved (Fig 2E). In the optimum volume - 85 ml - kidney
rudiments covered significantly more area (42%) than did filter-
grown controls and they produced 46% more ureteric bud tips and
81% more nephrons. The variability between kidneys was also
Figure 3. Normal segmentation of nephrons grown on filters
(A, C, E, G) and in low volumes on glass (B, D, F, H). (A, B) show
kidneys stained for calbindin, which stains the whole ureteric bud; (C, D)
show kidneys stained for Dolichos biflorus agglutinin (DBA), which
stains only the bud stalk–the ‘missing’ tips visible in A,B but not in C,D
are marked with yellow stars; (E, F) show kidneys stained for the WT1,
which is expressed strongly in crescents that consist of developing
podocytes: in these images, staining for Pax2, expressed in bud,
condensates and early nephrons, is used to reveal the general structure
of the rudiment and to place the developing podocytes in their
anatomical context: higher power views are shown in E9 and F9,
revealing the nuclear location of WT1. (G, H) show higher power views
of kidneys stained for the ureteric bud and distal tubule marker,
E-cadherin, and the proximal tubule marker megalin; the expression
of each of these markers is similar in both culture systems. Scale
bars = 50 mm; the scale bar shown in F applies to A–F, that shown in F9
to E9 and F9, and that shown in H applies to G and H.
doi:10.1371/journal.pone.0010550.g003
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reduced (standard deviations in measurements of area, branch
number and nephron number were all only about four fifths as
large, as a proportion of the means to which they applied, as they
were for filter-grown controls). Adding 500 ml of culture medium
to kidney rudiments that had already been cultured in 85 ml for 1
day of culture caused the kidneys to round up and to cease
developing well: they therefore require low volumes continuously,
and not just to promote initial settling on the glass.
The nephrons and ureteric bud branches of kidneys grown in
conventional organ culture showed patterns of gene expression
similar to those observed in vivo, as has been described before [28–
31]. The ureteric bud, for example, expressed calbindin D28K
(Fig 3A) and was divided into a stalk region that bound Dolichos
biflorus lectin and a tip region that did not (Fig 3C) [32;33] (Fig 3C).
The nephrons showed correctly-restricted expression of markers;
for example, the most proximal ends of the nephrons differentiated
into podocytes that expressed high levels of WT1 (Fig 3E: the weak
expression of WT1 in condensing mesenchyme is normal and
reflects an earlier role for that protein in nephron development
[21]), the proximal tubules expressed megalin and the distal
Figure 4. There is no significant difference after two days in rates of proliferation or cell death in nephrons formed in the two
culture systems. Proliferation was measured using BrdU incorporation and apoptosis by terminal end labelling (TUNEL); source images typical of
those analysed quantitatively are shown for BrdU (A glass; C filter) and TUNEL (B glass; D filter). Over many such images, the numbers of BrdU or
TUNEL-positive nuclei per unit area of visible nephron cross-section were counted. The data, from ten filter-grown kidneys and thirty one glass-grown
ones, (E) show no evidence for difference between culture systems (a two-tailed Student’s t-test yields p = 0.93 and p = 0.94 for BrdU and TUNEL
respectively). Scale bar is 100 mm.
doi:10.1371/journal.pone.0010550.g004
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tubules and ureteric bud expressed E-cadherin (Fig 3G). Nephrons
and ureteric buds of kidneys grown using our low volume culture
system showed the same organotypic expression of segment
marker genes. Ureteric buds were divided correctly into tip and
stalk zones (Fig 3B, D), developing podocytes expressed WT1
(Fig 3F), proximal tubules expressed megalin and distal tubule
expressed E-cadherin (Fig 3H). Rates of cell proliferation and
apoptosis in nephrons, measured by BrdU incorporation and
Terminal deoxynucleotidyl transferase dUTP nick end labelling
(TUNEL) respectively, were not significantly different in the two
culture systems after two days (Fig 4).
Kidney rudiments grown in the low volume system show
typical responses to positive and negative morphogens
Conventional kidney organ culture has been used to identify
various diffusible regulators of renal development, by applying
suspected regulators to the medium and observing any changes to
subsequent morphogenesis. We have tested kidneys growing in the
low volume system for their response to two known modulators of
morphogenesis, one positive and one negative. This had two
purposes; (a) to verify the normality of development and (b) to
check that the culture volume used is not so small that these
regulators become quickly exhausted or inactivated by cellular
secretions. The factors we used were TGF-b, a known inhibitor of
ureteric bud branching [34] and GDNF, a known activator [35].
Exogenous TGF-b, applied at 1 nM for four days [36], had
similar effects on the development of kidneys in conventional and
low volume culture, although the inhibitory effects were a little less
dramatic in the low volume method (Fig 5). Exogenous GDNF,
added at a final concentration of 100 ng/ml again for four days
[36] significantly increased branching morphogenesis in both
systems so that more than a doubling of the amount of nephrons
and ureteric bud branches was achieved.
Kidney rudiments develop cortico-medullary zonation
when cultured in this system
Kidney rudiments developing in conventional organ culture
show excellent recapitulation of in vivo development at a fine scale
but one important large-scale aspect of development is typically
lost, or at least seriously under-developed. In vivo, growth and
extension of stalks of the ureteric bud and the Loops of Henle
divides the kidney into two broad zones, an outer cortex
containing the glomeruli and ureteric bud tips, and an inner
medulla that is dominated by straight tubules of the collecting duct
Figure 5. Kidneys grown in the low volume glass system show normal responses to known morphogens. (A, B) show the enhanced
development of kidneys grown in 100 ng/ml GDNF in the low volume glass system and on conventional filters, stained for laminin (red) and
calbindin-D29k (green). (C, D) show kidneys grown in control medium and (E, F) show the decreased development of kidneys cultured in the presence
of 1 nM TGFb. (G) shows the effects of these molecules on ureteric bud (UB) branching, in the low volume and the filter systems and (H) shows their
effects on nephron number. Each bar represents data from between 10 and 71 kidneys. All values in (G) and (H) differ significantly from their
respective controls, by a two-tailed Student’s t-test assuming unequal variances, the weakest difference (that between nephrons in control and TGFb,
on glass) still having a p-value of 0.009. Scale bar 500 mm.
doi:10.1371/journal.pone.0010550.g005
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system and the loops of Henle. This organization is critical to
the urine-concentrating activity of the metanephros, so lack of a
good culture model to allow the development of cortico-
medullary differences to be studied is a serious limitation to the
field.
Long-term (10-day) culture in our low volume system resulted in
a substantial increase in area of the organ rudiment and the
formation of distinct cortical and medullary zones (Fig 6A). The
forming glomeruli were restricted to the cortical zone and the
medullary zone contained ureteric bud/collecting duct tubules
and also loops of Henle (Fig 6B). The new culture system
therefore has the substantial advantage, beyond economy
with reagents, that it shows more anatomically realistic renal
development.
Kidney rudiments cultured in the low volume system
show less evidence for stress than those grown in
conventional organ culture
Tissues subject to stress secrete specific cytokines that interact
with cells of the immune system to initiate an inflammatory
response [37]. These cytokines include tissue inhibitor of
metalloproteinase I (TIMP1), monocyte chemotactic protein 1
(MCP1, also called JE), the neutrophil chemokine CXCL1 (also
called KC) and interferon gamma (IFNc) [38–41]. Release of these
proteins into medium can therefore be used as an indicator for
how stressed cells are in culture [42–46].
Medium from kidneys cultured conventionally in 3 mls of
medium contained significant amounts of TIMP1 and MCP1 and
smaller but still detectable amounts of CXCL1 (not shown) and
IFNc (Fig 7). Medium from the low volume glass culture system
showed lower amounts of TIMP1 and less or equal of the other
pro-inflammatory cytokines, measured over either first 48 h or the
subsequent 48 h of culture (Fig 7), though the effects were stronger
by the second 48 h. These results suggest that the cells in this
system were significantly less stressed than those in conventional
culture.
Kidney rudiments may grow better in low culture
volumes because of a requirement for effects of surface
tension
Something that the conventional high-volume filter method of
culture has in common with the low-volume method, but not with
the much less effective high-volume methods (including our use of
120 and 200 ml instead of 85 ml the silicone rings), is that the organ
rudiment is at the gas-medium interface. There are two reasons
that this might be important. One is improved access to oxygen,
although this seems unlikely since kidneys grow very well in
conventional culture in low (3%) oxygen systems [47]. The other is
the effect of the surface itself. Molecules of liquid are mutually
attractive. Those in the bulk liquid are surrounded by other
molecules on all sides so therefore experience no directional force.
Those at a gas-liquid interface surface still have other attractive
molecules to the side of them and below them but not above them,
so they experience a net average force pulling them back into the
bulk liquid. For this reason, surfaces are drawn in until balanced
by compressive forces in the bulk liquid, and liquids minimize their
free surface area. Actions that would expand the surface area of a
liquid work against this tendency to minimize surface are therefore
met with an opposing force, usually called surface tension. Where
the liquid over a culture substrate is shallow compared to the
height of the organ culture itself, the raised profile of the organ
forces the surface of the liquid to be larger than it would otherwise
Figure 6. Kidneys grown on glass develop organotypic features including cortico-medially zonation. (A) Shows a time course of
development to 240 h (10 d). From about 108 h (4.5 d), the kidney spreads out enough that it begins to divide into two zones, an outer medullary
zone that features many nephrons and an inner medulla that contains more elongated tubules (mainly collecting ducts at this stage). By 240 h (10 d),
this effect has become more marked. The last panel of (A) shows a kidney rudiment cultured on a filter for 240 h: the organ occupies less area and
there is less evidence of corticomedullary zonation. The ‘grain’ in the photograph is an optical effect of the filter pores, which are beneath the kidney;
their absence in bright field imaging is another advantage of the glass system. (B) A high-power view of part of a 240 h kidney shows that nephrons
(red) are arranged organotypically, with the glomerulus (‘Glom’) and proximal convoluted tubule (‘PCT’) in the cortex and a loop of Henle (‘LoH’)
extending down into the medulla, forming a tight hair-slide shape parallel to the collecting ducts (green). Green = calbindin, red = laminin.
doi:10.1371/journal.pone.0010550.g006
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be and the organ will experience a flattening force due to surface
tension.
It is therefore possible that the flattening effect of surface tension
is important to renal development in vitro. We tested this idea by
using a surfactant to reduce surface tension in the medium to see
if this mimicked the effect of a high volume of medium.
The surfactant used, 1,2-dioleoyl-sn-glycero-3-phosphocholine
(DOPC), reduces surface tension by forming phospholipid bilayers
(rather than the monolayers formed by typical lab detergents) at
the air-medium interface [48]. Direct measurements of surface
tension in untreated and DOPC treated medium confirmed the
surface tension-lowering effects of DOPC (Fig 8A).
The presence of DOPC had no significant effect on the (already
poor) development of kidneys under large volumes of medium, as
would be expected since these should be relatively free from
surface effects (Fig 8B, C). In the low-volume (85 ml) system,
though, the presence of DOPC significantly reduced the renal
Figure 7. Kidneys grown in the low-volume glass system show
less evidence of stress. In (A) the samples labelled ‘short’ are of
medium conditioned from day 0–2 and those labelled ‘long’ are from
days 2–4. Spots marked ‘C’ are positive controls (to verify the detection
kit). The other spots, of TIMP1, KC, JE and IFNc represent these markers
of cellular stress (see main text). (B) shows, quantitatively, the results of
these molecules on the arrays, as means of three runs. The Y axis is %
relative to the signal provided by the manufacturers’ positive control.
The right-most part of the graph, showing TIMP (also shown as a spot in
A), is plotted to a different y axis. Although the data for each of the
molecules, each individual array spot being derived from 3 pooled
kidneys and 3 independent arrays being run for each condition,
suggests a decrease on glass, the variation in measurement is so large
that no one individual molecule has a change that can be regarded as
significant at the conventional p#0.05 (most have p<0.1). As all
molecules are markers for the same physiological state (cellular stress),
however, their measurements can be pooled for a one-tailed, paired
Student’s t-test that uses all 15 experiment-control measurement pairs
together (the 15 pairs coming from 5 target molecules x 3 runs each).
Viewed this way, the data show that glass culture does produce a
significant reduction in production of these stress proteins (p = 0.05).
Elements on the spot arrays not shown in this graph showed no
significant differences.
doi:10.1371/journal.pone.0010550.g007
Figure 8. Reduction of surface tension influences development
of cultured kidney rudiments. In (A) the reduction of surface
tension by the addition of the surfactant DOPC to the medium is
demonstrated; data represent means of a minimum of 18 measure-
ments. (B and C) show the influence of the surfactant on ureteric bud
branching and amount of nephrons, respectively, if compared to the
control; each bar represents data from a minimum of 17 kidneys. The
asterisk indicates significant difference (p = 3.461026 for branches and
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area, the number of ureteric bud tips formed and the number of
nephrons formed. This is compatible with the hypothesis that
surface tension is important.
Discussion
In this report, we have described an improved technique for
organ culture of mouse metanephric organ rudiments that is very
economical of medium, shows quantitatively better development
and also shows cortico-medullary zonation absent in the
conventional method. It also uses a transparent substrate, useful
for live imaging, that can also be coated easily with experimental
custom substrates.
Conventional culture and the low-volume method described
here both have the kidney supported at the air-medium interface,
with only a thin film of medium covering it; larger volumes of
medium, even in exactly the same system, support development
significantly less well. There are two obvious a priori hypotheses for
the importance of the surface: access to oxygen, or the physical
compression effect of surface tension. Previous reports of normal
development of cultured kidneys in just 3–5% oxygen [47;49]
make the first of these unlikely. We have shown that lowering the
surface tension of the medium using a surfactant results in
quantitatively poorer development. This supports the surface
tension hypothesis but does not prove it, for the lipid bilayer
formed at the surface by the surfactant may also affect the diffusion
of gases. To formally prove the biophysical hypothesis that kidneys
do better if gently squashed, it would be necessary to vary physical
forces only with no effect on chemistry [50]. A possible, though
technically difficult, way to achieve this might be to culture kidney
rudiments on glass, under large volumes of medium, in a
centrifuge.
As well as producing quantitatively better development, the
culture system showed a quantitatively strongly reduced expression
of markers of cellular stress. As well as arguing for the superiority
of the new culture system, this finding highlights a potential but
rarely measured problem in organ culture systems; the cells
involved might actually be under considerable stress. Some of the
molecules they produce as a result of this (and that we measured),
such as IFN-c, will probably only be bioactive in the context of an
animal with an immune system but others, such as MMP9 (matrix
metalloproteinase-9) and its antagonist Timp-1 (tissue inhibitor of
metalloproteinase 1), are important in matrix turnover during
development [51] and may therefore lead to culture results not
reflecting those obtained in vivo. In the kidney itself, there are
instances of this: endogenously-produced HGF is needed for
collecting duct branching in culture, for example, but HGF2/2
mice have normal kidneys [52]. It may be that one explanation of
why in vivo and in vitro results do not always agree is a reflection
of cellular stress, with measureable induction of protein expression,
rather than the often-assumed explanation that the intact body
provides some diffusible factor from elsewhere, that can perform
the same function as the molecule under study and therefore
creates redundancy in vivo, but not in vitro.
In summary, we have presented a culture method that extends
the range of questions that can be addressed in culture to include
those connected to corticomedullary zonation and loop of Henle
formation, and have made culture conditions more economical of
medium supplements. As well as making developmental processes
more easily visible, this method has the potential to significantly
reduce animal use by allowing the control of these aspects of
kidney development to be studied in vitro, for example by using
siRNAs, rather than by extensive breeding of genetically-modified
mice.
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Supplementary Figure 1 – Testing the ability of CellTracker-stained MMs to 
integrate into host kidney rudiments 
A and B – verification of CellTracker staining of whole isolated metanephric 
mesenchymes, A (bright field) and B (CellTracker fluorescence showing complete 
staining of the MMs) 
C – Schematic illustration of the experimental setup for testing the ability of 
CellTracker-stained mesenchymes to integrate in host kidney rudiments. Either 
whole (undamaged) host kidney rudiments were used, or kidney rudiments in which 




























Supplementary Figure 2 - Immunohistochemistry of kidney rudiments combined with 
CellTracker-stained mesenchymes in a hanging droplet 
After being kept for 24h in a hanging droplet the samples were transferred to filter culture 
and kept for further 3 days before fixation with 4% PFA. Undamaged host kidney rudiments 
were used. 
Blue – Calbindin, red – Laminin, green – CellTracker-stained MMs 
A, B, C, D – four different samples showing some integration of CT-labelled MM cells. In E 
and F, sections along the Z-axis are shown at the right and bottom part of the images to 
demonstrate that although CT-labelled MM cells have invaded the host kidney rudiment, no 
nephrons are formed. E and F show the same sample. 
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Supplementary Figure 3 - Immunohistochemistry of kidney rudiments combined 
with CellTracker-stained mesenchymes after induction of mechanical damage 
 
After being kept for 24h in a hanging droplet the samples were transferred to a filter 
culture and kept for further 3 days before fixation with 4% PFA. 
Blue – Calbindin, red – Laminin, green – CellTracker-stained MMs 
A, C, E – stacks of confocal sections 
B, D, F – confocal sections showing the integration of grafted CellTracker-labelled 
MM cells. The grafted cells do not integration in nephrons and the efficiency of 











Supplementary Figure 4: Possible CellTracker artefacts in the disaggregation-reaggregation 
system 
The first row shows confocal micrographs of Q1 human amniotic fluid stem cells (AFSCs) 
stained with CellTracker Green, mixed with disaggregated E11.5 kidney rudiments, 
reaggregated and cultured for 8D. The images show a CellTracker+ nephron suggesting that 
AFSCs successfully formed a nephron in the reaggregate. At the same time, reports have 
shown that mouse and human nuclei can be distinguished on the basis of a nuclear stain 
Moser et al., 1975). Mouse nuclei are brighter and show many lighter speckles - 
chromocentres. In contrast, human nuclei are larger, fainter and lack chromocentres. These 
data have also been confirmed by a control experiment with mixing GFP-tagged human ESCs 
into reaggregates (second row in the figure). Human nuclei (red arrows) are distinguishable 
from mouse nuclei (white arrows) in a large number of the cases. Please, note that not all 
hESCs are GFP+ due to the mosaicism of the cell line, as previously reported in Chapter 4. 
Re-evaluating the AFSC integration by looking at the nuclei suggests that the cells in the 
nephron might be mouse cells, as they are small, bright and have chromocentres (white 
arrows). This might suggest that the CellTracker dye could be filtered through and 
accumulated by renal tubules thereby creating artefacts. 
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Supplementary Figure 5 - Structures formed by disaggregated and then reaggregated 
mesonephroi show different intensities of Calbindin staining 
Disaggregated and reaggregated mesonephroi show structure formation (A, B, C and 
D). A and B – reformed structures show a weak (arrows) or strong (arrowheads) 
Calbindin staining. C – both reformed mesonephric nephrons (arrow, Laminin+ 
Calbindin-) and WD fragments (arrowhead, Laminin+ Calbindin-) were observed. 
Expression of Cytokeratin and Pax2 was normal. 
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Supplementary Figure 6 - Pax2 and Pax8 expression at the onset of kidney 
development (modified from Bouchard et al., 2002) 
A – initiation of Pax gene expression in the pronephric anlage of Pax2+/- embryos. 
Pax8 expression was first detected by in situ hybridisation at the 7-somite stage in the 
intermediate mesoderm at the level of the 5th and 6th somites, corresponding to the 
pronephric anlagen (B). Pax2 was also detected in the pronephric anlagen at the 9–
somite stage (A). Initiation of Pax2 expression was reported to happen at the 8-somite 
stage (Bouchard et al., 2002, not shown)  
E - shows the expression of Pax8 in Pax2+/- and Pax2-/- embryos at the 9-somite stage 
F – shows Pax8 expression in the mesonephros of a 19-somite stage embryo 
(from Bouchard et al., 2002)  
DC 
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Supplementary Figure 7 – The ability of cells and tissues from different embryonic stages to 
integrate into renal epithelia and generate renal-like structures in organ culture 
The respective embryonic stage is shown on the left; the isolated region was shown by a red 
dotted line if necessary; block arrows indicate cells integrating in UBs or forming Calbindin+ UB-
like structures in the last column of images; open arrows indicate cells integrating in nephrons or 
the formation of nephron-like structures in the last column of images 
A, D, G and J show that tauGFP+ cells from E11.5 metanephroi were able to integrate into both 
nephrons and UBs, where at least some of the integrating UB cells were Calbindin+; B, E, H and 
K show integration experiments performed with CellTracker-stained cells; Integration in both 
nephrons and UBs can be seen in B and E; integration in UB only in H, and no integration in K; 
organ culture experiments in C, F, I and L show that the tissues isolated from different 
embryonic stages (as indicated in the diagrammatic panels on the left) for both UB-like and 
nephron-like structures; the ability of Calbindin + structures to branch disappeared in I and L. 
 
 
